
<html lang="en"     class="pb-page"  data-request-id="220c27f9-41cc-492b-9988-d11f845e1f3b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c02104;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat" /></meta><meta name="dc.Creator" content="Ruoxi  Li" /></meta><meta name="dc.Creator" content="Dazheng  Ling" /></meta><meta name="dc.Creator" content="Tongke  Tang" /></meta><meta name="dc.Creator" content="Zhenghui  Huang" /></meta><meta name="dc.Creator" content="Manjiong  Wang" /></meta><meta name="dc.Creator" content="Yan  Ding" /></meta><meta name="dc.Creator" content="Taiping  Liu" /></meta><meta name="dc.Creator" content="Hanwen  Wei" /></meta><meta name="dc.Creator" content="Wenyue  Xu" /></meta><meta name="dc.Creator" content="Fei  Mao" /></meta><meta name="dc.Creator" content="Jin  Zhu" /></meta><meta name="dc.Creator" content="Xiaokang  Li" /></meta><meta name="dc.Creator" content="Lubin  Jiang" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Description" content="Previously, we identified the clinical anticancer drug candidate quisinostat as a novel and potent antimalarial lead compound. To further enhance the antimalarial effect and improve safety, 31 nove..." /></meta><meta name="Description" content="Previously, we identified the clinical anticancer drug candidate quisinostat as a novel and potent antimalarial lead compound. To further enhance the antimalarial effect and improve safety, 31 nove..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02104" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02104" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02104" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02104" /></link>
        
    
    

<title>Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02104" /></meta><meta property="og:title" content="Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0015.jpeg" /></meta><meta property="og:description" content="Previously, we identified the clinical anticancer drug candidate quisinostat as a novel and potent antimalarial lead compound. To further enhance the antimalarial effect and improve safety, 31 novel spirocyclic hydroxamic acid derivatives were synthesized based on the structure of quisinostat, and their antimalarial activities and cytotoxicity were evaluated. Among them, compound 11 displayed broad potency in vitro against several multiresistant malarial parasites, especially two artemisinin-resistant clinical isolates. Moreover, 11 could eliminate both liver and erythrocytic parasites in vivo, kill all morphological erythrocytic parasites with specific potency against schizonts, and show acceptable metabolic stability and pharmacokinetic properties. Western blot analysis, PfHDAC gene knockdown, and enzymatic inhibition experiments collectively confirmed that PfHDAC1 was the target of 11. In summary, 11 is a structurally novel PfHDAC1 inhibitor with the potential to prevent and cure malaria, overcome multidrug resistance, and provide a prospective prototype for antimalarial drug research." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02104"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02104">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02104&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02104&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02104&amp;href=/doi/10.1021/acs.jmedchem.0c02104" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 2254-2271</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02019" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02145" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel <i>Plasmodium falciparum</i> HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ruoxi Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruoxi Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruoxi++Li">Ruoxi Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dazheng Ling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dazheng Ling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dazheng++Ling">Dazheng Ling</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tongke Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tongke Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</div><div class="loa-info-affiliations-info">School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tongke++Tang">Tongke Tang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenghui Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenghui Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenghui++Huang">Zhenghui Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manjiong Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manjiong Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manjiong++Wang">Manjiong Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathogenic Biology, Army Medical University, Chongqing 400038, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Ding">Yan Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Taiping Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Taiping Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathogenic Biology, Army Medical University, Chongqing 400038, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Taiping++Liu">Taiping Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanwen Wei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanwen Wei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanwen++Wei">Hanwen Wei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenyue Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenyue Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathogenic Biology, Army Medical University, Chongqing 400038, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenyue++Xu">Wenyue Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fei Mao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fei Mao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Mao">Fei Mao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5871-6878" title="Orcid link">http://orcid.org/0000-0001-5871-6878</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jin Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jin Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Zhu">Jin Zhu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3934-0312" title="Orcid link">http://orcid.org/0000-0003-3934-0312</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaokang Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaokang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#dea6b5b2b79ebbbdabadaaf0bbbaabf0bdb0"><span class="__cf_email__" data-cfemail="c3bba8afaa83a6a0b6b0b7eda6a7b6eda0ad">[email protected]</span></a>. Phone: +86-21-64252584.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaokang++Li">Xiaokang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lubin Jiang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lubin Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</div><div class="loa-info-affiliations-info">School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, P.R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#214d434b48404f46614851520f40420f424f"><span class="__cf_email__" data-cfemail="19757b737078777e5970696a37787a377a77">[email protected]</span></a>. Phone: +86-21-54923072.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lubin++Jiang">Lubin Jiang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jian Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</div><div class="loa-info-affiliations-info">College of Pharmacy and Chemistry, Dali University, 5 Xue Ren Road, Dali 671000, China</div><div class="loa-info-affiliations-info">Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#b5dfdcd4dbd9dcf5d0d6c0c6c19bd0d1c09bd6db"><span class="__cf_email__" data-cfemail="600a09010e0c092005031513144e0504154e030e">[email protected]</span></a>. Phone: +86-21-64252584. Fax: +86-21-64252584.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02104&amp;href=/doi/10.1021%2Facs.jmedchem.0c02104" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 2254–2271</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 December 2020</li><li><span class="item_label"><b>Published</b> online</span>4 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02104" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02104</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2254%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRuoxi%2BLi%252C%2BDazheng%2BLing%252C%2BTongke%2BTang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c02104%26title%3DDiscovery%2Bof%2BNovel%2BPlasmodium%2Bfalciparum%2BHDAC1%2BInhibitors%2Bwith%2BDual-Stage%2BAntimalarial%2BPotency%2Band%2BImproved%2BSafety%2BBased%2Bon%2Bthe%2BClinical%2BAnticancer%2BDrug%2BCandidate%2BQuisinostat%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2271%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02104"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1096</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02104" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ruoxi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Dazheng&quot;,&quot;last_name&quot;:&quot;Ling&quot;},{&quot;first_name&quot;:&quot;Tongke&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Zhenghui&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Manjiong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Taiping&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Hanwen&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Wenyue&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Xiaokang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Lubin&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2254-2271&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02104&quot;},&quot;abstract&quot;:&quot;Previously, we identified the clinical anticancer drug candidate quisinostat as a novel and potent antimalarial lead compound. To further enhance the antimalarial effect and improve safety, 31 novel spirocyclic hydroxamic acid derivatives were synthesized based on the structure of quisinostat, and their antimalarial activities and cytotoxicity were evaluated. Among them, compound 11 displayed broad potency in vitro against several multiresistant malarial parasites, especially two artemisinin-resistant clinical isolates. Moreover, 11 could eliminate both liver and erythrocytic parasites in vivo, kill all morphological erythrocytic parasites with specific potency against schizonts, and show acceptable metabolic stability and pharmacokinetic properties. Western blot analysis, PfHDAC gene knockdown, and enzymatic inhibition experiments collectively confirmed that PfHDAC1 was the target of 11. In summary, 11 is a structurally novel PfHDAC1 inhibitor with the potential to prevent and cure malaria, overcome multidru&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02104&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02104" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02104&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02104" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02104&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02104" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02104&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02104&amp;href=/doi/10.1021/acs.jmedchem.0c02104" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02104" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02104" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02104%26sid%3Dliteratum%253Aachs%26pmid%3D33541085%26genre%3Darticle%26aulast%3DLi%26date%3D2021%26atitle%3DDiscovery%2Bof%2BNovel%2BPlasmodium%2Bfalciparum%2BHDAC1%2BInhibitors%2Bwith%2BDual-Stage%2BAntimalarial%2BPotency%2Band%2BImproved%2BSafety%2BBased%2Bon%2Bthe%2BClinical%2BAnticancer%2BDrug%2BCandidate%2BQuisinostat%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D2254%26epage%3D2271%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously, we identified the clinical anticancer drug candidate quisinostat as a novel and potent antimalarial lead compound. To further enhance the antimalarial effect and improve safety, 31 novel spirocyclic hydroxamic acid derivatives were synthesized based on the structure of quisinostat, and their antimalarial activities and cytotoxicity were evaluated. Among them, compound <b>11</b> displayed broad potency <i>in vitro</i> against several multiresistant malarial parasites, especially two artemisinin-resistant clinical isolates. Moreover, <b>11</b> could eliminate both liver and erythrocytic parasites <i>in vivo</i>, kill all morphological erythrocytic parasites with specific potency against schizonts, and show acceptable metabolic stability and pharmacokinetic properties. Western blot analysis, <i>PfHDAC</i> gene knockdown, and enzymatic inhibition experiments collectively confirmed that <i>Pf</i>HDAC1 was the target of <b>11</b>. In summary, <b>11</b> is a structurally novel <i>Pf</i>HDAC1 inhibitor with the potential to prevent and cure malaria, overcome multidrug resistance, and provide a prospective prototype for antimalarial drug research.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">Originally published ASAP on February 4, 2021; Figure 3 revised February 9, 2021.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria is a mosquito-transmitted severe infectious disease caused by <i>Plasmodium</i> parasites. The World Health Organization (WHO) estimated that in 2018, malaria caused 228 million cases of disease and 405,000 deaths globally, most of which were induced by <i>Plasmodium falciparum</i> (<i>P. falciparum</i>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Since no vaccine is currently available, chemical therapies are still the primary methods for treating and preventing malaria. After the pioneering discovery of quinine, several antimalarial drugs have been developed and launched into the campaign against malaria worldwide.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently, five artemisinin-based combination therapies (ACTs) are the only WHO-recommended first-line drug therapies for malaria.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, malaria parasites have developed resistance against nearly all drugs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> ACT-resistant malaria parasites derived from Cambodia have recently compromised the efficacy of malaria treatment in the Greater Mekong subregion.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Although remedial measures can alleviate the resistance dilemma,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> the prospects for malaria treatment remain worrisome. Therefore, the development of novel antimalarial drugs is an urgent requirement for solving resistance problems and controlling malaria worldwide in the future.</div><div class="NLM_p">As a critical epigenetic modulator of gene expression, histone deacetylase (HDAC) has long been involved in the pathogenesis and therapeutic investigation of many other human diseases, and four anticancer HDAC inhibitors have been approved by the U.S. FDA thus far (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Currently, five <i>P. falciparum</i> HDACs (<i>Pf</i>HDACs) have been identified in parasites, including class I-type <i>pf</i>HDAC1 and class II-type <i>Pf</i>HDAC2/3, which contain Zn<sup>2+</sup> cations as a cofactor, and class III-type <i>Pf</i>Sir2A/2B, which contain NAD<sup>+</sup> cations as a cofactor.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> They can regulate the acetylation level of both malarial histone and nonhistone proteins and play critical roles in the survival and reproduction of parasites.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16">(8−16)</a> Therefore, the inhibition of <i>Pf</i>HDAC may provide a potential approach for malarial treatment.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Since the pioneering discovery of Apicidin in 1996,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> several groups have reported the multistage therapeutic potency of <i>Pf</i>HDAC inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, no <i>Pf</i>HDAC inhibitors have successfully reached clinical treatment or study despite more than two decades of research. Although several <i>Pf</i>HDAC inhibitors displayed antimalarial potency <i>in vitro</i>, only a few compounds have been tested for erythrocytic therapeutic effects <i>in vivo</i>,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17−22)</a> and currently, no <i>Pf</i>HDAC inhibitor has been investigated for liver-stage therapeutic effects <i>in vivo.</i> Since the inhibition of <i>Pf</i>Sir2A/2B resulted only in weak antimalarial activity, most researchers have focused on inhibition studies on Zn<sup>2+</sup>-containing <i>Pf</i>HDACs.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, because of the difficulties of obtaining recombinant <i>Pf</i>HDAC protein samples, in previous reports, most compounds have been tested only for pan-<i>Pf</i>HDAC inhibitory effects, and only a few compounds have been tested for inhibition against <i>Pf</i>HDAC1<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23−26)</a> since this was the only available isolated <i>Pf</i>HDAC protein. Overall, detailed exploration of therapeutic effects <i>in vivo</i>, target elucidation and the inhibition of different <i>Pf</i>HDAC subtypes are still unsolved problems in antimalarial HDAC inhibitor research.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of US FDA-approved anticancer HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In previous work, we identified the class I and II-type human HDAC inhibitor quisinostat (<b>1</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), an anticancer drug candidate entering phase II clinical trials, as a novel antimalarial compound with prominent <i>in vitro</i> activity identified by screening an epigenetic inhibitor library.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>1</b> could inhibit both wild-type and drug-resistant <i>P. falciparum</i> strains with IC<sub>50</sub> 5–7 nM albeit with relative less selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Nevertheless, we still considered <b>1</b> as a promising antimalarial lead compound with attractive development prospect.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Since our group has been devoted to research on the redevelopment of launched drugs or drug candidates,<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29−33)</a> in this paper, drug redevelopment research has been systematically conducted by treating <b>1</b> as a lead compound to further improve its antimalarial effect, reduce toxicity, and discover new chemical entities with new structure prototypes. Therefore, 31 novel hydroxamic acid derivatives (<b>2–32</b>) were designed and synthesized, and their antimalarial activities and cytotoxicity were systematically evaluated. Among them, compound <b>11</b> showed potency against several multiresistant malarial parasites <i>in vitro</i>, including two artemisinin-resistant clinical isolates, attenuated cytotoxicity, and both erythrocytic and liver-stage therapeutic effects <i>in vivo</i> with acceptable animal safety. Compound <b>11</b> displayed improved stability toward mouse liver microsomes, and the pharmacokinetic properties of <b>11</b> were also investigated. Western blot analysis showed that <b>11</b> could inhibit the function of <i>Pf</i>HDAC, and we further identified <i>Pf</i>HDAC1 as the target of <b>11</b> via <i>PfHDAC1/2</i> gene knockdown experiments. Hence, <b>11</b> was identified in our research as a prospective prototype for innovation in malaria treatment.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design of Novel Spirocyclic Hydroxamic Acid Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Antiplasmodium Activity and Cytotoxicity of Compounds <b>1</b> and <b>2</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0011.gif" alt="" id="gr10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Results are the mean ± SD obtained from two independent biological repeats, DHA = dihydroartemisinin, ND = not determined.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index for human cells is defined as IC<sub>50</sub> (human cell)/IC<sub>50</sub> (3D7).</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Design and Synthesis of Derivatives</h3><div class="NLM_p">Similar to other HDAC inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><b>1</b> consists of three components as follows: a hydroxamic acid group serving as a zinc-binding group (ZBG) that chelates the Zn<sup>2+</sup> cofactor in the catalytic pocket, an <i>N</i>-methylindole fragment (CAP region) that recognizes and interacts with the amino acid residues at the entrance of the catalytic pocket, and a pyrimidinyl 4-aminomethyl piperidine fragment (linker) that connects the ZBG and CAP groups. Since hydroxamic acid and indole are critical pharmacophores and pyrimidinyl can improve hydrophilicity and synthetic feasibility, these structural domains were reserved in the preliminary stage of the structure design. Since the flexible aliphatic diamine linkers have been widely applied into HDAC inhibitiors,<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38">(34−38)</a> a strategy of introducing the rigid spirocyclic linker was envisaged by us.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39−42)</a> This strategy not only brought novel antimalarial chemical prototype but may also influence the biological properties of new compounds and reduce the cytotoxicity. On the other hand, replacement of the CAP group could also adjust the antimalarial potencies and safety of the newly designed derivatives (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> depicts the synthesis of spirocyclic derivatives <b>2–32</b>. This procedure was modified from the reported synthetic route of <b>1</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Briefly, <i>tert-</i>butyl 2,8-diazaspiro[4.5]decane-2-carboxylate (<b>33</b>) coupled with ethyl 2-chloropyrimidine-5-carboxylate under alkaline condition to produce <b>34</b>. Then, the <i>tert</i>-butoxycarbonyl (Boc) protecting group in <b>34</b> was removed in hydrogen chloride solution, and the resultant <b>35</b> was converted into <b>36</b> via benzyloxycarbonyl (Cbz) protection of the free amine group. Hydrolysis of ethyl ester produced acid <b>37</b>, which was converted into <b>38</b> via condensation with <i>O-</i>(tetrahydro<i>-</i>2<i>H</i>-pyran-2-yl)hydroxylamine. Hydrogenolysis of the Cbz group produced <b>39</b>, and compounds <b>2–32</b> were finally obtained by reductive amination and deprotection of the 2-tetrahydropyranyl (THP) group in hydrogen chloride.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2–32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl 2-chloropyrimidine-5-carboxylate, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (b) HCl/1,4-dioxane (4 M), CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (c) PhCH<sub>2</sub>OC(O)Cl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (d) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, H<sub>2</sub>O, 65 °C; (e) THPONH<sub>2</sub>, EDCI, HOBt, Et<sub>3</sub>N, Me<sub>2</sub>NCHO, 25 °C; (f) Et<sub>3</sub>SiH, Pd/C, CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub> (1:1 v/v), 25 °C; (g) R-CHO, NaBH<sub>3</sub>(CN), CH<sub>3</sub>OH, 25 °C; (h) HCl/1,4-dioxane (4 M), CH<sub>2</sub>Cl<sub>2</sub>, 25 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Antiplasmodium Activity and Cytotoxicity of Compounds <b>1</b>–<b>32</b></h3><div class="NLM_p">To preliminarily estimate their antiplasmodium potency, all derivatives were assayed for inhibitory activities against two <i>P. falciparum</i> parasites (3D7 and Dd2). The cytotoxicity of each derivative was also investigated in two human cell lines (HepG2 and 293T). For each compound, the potency against wild-type parasites (3D7) and chloroquine-resistant parasites (Dd2) was similar, signifying that cross resistance was absent. Encouragingly, <b>2</b> displayed slightly improved antiplasmodium activities and significantly attenuated cytotoxicity compared with <b>1</b>, implying that linker modification was tolerant and could reduce cytotoxicity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Subsequently, the <i>N</i>-methyl-3-indolyl group in the CAP region was replaced by other ring systems (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Notably, all derivatives displayed potent antiplasmodium activities (< 50 nM) regardless of different CAP groups. Considering the relative disadvantages of monocyclic and excessively large CAP groups, we systematically investigated various aromatic bicyclic CAP groups. To our delight, two naphthyl derivatives <b>20</b> and <b>26</b> displayed similar potency and selectivity compared to <b>2</b>. Further screening of indolyl-shaped CAP groups revealed that several indolyl (<b>11</b>) and azaindolyl (<b>16</b>–<b>19</b>) groups could improve selectivity while scarcely weaken the potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Antiplasmodium Activity and Cytotoxicity of Compounds <b>2–32</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0013.gif" alt="" id="gr12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0014.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Results are the mean ± SD obtained from two independent biological repeats, DHA = dihydroartemisinin, ND = not determined.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index for human cells is defined as IC<sub>50</sub> (human cell)/IC<sub>50</sub> (3D7).</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SAR of Compounds <b>1</b>–<b>32</b></h3><div class="NLM_p last">Preliminary data of bioassay <i>in vitro</i> revealed some noteworthy structure–activity relationship (SAR) characteristics compounds <b>1–32</b> as follows: (1) the conformation and flexibility of linker can be regulated subtly, and the fixation strategy via spirocycle formation can be tolerated (<b>2</b><i>vs</i><b>1</b>); (2) modification of the substituents in the CAP region can regulate the antiplasmodium activity and cytotoxicity; (3) monocyclic (<b>3–10</b>), tricyclic, and tetracyclic (<b>29–32</b>) CAP groups are not beneficial for antiplasmodium activity; (4) when the CAP region is a naphthyl, quinolyl or isoquinolyl group, 2-naphthyl, and its nitrogen-containing ring analogues are slightly more potent than 1-naphthyl and corresponding nitrogen-containing ring analogues in antiplasmodium activity, but all are weaker than <b>2</b> (<b>20–28</b>); (5) when the CAP region is an indolyl-shaped group, replacing the nitrogen atom by oxygen or sulfur atoms can undermine antiplasmodium potency, and the simple removal of <i>N</i>-methyl in the indolyl can alleviate the acute cytotoxicity (<b>2</b><i>vs</i><b>11–13</b>); (6) generally, when the CAP region is one of various electron-deficient aromatic rings, the cytotoxicity of the compounds is attenuated; however, their antiplasmodium activity can be compromised, and only azaindolyl derivatives <b>16–19</b> have similar potency to <b>1</b>. Based on these results, <b>2</b>, indolyl derivative <b>11</b> and azaindolyl derivatives <b>16–19</b> were selected for further investigation of whether our modifications were reasonable.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vitro</i> Antiplasmodium Activity of Compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b> against Clinical Multidrug-Resistant Parasites</h3><div class="NLM_p">To further investigate the ability to adapt these new derivatives for application, we evaluated the antiplasmodium activity of compounds <b>1</b>, <b>2</b>, <b>11,</b> and <b>16–19</b> against five clinical <i>P. falciparum</i> isolates carrying various phenotypes of resistance against mainstream antimalarial drugs (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), including two artemisinin-resistant parasites (6218 and 6320).<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> In this 72 h assay, for each compound, the differences in IC<sub>50</sub> values between multidrug-resistant parasites and 3D7 parasites (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were not significant, which implied the absence of cross resistance between the tested compounds and clinical antimalarial drugs. Remarkably, all compounds displayed low nanoscale IC<sub>50</sub> values similar to DHA. Therefore, compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16–19</b> have the potential to resolve the problem of antimalarial drug resistance.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Antiplasmodium Activity of Compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16–19</b> against Five Clinical Multidrug-Resistant Parasites</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char="±">erythrocytic IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char="±">GB4</th><th class="colsep0 rowsep0" align="center" char="±">C2A</th><th class="colsep0 rowsep0" align="center" char="±">CP286</th><th class="colsep0 rowsep0" align="center" char="±">6218</th><th class="colsep0 rowsep0" align="center" char="±">6320</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.53 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">2.04 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">1.62 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">4.87 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.26 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">6.18 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">6.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">9.5 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">11.7 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">11.1 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">8.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">4.04 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DHA</b></td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Results are the mean ± SD obtained from two independent biological repeats, DHA = dihydroartemisinin.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>In Vitro</i> Metabolic Stability of Compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b></h3><div class="NLM_p">Before the therapeutic assay <i>in vivo</i>, we preliminarily compared the metabolic stability of compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16–19</b>. The metabolic stability was tested via a mouse liver microsome assay <i>in vitro</i> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). While the stability of <b>2</b> was similar to that of <b>1</b>, the half-life of <b>11</b> was 4 times longer than that of <b>1</b>. Remarkably, the half-life of azaindolyl derivatives <b>16–19</b> was even longer, which might result from the resistance of electron-deficient azaindolyl toward metabolic enzymes.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vitro</i> Metabolic Stability of Compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16–19</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">13.31</td><td class="colsep0 rowsep0" align="char" char=".">410.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">12.87</td><td class="colsep0 rowsep0" align="char" char=".">424.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">44.98</td><td class="colsep0 rowsep0" align="char" char=".">121.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">165.00</td><td class="colsep0 rowsep0" align="char" char=".">33.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">183.78</td><td class="colsep0 rowsep0" align="char" char=".">29.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">125.40</td><td class="colsep0 rowsep0" align="char" char=".">43.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">135.01</td><td class="colsep0 rowsep0" align="char" char=".">40.42</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vivo</i> Erythrocytic Anti-Malarial Activity of Compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b></h3><div class="NLM_p">Blood-stage antimalarial activity <i>in vivo</i> was tested via a <i>P. yoelli</i>-balb/c malaria model. Parasites were injected intraperitoneally into each mouse 24 h before treatment. Compounds were delivered once a day intraperitoneally for 5 consecutive days. Piperaquine phosphate (PPQ) was selected as a positive control. In the first 20 day experiment, <b>11</b> and <b>17</b> were compared with <b>1</b> at doses of 10 and 30 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). One mouse died in each <b>1</b>-treated group (10 and 30 mg/kg dose groups) on day 6, and no deaths occurred in the <b>11</b>-treated and <b>17</b>-treated groups, indicating that the newly designed derivatives <b>11</b> and <b>17</b> showed better safety than the lead compound <b>1</b>. Although no parasitemia was observed on day 20 in the surviving mice, they all suffered from recrudescence after treatment. The intensity of recrudescence increased in the order <b>1</b> > <b>17</b> > <b>11</b>. Therefore, <b>11</b> was selected for further experiments.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>In vivo</i> erythrocytic antimalarial activity of compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b>. Blank indicates the non-drug-treated group. Each group contained five mice. Piperaquine phosphate (PPQ) was selected as a positive control. Mice were infected by 10<sup>5</sup><i>P. yoelli</i> in red blood cells (RBCs) with saline via intraperitoneal injection at day 0, and compound in vehicle or vehicle alone (blank) was delivered intraperitoneally once a day on days 1–5. Tail vein blood smears were collected on the indicated days, and the percentage of parasitemia was determined via microscopic examination of 5000 red bold cells and expressed as the mean ± SD. Percentage of parasitemia (A) and survival ratio (B) of compounds <b>1</b>, <b>11</b>, and <b>17</b> at doses of 10 and 30 mg/kg. Percentage of parasitemia (C) and the survival ratio (D) of compounds <b>1</b>, <b>2</b>, <b>11</b>, <b>16</b>, <b>18</b>, and <b>19</b> at a dose of 60 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Since recrudescence hinted at the need for a higher dosage, in the second experiment, the dose was increased to 60 mg/kg, and the period of observation was extended to 30 days to confirm the therapeutic effect (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). Comparison of the mouse survival ratios of <b>1</b> and <b>2</b> revealed that simply replacing the diamine group could reduce animal toxicity. Compounds <b>2</b> and <b>18</b> were not totally tolerated, as one mouse in each group died after treatment. Although <b>16</b> and <b>19</b> manifested less toxicity, they could not prevent severe recrudescence. Only <b>11</b> achieved a balance between curative effect and toxicity, as all the treated mice survived, and no parasitemia was observed on day 30. In summary, <b>11</b> was better than both <b>1</b> and other derivatives in the balance of <i>in vivo</i> therapeutic effects and safety properties and was selected for further study.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Vivo</i> Liver-Stage Antimalarial Activity of <b>1</b> and <b>11</b></h3><div class="NLM_p">Before invading RBCs, malarial parasites develop asymptomatically in hepatocytes.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The elimination of liver-stage parasites will prevent paroxysm and the other devastating consequences of malaria. Therefore, <b>1</b> and <b>11</b> were tested against rodent <i>P. berghei</i> ANKA parasites (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Each mouse was infected with 5000 sporozoites followed by the simultaneous intravenous administration of the test compound at a single dose of 30 mg/kg. KDU691<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> was used as a positive control. Bioluminescence assays showed that after parasite inoculation, the blank group developed distinct liver-stage infection in the first 48 h followed by the systemic spread of erythrocytic development. At a single dose of 30 mg/kg, <b>1</b> was still not tolerated (three mice died in 2 h after compound administration) and could not wholly eradicate liver-stage infection since minor systemic spread was observed in one surviving mouse. However, the <b>11</b>-treated groups showed neither disease development nor mouse death until 96 h after inoculation. Therefore, <b>11</b> could prevent liver-stage disease development with acceptable safety.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> liver-stage antimalarial activity of compounds <b>1</b> and <b>11</b>. Blank indicates the non-drug-treated group. Each group contained five mice. KDU-691 was selected as a positive control. Mice were intravenously administered vehicle alone (blank) or a single dose of the test compound in the vehicle at the indicated dose after inoculation with of 5000 sporozoites at day 0. Bioluminescence was detected on days 1–4 after inoculation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Erythrocytic Stage-Specific Parasite Inhibition by <b>1</b> and <b>11</b></h3><div class="NLM_p">Malarial parasites undergo complicated life stages and morphogenesis events during blood-stage development. To further investigate their erythrocytic parasite-killing properties, synchronized 3D7 parasites were treated with <b>1</b> or <b>11</b> at a 10 × IC<sub>50</sub> (3D7) concentration in three indicated 12 h periods corresponding to three stages of the parasite life cycle (ring, trophozoite, and schizont). After treatment, the residual compound was removed by washing three times with the fresh culture medium, and parasites were cultivated in the compound-free medium for further observation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). At 50 h, parasites treated with compounds <b>1</b> or <b>11</b> could not develop normally into a new ring stage on morphological analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Although the occurrence of parasitemia was similar in all treated groups at 50 h, after a further 96 h cultivation, the parasites treated with drugs in the schizont stage group showed the lowest parasitemia growth (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Therefore, although they could eliminate all-stage parasites, <b>1</b> and <b>11</b> displayed preferable antiplasmodium potency against schizonts, which might interdict schizont growth or reinvasion of late-stage erythrocytic parasites.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> erythrocytic stage-specific inhibition of compounds <b>1</b> and <b>11</b>. (A) Schematic diagram of the experimental design. Highly synchronized ring-stage 3D7 parasites were incubated with <b>1</b> or <b>11</b> at a concentration of 10 × IC<sub>50</sub> (3D7) for three consecutive periods of 12 h corresponding to the parasite erythrocytic life cycle. Then, the parasites were transferred into compound-free culture medium and was diluted to 1/40. Dimethyl sulfoxide (DMSO) was used as a negative control. At 50 ± 2 hpi, morphological analysis of the parasites was conducted by microscopy. At 50 ± 2 and 146 ± 2 hpi, parasitemia was counted by flow cytometry. hpi, hours post infection. (B) Morphological analysis of the parasites at 50 ± 2 hpi observed by Giemsa-staining smear. (C) Parasitemia from reinvasion analysis at 50 ± 2 hpi counted by flow cytometry. (D) Parasitemia from growth analysis at 146 ± 2 hpi. For (C) and (D), parasitemia is shown as the mean ± SEM of 100,000 RBCs from three independent biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> RSA Assay of Compounds <b>1</b> and <b>11</b> against Artemisinin-Resistant Parasites</h3><div class="NLM_p">Artemisinin-resistant parasites 6218 and 6320 mainly displayed drug resistance in the early ring stage, whereas it could not be directly detected during the 72 h assay (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Clinical ring-stage survival assays (RSAs) are the standard process to identify artemisinin drug resistance.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Therefore, we chose compounds <b>1</b> and <b>11</b> to evaluate their “real” antimalarial potency against artemisinin-resistant parasites via RSA. Encouragingly, while DHA failed to completely clear 6218 and 6320, both <b>1</b> and <b>11</b> greatly reduced the ring-stage parasite burden, attenuating the risk of incomplete treatment (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Ring-stage 3D7 parasites, used as a control, were efficiently eliminated by DHA, <b>1</b>, and <b>11</b>. These results collectively demonstrated the medical potential of <b>11</b> to overcome the threat of ART-resistant parasites.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vitro</i> RSA of DHA, <b>1</b>, and <b>11</b> against artemisinin-resistant Parasites. Highly synchronized ring-stage 6218 and 6320 parasites carrying the kelch 13 C508Y mutation were incubated with 700 nM concentrations of compound <b>1</b>, compound <b>11</b>, DHA, or DMSO (same volume, negative control) for 6 h and then washed three times with the fresh medium and further cultivated in the compound-free medium for 66 h. Blood smears were collected, and parasitemia was counted in at least 10,000 RBCs by microscopy. The percentage of parasite survival was defined as parasitemia (compound) / parasitemia (DMSO) × 100%</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Target Elucidation of Compounds <b>1</b> and <b>11</b></h3><div class="NLM_p">Since <b>1</b> was previously identified as a potent class I and II-type human HDAC inhibitor,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> we speculated that <b>1</b> and <b>11</b> might also inhibit the function of <i>Pf</i>HDACs. Encouragingly, western blot analysis clearly displayed the hyperacetylation of parasite histone after treatment with a 20 × IC<sub>50</sub> concentration of compound <b>1</b> or <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figure S4</a> in the Supporting Information), suggesting that <b>1</b> and <b>11</b> could interfere with the function of <i>Pf</i>HDACs.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hyperacetylation analysis of <i>P. falciparum</i> histone H3 by compounds <b>1</b> and <b>11</b>. DMSO was selected as the blank control, vorinostat (SAHA) as the positive control, and H3 as the loading control. Asynchronous 3D7 parasites were treated with DMSO or a 20 × IC<sub>50</sub> concentration of SAHA, <b>1</b>, or <b>11</b> for 4 h, and then parasite nuclear protein samples were harvested for the histone H3 acetylation level (H3-Ac) detection via the western blot assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Considering the homology between <i>Pf</i>HDAC1 and human HDACs,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> we were further interested in whether <i>Pf</i>HDAC1 was the target of <b>1</b> and <b>11</b>. To evaluate the inhibitory effect of compounds against <i>Pf</i>HDACs, a <i>glmS</i> ribozyme system was introduced at the 3′-terminus of the <i>PfHDAC1</i> gene to generate 3D7<sup>HDAC1-<i>glmS</i></sup> parasites.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> This ribozyme will autocleave the corresponding mRNA once exogenous 2-amino-2-deoxy-D-glucose (GlcN) is added, resulting in posttranscriptionally downregulated expression of <i>PfHDAC1</i>. As a control, an epitope TY1 that is unable to degrade mRNA was substituted for the <i>glmS</i> sequence, generating 3D7<sup>HDAC1-TY1</sup> parasites. Considering the relevance between <i>Pf</i>HDAC1 and other class II HDACs, <i>Pf</i>HDAC2 was also downregulated via this method (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figure S2A</a> in the Supporting Information). The genetic modifications were examined by PCR analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figure S2B-E</a> in the Supporting Information), and RT-qPCR analysis further confirmed that the mRNA of <i>PfHDAC1</i> or <i>PfHDAC2</i> genes was reduced in 3D7<sup>HDAC1-<i>glmS</i></sup> or 3D7<sup>HDAC2-<i>glmS</i></sup>, respectively, upon the exogenous introduction of GlcN, which was absent in TY1-tagged parasites (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,D). The down-regulation of <i>Pf</i>HDAC1 was further demonstrated by western blot examination (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figure S3</a> in the Supporting Information). Importantly, while the GlcN-induced gene downregulation of 3D7<sup>HDAC2-<i>glmS</i></sup> was unable to significantly alter the antimalarial IC<sub>50</sub> values of compounds <b>1</b> and <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E–G, <i>P</i> = 0.16 and 0.1189, respectively), the downregulation of 3D7<sup>HDAC1-<i>glmS</i></sup> induced hypersensitivity of the parasites toward <b>1</b> and <b>11</b> treatment (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,C,G, <i>P</i> < 0.001 and = 0.0014, respectively). These results indirectly demonstrated that <i>Pf</i>HDAC1 is an antimalarial molecular target of compounds <b>1</b> and <b>11</b>. Currently, among three Zn<sup>2+</sup>-containing <i>Pf</i>HDACs, only <i>Pf</i>HDAC1 has been produced as a recombinant protein. Although the purification and activity of protein samples have been doubted,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> we still performed the inhibitory study of <b>1</b> and <b>11</b> against recombinant <i>Pf</i>HDAC1. Fortunately, both two compounds significantly suppressed the function of <i>Pf</i>HDAC1 with low nanoscale IC<sub>50</sub> values (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>G). These results further justify that <b>1</b> and <b>11</b> were <i>Pf</i>HDAC1 inhibitors.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effect of compounds <b>1</b> and <b>11</b> against <i>Pf</i>HDAC1/2. (A, D) RT-qPCR verification of the gene expression of <i>PfHDCA1</i> (A) or <i>PfHDAC2</i> (D) in 3D7<sup>HDAC1-TY1</sup>/3D7<sup>HDAC1-<i>glmS</i></sup> (A) or 3D7<sup>HDAC2-TY1</sup>/3D7<sup>HDAC2-<i>glmS</i></sup> (D) parasites in the ring (R), trophozoite (T), and schizont (S) stages after cultivation with 2.5 mM glucosamine (GlcN). The expression values were normalized by the housekeeping gene <i>seryl-tRNA synthetase</i>. (B, E) Inhibition rate curves of compound <b>1</b> against transgenic 3D7 parasites from (A) and (D), respectively. (C, F) Inhibition rate curves of compound <b>11</b> against transgenic 3D7 parasites from (A) and (D), respectively. (C, F) Inhibition rate curves and IC<sub>50</sub> values of compound <b>11</b> against transgenic 3D7 parasites from (A) and (D), respectively. (G) IC<sub>50</sub> values of compounds <b>1</b> and <b>11</b> against four transgenic 3D7 parasites treated with GlcN or recombinant <i>Pf</i>HDAC1 protein. Data in (A)–(G) are the mean ± SEM obtained from three biological repeats except the inhibition against <i>Pf</i>HDAC1 are the mean ± SD obtained from two independent biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Inhibition of Compounds <b>1</b> and <b>11</b> against Human HDACs</h3><div class="NLM_p">In previous anticancer research, <b>1</b> significantly suppressed the functions of human HDACs.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Considering the structural similarity between <b>1</b> and <b>11</b>, in this section, we also compared the inhibitory effects of compounds <b>1</b> and <b>11</b> against six recombinant human HDACs (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). These HDACs contain class I (<i>h</i>HDAC1 ∼3 and 8), class II (<i>h</i>HDAC6) and class III (<i>h</i>Sirt2) HDACs. Similar to previous report, <b>1</b> significantly suppressed the enzymatic activities of all class I <i>h</i>HDACs with IC<sub>50</sub> values lower than 10 nM and inhibited <i>h</i>HDAC6 with slightly reduced potency. Unfortunately, <b>11</b> was merely improved in <i>h</i>HDAC inhibition compared to <b>1</b>. Hence, in the future modifications, we would focus on reducing this adverse inhibition of human HDACs. Although <b>11</b> was similar to <b>1</b> in inhibiting human HDACs, in the cell and animal experiments, the toxicity of compound <b>11</b> is significantly lower than that of compound <b>1</b>. These results might imply that the cause of compound <b>1</b>’s high toxicity is at least not only due to its inhibitory activity on human HDACs. In addition, both <b>1</b> and <b>11</b> did not interfere with <i>h</i>Sirt2 since the absence of the Zn<sup>2+</sup> cation in this enzyme.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Effect of Compounds <b>1</b> and <b>11</b> against Six Human HDACs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">inhibitory activity, IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">comp.</th><th class="colsep0 rowsep0" align="center"><i>h</i>HDAC1</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>HDAC2</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>HDAC3</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>HDAC8</th><th class="colsep0 rowsep0" align="center"><i>h</i>HDAC6</th><th class="colsep0 rowsep0" align="center" char="."><i>h</i>Sirt2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.46</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="char" char=".">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="center">0.58</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">>10,000</td></tr></tbody></table></div></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Mouse Pharmacokinetic Parameters of Compounds <b>1</b> and <b>11</b><i>In Vivo</i></h3><div class="NLM_p">As compound <b>11</b> showed potent therapeutic effects in a mouse model, we primarily compared its mouse pharmacokinetic (PK) properties <i>in vivo</i> with those of <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Female BALB/c mice were administered a single dose of the tested compound intravenously (2 mg/kg) intraperitoneally (5 mg/kg) or orally (10 mg/kg). After intravenous administration, <b>11</b> had a <i>C</i><sub>max</sub> of 260 ng/mL and a <i>T</i><sub>1/2</sub> of 0.72 h. Although the intraperitoneal half-life and AUC value of <b>11</b> were lower than <b>1</b>, the <i>C</i><sub>max</sub> of <b>11</b> was higher than <b>1</b>, which might account for the improved erythrocytic therapeutic effect of <b>11</b><i>in vivo</i>. However, for compound <b>11</b>, the oral <i>C</i><sub>max</sub> was significantly lower than intraperitoneal value, and the oral bioavailability was only 0.5%. These results justified the reasonability of intraperitoneal administration of <b>11</b> in animal experiments.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vivo</i> Mouse Pharmacokinetic Parameters of Compounds <b>1</b> and <b>11</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="."><b>11</b></th><th class="rowsep1 colsep0" align="center" char="."><b>1</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameters</th><th class="colsep0 rowsep0" align="center" char=".">i.v. (2 mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">i.p. (5 mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">p.o. (10 mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">i.p. (5 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.250</td><td class="colsep0 rowsep0" align="char" char=".">0.0830</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">107.6</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td><td class="colsep0 rowsep0" align="char" char=".">88.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">1.73</td><td class="colsep0 rowsep0" align="char" char=".">6.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>t</i></sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">117</td><td class="colsep0 rowsep0" align="char" char=".">81.9</td><td class="colsep0 rowsep0" align="char" char=".">2.94</td><td class="colsep0 rowsep0" align="char" char=".">157</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">119</td><td class="colsep0 rowsep0" align="char" char=".">95.1</td><td class="colsep0 rowsep0" align="char" char=".">5.98</td><td class="colsep0 rowsep0" align="char" char=".">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>Z</sub>/F (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">1672</td><td class="colsep0 rowsep0" align="char" char=".">27.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">V<sub>Z</sub>/F (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">60.4</td><td class="colsep0 rowsep0" align="char" char=".">4172</td><td class="colsep0 rowsep0" align="char" char=".">245</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>/%</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The crisis of multidrug resistance calls for the discovery of next-generation antimalarial drugs. In this study, structurally novel <i>Pf</i>HDAC inhibitors with enhanced antimalarial activity were discovered via chemical modification. Based on clinical anticancer candidate <b>1</b>, 31 completely new spirocyclic pyrimidinyl hydroxamic acid derivatives have been designed, synthesized, and tested for antimalarial potency and cytotoxicity, among which five derivatives, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b>, were found to inherit the nanoscale IC<sub>50</sub> values of <b>1</b> against drug-sensitive and chloroquine-resistant <i>P. falciparum</i> parasites, while their cytotoxicity was attenuated 3–10 times compared to that of <b>1</b>. A preliminary SAR study showed that the fixation of central diamine via spirocycle formation led to reduced cytotoxicity, and appropriate structural optimizations of the CAP group could further weaken cytotoxicity while preserving antimalarial potency.</div><div class="NLM_p last">Compounds <b>11</b> and <b>16</b>–<b>19</b> could also eliminate several multidrug-resistant <i>P. falciparum</i> clinical isolates, and they also had enhanced metabolic stability against mouse liver microsomes <i>in vitro</i> compared to <b>1</b>. However, only <b>11</b> effectively cured blood-stage parasites with sufficient safety margins <i>in vivo</i> at 60 mg/kg. Compound <b>11</b> could also prevent asymptomatic liver-stage infection from invading RBCs <i>in vivo</i>. Western blot analysis clearly showed that <b>11</b> eliminated parasites by inhibiting the function of <i>Pf</i>HDACs. <i>PfHDAC1/2</i> gene downregulation and <i>in vitro</i> inhibition of recombinant <i>Pf</i>HDAC1 experiments further confirmed <b>11</b> as a novel <i>Pf</i>HDAC1 inhibitor. Although <b>11</b> still significantly inhibited several human HDACs, considering that only a few <i>Pf</i>HDAC1 inhibitors have been reported thus far, <b>11</b> will not only be a new starting point for antimalarial drug development but also play a critical role in the chemobiological study of <i>Pf</i>HDAC1 regulation in the survival, reproduction, and virulence of malarial parasites. Further structural optimization of <b>11</b> is currently in progress in our laboratory.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemical Synthesis and Analytical Data</h3><div class="NLM_p last">Sample <b>1</b> was purchased from WuXi AppTec. Unless otherwise noted, reagents and solvents were purchased from commercial suppliers and were directly used without further purification. Reaction conditions were not optimized. Analytical thin-layer chromatography (TLC) was performed using an HSGF 254 (150–200 μm thickness; Yantai Huiyou Co., China), and spots were visualized with UV light, iodine, and potassium permanganate staining. Flash column chromatography was performed using an HSGF 254 (Yantai Huiyou Co., China). Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker AMX-400 NMR and Ascend 600 MHz NMR (IS as TMS). Chemical shifts were reported in parts per million (ppm, δ) downfield from tetramethylsilane. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). High-resolution mass spectra (HRMS) were obtained by electrospray ionization (ESI) using a Waters GCT Premie and Waters LCT. Melting point analysis of solid compounds was performed on a SGW X-4 microscopic melting point apparatus equipped with a JM 628 digital thermometer, and the melting point was not corrected. HPLC analysis of final compounds was performed on an Agilent 1100 with a quaternary pump and diode-array detector (DAD). The HPLC peak purity of final compounds was verified by UV spectra, and all compounds were confirmed to be ≥95% pure. All derivatives were identified with non-PAINS on the web at <a href="http://zinc15.docking.org/patterns/home/" class="extLink">http://zinc15.docking.org/patterns/home/</a> recommended by editors from the ACS (American Chemical Society).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of <i>tert</i>-Butyl 8-(5-(Ethoxycarbonyl)pyrimidine-2-yl)-2,8-diazaspiro[4.5]decane-2-carboxylate (<b>34</b>)</h3><div class="NLM_p last">Compound <b>33</b> (24 g, 100 mmol) and ethyl 2-chloropyrimidine-5-carboxylate (22.4 g, 120 mmol) were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) under nitrogen protection. The solution was cooled to 0–5 °C, and <i><sup>i</sup></i>Pr<sub>2</sub>NEt (25 mL, 151 mmol) was added in one portion. The mixture was then stirred at 25 °C until TLC (PE/EA = 3/1) implied the completion of the reaction (ca. 6 h). The mixture was washed with water (500 mL) and brine (500 mL), and the organic phase was evaporated <i>in vacuo</i> to dryness. The residue was purified by flash column chromatography (SiO<sub>2</sub>, PE/EA) to obtain compound <b>34</b> (33.7 g, 86% yield). mp 108–110 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 2H), 4.26 (q, <i>J</i> = 7.1 Hz, 2H), 3.93 (m, 2H), 3.81 (m, 2H), 3.31 (m, 2H), 3.15 (m, 2H), 1.77 (m, 2H), 1.52 (m, 4H), 1.40 (s, 9H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of Ethyl 2-(2,8-Diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxylate (<b>35</b>)</h3><div class="NLM_p last">Compound <b>34</b> (39 g, 100 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (500 mL), and HCl/1,4-dioxane solution (4 M, 100 mL, 400 mmol) was added gradually in one portion. The mixture was stirred at 25 °C for 6 h; during that time, a white solid precipitated from the solution. After TLC (PE/EA = 2/1) showed that the reaction was complete, the mixture was evaporated <i>in vacuo</i> to dryness. The resultant oily crude <b>35</b> product was directly used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 2H), 4.26 (q, <i>J</i> = 7.1 Hz, 2H), 3.90 (m, 2H), 3.78 (m, 2H), 3.24 (m, 2H), 3.10 (m, 2H), 1.77 (m, 2H), 1.52 (m, 4H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of Benzyl 8-(5-(Ethoxycarbonyl)pyrimidine-2-yl)-2,8-diazaspiro[4.5]decane-2-carboxylate (<b>36</b>)</h3><div class="NLM_p last">To above-obtained oily crude <b>36</b> (synthesized from 39 g of <b>34</b>) was added CH<sub>2</sub>Cl<sub>2</sub> (500 mL), and the mixture was stirred under nitrogen protection until the oil completely dissolved. The solution was cooled to 0–5 °C, and <i><sup>i</sup></i>Pr<sub>2</sub>NEt (41 mL, 250 mmol) was added in one portion. After the addition of benzyl chloroformate (17 mL, 120 mmol), the mixture was stirred at 25 °C for approximately 6 h. After TLC (PE/EA = 2/1) showed that the reaction was complete, the mixture was poured into saturated aqueous sodium bicarbonate solution. The mixture was shaken, and the organic phase was dried via anhydrous sodium sulfate and then evaporated <i>in vacuo</i> to dryness. The residue was purified by flash column chromatography (SiO<sub>2</sub>, PE/EA) to obtain compound <b>36</b> (37 g, 87% yield). mp 107–109 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 2H), 7.48–7.27 (m, 5H), 5.07 (s, 2H), 4.26 (q, <i>J</i> = 7.1 Hz, 2H), 4.01–3.75 (m, 4H), 3.41 (m, 2H), 3.26 (m, 2H), 1.80 (m, 2H), 1.54 (m, 4H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of 2-(2-((Benzyloxy)carbonyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxylic Acid (<b>37</b>)</h3><div class="NLM_p last">To a mixture of <b>36</b> (40 g, 94 mmol) and potassium carbonate (35 g, 253 mmol) were added 250 mL of distilled water and 250 mL of CH<sub>3</sub>OH. The mixture was heated to 65–70 °C and stirred for approximately 8 h until TLC (PE/EA = 2/1) showed that the reaction was complete. The mixture was evaporated <i>in vacuo</i> to dryness. The residue was then acidified to pH = ∼1 with 2 M HCl, causing solid precipitation. This solid was collected, washed with water to pH = ∼7, and dried at 70 °C for 12 h <i>in vacuo</i>. The resultant solid crude <b>37</b> product was directly used without further purification. mp 123–125 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75 (m, 2H), 7.43–7.25 (m, 5H), 5.07 (s, 2H), 4.03–3.73 (m, 4H), 3.41 (m, 2H), 3.26 (m, 2H), 1.80 (m, 2H), 1.54 (m, 4H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of Benzyl 8-(5-(((Tetrahydro-2<i>H</i>-pyran-2-yl)oxy)carbamoyl)pyrimidine-2-yl)-2,8-diazaspiro[4.5]decane-2-carboxylate (<b>38</b>)</h3><div class="NLM_p last">Solid crude <b>37</b> (synthesized from 40 g <b>36</b>) was dissolved in 235 mL of <i>N</i>,<i>N</i>-dimethylformamide and 235 mL of CH<sub>2</sub>Cl<sub>2</sub> under nitrogen protection, and HOBt (25.4 g, 188 mmol) and EDCI (36 g, 188 mmol) were added in turn. After the mixture was stirred for 30 min, THPONH<sub>2</sub> (33.5 g, 286 mmol), and Et<sub>3</sub>N (40 mL, 288 mmol) were added in turn. The mixture was further stirred for 48 h. After TLC (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH = 9/1) showed that the reaction was complete, the mixture was poured into saturated aqueous sodium bicarbonate solution. The organic phase was first washed with a large amount of water, shaken twice with brine (200 mL), and then dried with anhydrous sodium sulfate. The solvent was evaporated <i>in vacuo</i>, and the residue was purified by flash column chromatography (SiO<sub>2</sub>, PE/EA) to obtain compound <b>38</b> (38.5 g, 82% yield). mp 182–184 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.51 (s, 1H), 8.67 (s, 2H), 7.46–7.28 (m, 5H), 5.07 (s, 2H), 4.95 (m, 1H), 4.09–3.99 (m, 1H), 3.96–3.72 (m, 4H), 3.53 (m, 1H), 3.41 (m, 2H), 3.25 (m, 2H), 1.80 (m, 2H), 1.70 (m, 3H), 1.53 (m, 7H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Synthesis of 2-(2,8-Diazaspiro[4.5]decan-8-yl)-<i>N</i>-((tetrahydro-2<i>H</i>-pyran-2-yl)oxy)pyrimidine-5-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Compound <b>38</b> (0.5 g 1 mmol) was dissolved in 2.5 mL of CH<sub>2</sub>Cl<sub>2</sub> and 2.5 mL of CH<sub>3</sub>OH, and 10% Pd/C (0.21 g, wetted with ca. 55% water) and Et<sub>3</sub>SiH (0.8 mL, 5 mmol) were added under nitrogen protection. The mixture was stirred until TLC (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH = 9/1) showed that the reaction was complete. The mixture was filtered through Celite, and the solid residue was washed with a large amount of CH<sub>3</sub>OH. The solvent was evaporated to dryness in a rotary evaporator, and the residue was purified by column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH) to obtain compound <b>39</b>. mp 156–158 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (s, 2H), 4.95 (m, 1H), 4.02 (m, 1H), 3.82 (m, 4H), 3.50 (m, 1H), 3.20 (m, 2H), 2.98 (s, 2H), 1.80 (m, 2H), 1.69 (m, 3H), 1.54 (m, 7H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Synthesis of Compounds <b>2</b>–<b>32</b></h3><div class="NLM_p">To compound <b>39</b> (0.36 g, 1 mmol) was added CH<sub>3</sub>OH (10 mL), corresponding R-CHO (1.2 mmol), and NaBH<sub>3</sub>CN (0.31 g, 5 mmol), and the mixture stirred at 25 °C for 24 h. The reaction mixture was then poured into saturated aqueous sodium bicarbonate solution, and the aqueous phase was extracted three times with CH<sub>2</sub>Cl<sub>2</sub> (25 mL). The combined organic layers were washed once with brine (100 mL) and dried with anhydrous sodium sulfate, and the solvent was removed <i>in vacuo</i>. The residue was purified by flash column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH), and the product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) under a nitrogen atmosphere. HCl/1,4-dioxane (4 M, 2.4 equiv) was then added in one portion. After stirring at 25 °C for 30 min, the mixture was filtered, and the filtrate was washed with a large amount of CH<sub>2</sub>Cl<sub>2</sub> and dried <i>in vacuo</i> to obtain the compound.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-indol-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>2</b>)</h4><div class="NLM_p last">Compound <b>2</b> was synthesized according to the above general synthetic method. 148 mg (32% yield from <b>39</b>); mp 183–185 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.20 (s, 1H), 8.68 (s, 2H), 7.87 (d, <i>J</i> = 7.9 Hz, 1H), 7.67 (s, 1H), 7.48 (d, <i>J</i> = 8.2 Hz, 1H), 7.22 (t, <i>J</i> = 7.5 Hz, 1H), 7.14 (t, <i>J</i> = 7.4 Hz, 1H), 4.50 (m, 2H), 3.82 (s, 5H), 3.70 (m, 2H), 3.46 (m, 1H), 3.36 (m, 1H), 3.27 (m, 1H), 3.02 (m, 1H), 1.99 (m, 1H), 1.88 (m, 1H), 1.74–1.54 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.13, 160.42, 156.45, 135.75, 131.74, 126.86, 121.13, 119.06, 118.26, 113.72, 109.48, 102.50, 60.36, 50.54, 47.40, 40.40, 40.21, 39.89, 34.33, 34.23, 33.28, 32.10; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>29</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 421.2352, found 421.2353; purity: 100% (254 nm, RT = 5.079 min).</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(2-(Cyclopentylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was synthesized according to the above general synthetic method. 114 mg (29% yield from <b>39</b>); mp 146–148 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 8.69 (s, 2H), 3.83 (m, 4H), 3.61 (m, 1H), 3.53 (m, 1H), 3.13 (m, 3H), 2.91 (m, 1H), 2.21 (m, 1H), 1.96 (m, 2H), 1.84 (m, 2H), 1.76–1.44 (m, 8H), 1.36–1.18 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.86, 160.90, 159.05, 111.81, 61.51, 58.90, 52.25, 40.50, 40.44, 39.88, 35.53, 34.56, 34.39, 33.50, 30.19, 24.01, 23.97; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>19</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 360.2400, found 360.2401; purity: 99.8% (254 nm, RT = 5.117 min).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(2-(Cyclohexylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was synthesized according to the above general synthetic method. 109 mg (27% yield from <b>39</b>); mp 152–154 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 8.70 (s, 2H), 3.91–3.73 (m, 4H), 3.62 (m, 1H), 3.58–3.51 (m, 1H), 3.15 (m, 1H), 3.00 (m, 2H), 2.91 (m, 1H), 2.01–1.89 (m, 3H), 1.83 (m, 1H), 1.67 (m, 8H), 1.31–1.06 (m, 3H), 0.94 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.86, 160.92, 159.05, 111.81, 61.55, 60.40, 52.55, 40.46, 39.94, 34.60, 34.32, 33.49, 33.28, 29.91, 29.88, 24.91, 24.46, 24.40; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>20</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 374.2556, found 374.2558; purity: 99.6% (254 nm, RT = 5.168 min).</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(2-Benzyl-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was synthesized according to the above general synthetic method. 121 mg (30% yield from <b>39</b>); mp 150–152 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.50 (s, 1H), 8.68 (s, 2H), 7.67 (m, 2H), 7.53–7.40 (m, 3H), 4.36 (m, 2H), 3.90 (m, 2H), 3.78–3.64 (m, 2H), 3.48–3.43 (m, 1H), 3.25 (m, 2H), 2.97 (m, 1H), 2.03 (m, 1H), 1.92 (m, 1H), 1.66 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.41, 159.03, 156.45, 130.72, 130.11, 128.59, 128.09, 113.70, 60.99, 56.58, 51.30, 40.39, 40.22, 39.94, 34.37, 34.21, 33.17; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>20</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 368.2087, found 368.2086; purity: 100% (254 nm, RT = 5.122 min).</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-Hydroxy-2-(2-(pyridin-2-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was synthesized according to the above general synthetic method. 117 mg (29% yield from <b>39</b>); mp 180–182 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (s, 1H), 8.78–8.63 (m, 3H), 8.05 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 7.8 Hz, 1H), 7.58 (dd, <i>J</i> = 7.6, 5.1 Hz, 1H), 4.62 (s, 2H), 3.89 (m, 2H), 3.79–3.67 (m, 2H), 3.49 (s, 2H), 3.28 (s, 2H), 2.00 (m, 2H), 1.67 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO) δ 165.90, 161.86, 160.08, 150.18, 148.21, 140.11, 126.42, 125.42, 112.91, 62.60, 60.15, 57.40, 53.16, 41.50, 41.16, 35.28, 34.37, 31.73; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>19</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 369.2039, found 369.2040; purity: 99.2% (254 nm, RT = 5.093 min).</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-Hydroxy-2-(2-(pyridin-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was synthesized according to the above general synthetic method. 122 mg (30% yield from <b>39</b>); mp 181–183 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.22 (s, 1H), 9.22 (d, <i>J</i> = 1.9 Hz, 1H), 8.98 (dd, <i>J</i> = 5.7, 1.4 Hz, 1H), 8.90 (dt, <i>J</i> = 8.1, 1.7 Hz, 1H), 8.69 (s, 2H), 8.11 (dd, <i>J</i> = 8.1, 5.6 Hz, 1H), 4.77–4.53 (m, 2H), 3.79 (m, 4H), 3.57 (m, 1H), 3.45–3.27 (m, 2H), 3.09 (m, 1H), 2.06 (m, 1H), 1.92 (m, 1H), 1.68 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.90, 161.88, 160.09, 148.38, 144.34, 142.95, 131.31, 127.52, 112.90, 61.80, 60.15, 53.52, 52.72, 41.59, 41.39, 41.19, 34.62, 31.72; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>19</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 369.2039, found 369.2040; purity: 95% (254 nm, RT = 5.110 min).</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-Hydroxy-2-(2-(pyridin-4-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was synthesized according to the above general synthetic method. 111 mg (27% yield from <b>39</b>); mp 177–179 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.34 (s, 1H), 8.99 (d, <i>J</i> = 5.8 Hz, 2H), 8.68 (s, 2H), 8.33 (d, <i>J</i> = 5.8 Hz, 2H), 4.79–4.61 (m, 2H), 3.78 (m, 4H), 3.58 (m, 1H), 3.43–3.37 (m, 1H), 3.30 (m, 1H), 3.01 (m, 1H), 2.15–2.04 (m, 1H), 2.00–1.91 (m, 1H), 1.76–1.62 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.98, 159.87, 158.97, 156.40, 149.68, 141.34, 128.07, 61.04, 54.57, 52.12, 40.55, 40.39, 40.21, 34.33, 34.12, 33.60; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>19</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 369.2039, found 369.2040; purity: 100% (254 nm, RT = 5.116 min).</div></div><div id="sec4_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(2-(Furan-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was synthesized according to the above general synthetic method. 102 mg (26% yield from <b>39</b>); mp 176–178 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.63 (s, 1H), 8.69 (s, 2H), 7.88 (d, <i>J</i> = 1.4 Hz, 1H), 7.73 (t, <i>J</i> = 1.8 Hz, 1H), 6.85 (d, <i>J</i> = 1.9 Hz, 1H), 4.27–4.13 (m, 2H), 3.95–3.82 (m, 2H), 3.73 (m, 2H), 3.51–3.41 (m, 1H), 3.30 (m, 1H), 3.27–3.13 (m, 1H), 2.94 (m, 1H), 2.08–1.85 (m, 2H), 1.74–1.54 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO) δ 165.95, 161.99, 160.13, 144.50, 144.26, 116.23, 112.91, 112.26, 61.65, 51.94, 48.47, 41.55, 41.35, 41.10, 35.34, 35.17, 34.34; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>18</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>, [M + H]<sup>+</sup> 358.1879, found 358.1880; purity: 95.6% (254 nm, RT = 5.080 min).</div></div><div id="sec4_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-Hydroxy-2-(2-(thiophen-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was synthesized according to the above general synthetic method. 108 mg (26% yield from <b>39</b>); mp 173–175 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.56 (s, 1H), 8.68 (s, 2H), 7.81 (d, <i>J</i> = 3.0 Hz, 1H), 7.63 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.44 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 4.43–4.30 (m, 2H), 3.96–3.89 (m, 2H), 3.70 (m, 2H), 3.43 (m, 1H), 3.32–3.15 (m, 2H), 2.96 (m, 1H), 2.06–1.99 (m, 1H), 1.92 (m, 1H), 1.77–1.55 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.84, 160.86, 159.02, 131.27, 128.63, 127.46, 126.50, 111.82, 60.68, 51.03, 50.98, 40.48, 40.30, 40.00, 34.28, 34.15, 33.20; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>18</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub>S, [M + H]<sup>+</sup> 374.1651, found 374.1650; purity: 99.9% (254 nm, RT = 5.022 min).</div></div><div id="sec4_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(2-((1<i>H</i>-Indol-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was synthesized according to the above general synthetic method. 123 mg (28% yield from <b>39</b>); mp 176–178 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d<sub>6</sub></i>) δ 11.50 (d, <i>J</i> = 2.7 Hz, 1H), 11.06 (s, 1H), 8.67 (s, 2H), 7.83 (d, <i>J</i> = 7.8 Hz, 1H), 7.69 (d, <i>J</i> = 2.6 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (t, <i>J</i> = 7.4 Hz, 1H), 7.09 (t, <i>J</i> = 7.3 Hz, 1H), 4.50 (m, 2H), 3.93–3.81 (m, 2H), 3.68 (m, 2H), 3.49–3.40 (m, 1H), 3.35 (m, 1H), 3.30–3.19 (m, 1H), 3.02 (m, 1H), 1.99 (m, 1H), 1.87 (m, 1H), 1.72–1.52 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.28, 160.65, 156.51, 135.27, 127.72, 126.49, 120.99, 118.85, 117.96, 113.72, 111.21, 60.52, 50.58, 47.75, 40.25, 39.89, 39.41, 34.33, 33.34; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 407.2195, found 407.2196; purity: 97.3% (254 nm, RT = 5.023 min).</div></div><div id="sec4_8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(2-(Benzofuran-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was synthesized according to the above general synthetic method. 129 mg (29% yield from <b>39</b>); mp 183–185 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.38 (s, 1H), 8.78 (s, 1H), 8.67 (s, 2H), 8.31 (s, 1H), 8.00 (d, <i>J</i> = 7.5 Hz, 1H), 7.65 (d, <i>J</i> = 7.9 Hz, 1H), 7.38 (m, 2H), 4.56 (m, 2H), 3.93–3.84 (m, 2H), 3.80–3.65 (m, 3H), 3.55 (m, 1H), 3.37–3.29 (m, 1H), 3.09 (m, 1H), 2.04 (m, 1H), 1.91 (m, 1H), 1.73–1.65 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.94, 162.00, 160.13, 157.56, 155.08, 148.62, 127.87, 125.88, 123.83, 122.28, 111.86, 110.40, 62.16, 52.63, 49.97, 41.56, 41.34, 41.22, 35.30, 35.17, 34.43; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>, [M + H]<sup>+</sup> 408.2036, found 408.2035; purity: 98.9% (254 nm, RT = 5.087 min).</div></div><div id="sec4_8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2-(Benzo[<i>b</i>]thiophen-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was synthesized according to the above general synthetic method. 136 mg (30% yield from <b>39</b>); mp 180–182 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (s, 1H), 8.69 (s, 2H), 8.30 (s, 1H), 8.19 (d, <i>J</i> = 7.9 Hz, 1H), 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.47 (m, 2H), 4.69 (m, 2H), 3.94–3.84 (m, 2H), 3.80–3.65 (m, 2H), 3.52 (m, 1H), 3.47–3.40 (m, 1H), 3.36–3.27 (m, 1H), 3.08 (m, 1H), 2.06 (m, 1H), 1.93 (m, 1H), 1.77–1.58 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.95, 158.96, 156.37, 138.76, 137.42, 130.12, 125.60, 124.20, 123.92, 122.37, 121.76, 113.67, 111.83, 61.12, 51.45, 48.80, 40.55, 40.39, 39.95, 34.35, 34.24, 33.32; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>26</sub>N<sub>5</sub>O<sub>2</sub>S, [M + H]<sup>+</sup> 424.1807, found 424.1805; purity: 95.2% (254 nm, RT = 5.090 min).</div></div><div id="sec4_8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-indazol-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was synthesized according to the above general synthetic method. 139 mg (30% yield from <b>39</b>); mp 169–171 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.52 (s, 1H), 8.70 (s, 2H), 8.10 (d, <i>J</i> = 8.2 Hz, 1H), 7.71 (d, <i>J</i> = 8.5 Hz, 1H), 7.53–7.40 (m, 1H), 7.24 (t, <i>J</i> = 7.5 Hz, 1H), 4.75 (m, 2H), 4.10 (s, 3H), 3.88 (m, 2H), 3.69 (m, 2H), 3.63–3.55 (m, 1H), 3.47 (m, 1H), 3.42–3.33 (m, 1H), 3.14 (m, 1H), 2.01 (m, 1H), 1.90 (m, 1H), 1.75–1.51 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.02, 160.76, 158.99, 156.42, 139.84, 133.76, 126.00, 122.23, 120.47, 119.96, 109.40, 60.93, 51.34, 47.72, 40.48, 40.32, 39.99, 35.06, 34.21, 34.17, 33.27; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup>422.2304, found 422.2305; purity: 98% (254 nm, RT = 5.112 min).</div></div><div id="sec4_8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-Hydroxy-2-(2-(imidazo[1,2-<i>a</i>]pyridin-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was synthesized according to the above general synthetic method. 134 mg (30% yield from <b>39</b>); mp 197–199 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.21 (s, 1H), 9.44 (d, <i>J</i> = 6.9 Hz, 1H), 8.71 (s, 2H), 8.58 (s, 1H), 8.05 (d, <i>J</i> = 6.2 Hz, 1H), 7.60 (td, <i>J</i> = 6.5, 2.3 Hz, 1H), 5.12–4.96 (m, 2H), 3.93–3.74 (m, 4H), 3.66 (m, 1H), 3.58–3.52 (m, 1H), 3.45 (m, 1H), 3.22 (m, 1H), 2.07 (m, 1H), 1.92 (m, 1H), 1.71 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.83, 160.85, 159.03, 156.46, 139.26, 133.44, 128.13, 125.18, 117.30, 116.00, 111.52, 60.49, 51.29, 43.65, 40.50, 40.32, 40.02, 34.54, 34.32, 33.65; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>21</sub>H<sub>26</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 408.2148, found 408.2146; purity: 98.2% (254 nm, RT = 5.113 min).</div></div><div id="sec4_8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was synthesized according to the above general synthetic method. 122 mg (27% yield from <b>39</b>); mp 182–184 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (s, 1H), 8.69 (s, 2H), 8.59 (d, <i>J</i> = 7.9 Hz, 2H), 8.40 (d, <i>J</i> = 4.9 Hz, 3H), 7.93 (s, 1H), 7.34–7.27 (m, 1H), 4.56 (m, 2H), 3.92 (s, 3H), 3.86 (m, 2H), 3.81–3.65 (m, 2H), 3.53–3.44 (m, 1H), 3.35 (m, 1H), 3.27 (m, 1H), 3.03 (m, 1H), 2.01 (m, 1H), 1.96–1.82 (m, 1H), 1.77–1.54 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.12, 160.39, 159.03, 156.45, 144.52, 140.39, 132.82, 129.46, 120.25, 115.29, 113.72, 102.32, 60.39, 50.72, 47.10, 40.43, 40.23, 39.90, 34.40, 34.22, 33.35, 31.15; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup>422.2304, found 422.2305; purity: 100% (254 nm, RT = 5.052 min).</div></div><div id="sec4_8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> was synthesized according to the above general synthetic method. 125 mg (27% yield from <b>39</b>); mp 188–190 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 9.46 (s, 1H), 8.68 (s, 2H), 8.55 (m, 2H), 8.45 (d, <i>J</i> = 6.5 Hz, 1H), 4.78–4.60 (m, 2H), 4.10 (s, 3H), 3.92–3.66 (m, 4H), 3.54–3.46 (m, 1H), 3.34 (m, 2H), 3.06 (m, 1H), 2.04 (m, 1H), 1.97–1.84 (m, 1H), 1.65 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.16, 160.54, 156.48, 143.73, 135.91, 131.27, 127.73, 126.56, 115.85, 113.73, 105.56, 60.37, 50.82, 45.95, 40.39, 40.19, 39.95, 34.47, 34.27, 33.64, 33.45; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup>422.2304, found 422.2303; purity: 99.9% (254 nm, RT = 5.082 min).</div></div><div id="sec4_8_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridin-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was synthesized according to the above general synthetic method. 133 mg (29% yield from <b>39</b>); mp 184–186 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.87 (s, 1H), 9.77 (s, 1H), 8.70 (s, 2H), 8.55 (d, <i>J</i> = 6.7 Hz, 1H), 8.24 (s, 1H), 8.18 (d, <i>J</i> = 6.7 Hz, 1H), 4.74 (m, 2H), 4.02 (s, 3H), 3.93–3.67 (m, 4H), 3.52 (m, 1H), 3.43–3.30 (m, 2H), 3.12 (m, 1H), 2.06 (m, 1H), 1.92 (m, 1H), 1.69 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.63, 159.07, 156.50, 141.63, 138.12, 135.72, 130.21, 122.77, 113.76, 107.71, 107.05, 60.56, 51.05, 46.32, 40.38, 40.19, 39.98, 34.50, 34.24, 33.48, 33.07; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup>422.2304, found 422.2306; purity: 100% (254 nm, RT = 5.057 min).</div></div><div id="sec4_8_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-Hydroxy-2-(2-((1-methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-3-yl)methyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was synthesized according to the above general synthetic method. 116 mg (25% yield from <b>39</b>); mp 192–194 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.61 (s, 1H), 8.83 (d, <i>J</i> = 8.4 Hz, 1H), 8.76 (d, <i>J</i> = 5.7 Hz, 1H), 8.69 (s, 2H), 8.51 (s, 1H), 7.78 (dd, <i>J</i> = 8.3, 5.7 Hz, 1H), 4.90 (m, 2H), 4.06 (s, 3H), 3.90–3.69 (m, 4H), 3.56 (m, 1H), 3.50–3.36 (m, 2H), 3.24 (m, 1H), 2.14–2.01 (m, 1H), 1.89 (m, 1H), 1.79–1.61 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.19, 161.50, 157.54, 142.39, 135.43, 135.22, 133.34, 128.07, 117.39, 114.82, 100.45, 61.35, 55.42, 51.82, 47.07, 41.51, 41.32, 41.15, 35.45, 35.25, 34.65; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>7</sub>O<sub>2</sub>, [M + H]<sup>+</sup>422.2304, found 422.2306; purity: 100% (254 nm, RT = 5.060 min).</div></div><div id="sec4_8_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-Hydroxy-2-(2-(naphthalen-1-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>20</b>)</h4><div class="NLM_p last">Compound <b>20</b> was synthesized according to the above general synthetic method. 136 mg (30% yield from <b>39</b>); mp 178–180 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11 (s, 1H), 8.68 (s, 2H), 8.41 (d, <i>J</i> = 8.3 Hz, 1H), 8.12–7.94 (m, 3H), 7.63 (m, 3H), 5.03–4.82 (m, 2H), 3.89 (m, 2H), 3.76 (m, 1H), 3.67 (m, 1H), 3.44 (m, 3H), 3.15 (m, 1H), 2.07 (m, 1H), 1.91 (m, 1H), 1.69 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.82, 159.00, 156.43, 132.76, 130.92, 129.65, 129.31, 128.12, 126.73, 126.31, 125.63, 124.79, 123.34, 111.82, 61.58, 52.92, 51.83, 40.47, 40.35, 39.89, 34.52, 34.35, 33.32; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 418.2243, found 418.2244; purity: 99.4% (254 nm, RT = 5.107 min).</div></div><div id="sec4_8_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-Hydroxy-2-(2-(isoquinolin-4-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was synthesized according to the above general synthetic method. 124 mg (27% yield from <b>39</b>); mp 198–200 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.46 (s, 1H), 9.84 (s, 1H), 9.08 (s, 1H), 8.68 (m, 3H), 8.51 (d, <i>J</i> = 8.1 Hz, 1H), 8.21 (t, <i>J</i> = 7.7 Hz, 1H), 8.01 (t, <i>J</i> = 7.6 Hz, 1H), 5.05 (m, 2H), 3.84 (m, 3H), 3.70 (m, 1H), 3.61–3.49 (m, 2H), 3.45–3.37 (m, 1H), 3.29–3.14 (m, 1H), 2.08 (m, 1H), 1.97–1.83 (m, 1H), 1.80–1.60 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.81, 161.08, 156.45, 147.92, 136.46, 136.03, 134.52, 130.69, 130.00, 126.77, 125.82, 124.08, 113.69, 61.35, 52.06, 49.31, 40.48, 40.35, 39.95, 34.60, 34.44, 33.60; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2196; purity: 99.9% (254 nm, RT = 5.124 min).</div></div><div id="sec4_8_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-Hydroxy-2-(2-(quinolin-4-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was synthesized according to the above general synthetic method. 129 mg (28% yield from <b>39</b>); mp 205–207 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.18 (s, 1H), 9.35 (d, <i>J</i> = 5.4 Hz, 1H), 8.69 (m, 3H), 8.57 (d, <i>J</i> = 5.4 Hz, 1H), 8.46 (d, <i>J</i> = 8.5 Hz, 1H), 8.14 (t, <i>J</i> = 7.8 Hz, 1H), 7.99 (t, <i>J</i> = 7.8 Hz, 1H), 5.32–5.18 (m, 2H), 3.90–3.74 (m, 4H), 3.72–3.65 (m, 1H), 3.63–3.57 (m, 1H), 3.45 (m, 1H), 3.16 (m, 1H), 2.16–2.05 (m, 1H), 2.05–1.95 (m, 1H), 1.72 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.84, 159.04, 156.47, 145.31, 145.03, 139.26, 132.98, 128.90, 126.46, 124.84, 123.00, 122.54, 113.74, 61.65, 52.49, 51.87, 40.43, 40.32, 40.17, 34.50, 34.27, 33.62; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2196; purity: 100% (254 nm, RT = 5.102 min).</div></div><div id="sec4_8_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-Hydroxy-2-(2-(quinolin-5-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was synthesized according to the above general synthetic method. 130 mg (29% yield from <b>39</b>); mp 202–204 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 9.70 (d, <i>J</i> = 8.7 Hz, 1H), 9.35 (d, <i>J</i> = 5.1 Hz, 1H), 8.69 (s, 2H), 8.54 (d, <i>J</i> = 8.6 Hz, 1H), 8.38 (d, <i>J</i> = 7.2 Hz, 1H), 8.25–8.17 (m, 1H), 8.13 (dd, <i>J</i> = 8.7, 5.1 Hz, 1H), 5.09 (m, 2H), 3.92–3.77 (m, 3H), 3.70 (m, 1H), 3.52 (m, 1H), 3.46–3.39 (m, 2H), 3.18 (m, 1H), 2.08 (m, 1H), 1.93 (m, 1H), 1.81–1.63 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.90, 160.09, 157.53, 145.79, 143.73, 139.30, 134.00, 130.19, 128.14, 123.56, 122.57, 114.76, 112.90, 62.37, 60.16, 52.95, 41.52, 41.43, 40.96, 35.73, 35.52, 34.58; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2197; purity: 98.9% (254 nm, RT = 5.121 min).</div></div><div id="sec4_8_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-Hydroxy-2-(2-(isoquinolin-8-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was synthesized according to the above general synthetic method. 126 mg (28% yield from <b>39</b>); mp 196–198 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 10.41 (s, 1H), 8.75 (d, <i>J</i> = 6.4 Hz, 1H), 8.69 (m, 2H), 8.57 (d, <i>J</i> = 6.4 Hz, 1H), 8.42 (d, <i>J</i> = 8.4 Hz, 1H), 8.39 (d, <i>J</i> = 7.2 Hz, 1H), 8.29–8.20 (m, 1H), 5.15 (m, 2H), 3.96–3.76 (m, 3H), 3.70 (m, 1H), 3.57 (m, 1H), 3.51–3.39 (m, 2H), 3.22 (m, 1H), 2.09 (m, 1H), 1.92 (m, 1H), 1.72 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.83, 160.86, 159.02, 144.77, 138.20, 134.95, 134.24, 131.05, 130.74, 128.70, 125.54, 124.79, 111.81, 61.33, 59.09, 51.94, 40.44, 40.40, 39.92, 34.64, 33.50, 30.68; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2197; purity: 100% (254 nm, RT = 5.114 min).</div></div><div id="sec4_8_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-Hydroxy-2-(2-(quinolin-8-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was synthesized according to the above general synthetic method. 125 mg (27% yield from <b>39</b>); mp 201–203 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.46 (s, 1H), 8.69 (m, 2H), 8.53 (d, <i>J</i> = 8.5 Hz, 1H), 8.11 (d, <i>J</i> = 8.5 Hz, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.90–7.82 (m, 2H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 4.81 (m, 2H), 3.90 (m, 2H), 3.82–3.70 (m, 2H), 3.57 (m, 3H), 2.04 (m, 2H), 1.71 (m, 5H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.79, 160.95, 158.98, 156.40, 151.16, 144.82, 138.36, 130.47, 127.62, 126.88, 121.45, 113.69, 111.84, 61.72, 57.13, 52.32, 40.48, 40.16, 34.21, 34.16, 33.40, 30.68; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2196; purity: 100% (254 nm, RT = 5.100 min).</div></div><div id="sec4_8_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Hydroxy-2-(2-(naphthalen-2-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was synthesized according to the above general synthetic method. 133 mg (29% yield from <b>39</b>); mp 181–183 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.66 (s, 1H), 8.68 (s, 2H), 8.16 (s, 1H), 8.02–7.92 (m, 3H), 7.87 (d, <i>J</i> = 8.5 Hz, 1H), 7.63–7.53 (m, 2H), 4.54 (m, 2H), 3.90 (m, 2H), 3.70 (m, 2H), 3.48 (m, 1H), 3.32 (m, 2H), 3.05 (m, 1H), 2.06 (m, 1H), 1.94 (m, 1H), 1.67 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.83, 160.81, 159.00, 156.43, 132.35, 131.90, 129.73, 128.34, 127.71, 127.42, 127.16, 127.06, 126.32, 126.01, 111.81, 60.99, 56.73, 51.44, 40.47, 40.28, 39.99, 34.37, 34.19, 33.25; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>24</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 418.2243, found 418.2242; purity: 100% (254 nm, RT = 5.110 min).</div></div><div id="sec4_8_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-Hydroxy-2-(2-(quinolin-3-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was synthesized according to the above general synthetic method. 122 mg (27% yield from <b>39</b>); mp 199–201 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1H), 9.56 (d, <i>J</i> = 1.9 Hz, 1H), 9.32 (s, 1H), 8.68 (s, 2H), 8.41 (d, <i>J</i> = 8.6 Hz, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 8.15 (ddd, <i>J</i> = 8.4, 6.9, 1.4 Hz, 1H), 7.95 (t, <i>J</i> = 7.6 Hz, 1H), 4.85–4.68 (m, 2H), 3.88–3.71 (m, 4H), 3.65–3.57 (m, 1H), 3.49–3.39 (m, 2H), 3.16 (m, 1H), 2.08 (m, 1H), 1.93 (m, 1H), 1.70 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.83, 159.03, 156.45, 146.19, 138.58, 133.89, 129.04, 128.81, 127.09, 124.83, 121.53, 120.17, 113.71, 60.69, 52.96, 40.46, 40.25, 40.13, 34.45, 34.16, 33.62, 30.68; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2194; purity: 100% (254 nm, RT = 5.100 min).</div></div><div id="sec4_8_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-Hydroxy-2-(2-(quinolin-2-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was synthesized according to the above general synthetic method. 124 mg (27% yield from <b>39</b>); mp 203–205 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.07 (s, 1H), 9.07 (dd, <i>J</i> = 4.3, 1.7 Hz, 1H), 8.67 (s, 2H), 8.59 (d, <i>J</i> = 8.0 Hz, 1H), 8.25 (d, <i>J</i> = 7.1 Hz, 1H), 8.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.79–7.69 (m, 2H), 5.06 (m, 2H), 3.86 (m, 2H), 3.73 (m, 2H), 3.55–3.34 (m, 3H), 3.22 (m, 1H), 2.11–1.87 (m, 2H), 1.68 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d<sub>6</sub></i>) δ 165.85, 160.04, 157.45, 149.43, 142.98, 141.35, 135.60, 130.95, 128.96, 127.89, 127.24, 122.70, 112.90, 62.34, 52.87, 52.74, 41.56, 41.09, 35.41, 34.51; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 419.2195, found 419.2194; purity: 99% (254 nm, RT = 5.098 min).</div></div><div id="sec4_8_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(2-(Anthracen-9-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>29</b>)</h4><div class="NLM_p last">Compound <b>29</b> was synthesized according to the above general synthetic method. 117 mg (23% yield from <b>39</b>); mp 200–202 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 8.84 (s, 1H), 8.73–8.57 (m, 4H), 8.21 (d, <i>J</i> = 8.4 Hz, 2H), 7.73 (dd, <i>J</i> = 8.6, 6.8 Hz, 2H), 7.67–7.53 (m, 2H), 5.56 (m, 2H), 3.96–3.74 (m, 3H), 3.61 (m, 3H), 3.37 (m, 2H), 2.08 (m, 1H), 1.90–1.70 (m, 3H), 1.63 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.86, 160.02, 157.46, 135.02, 131.64, 131.36, 130.87, 129.65, 127.80, 127.19, 125.97, 125.06, 122.52, 112.91, 63.33, 53.41, 49.56, 41.65, 41.59, 40.79, 35.81, 35.63, 34.55; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>28</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 468.2400, found 468.2401; purity: 100% (254 nm, RT = 5.090 min).</div></div><div id="sec4_8_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-Hydroxy-2-(2-(phenanthren-9-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was synthesized according to the above general synthetic method. 113 mg (22% yield from <b>39</b>); mp 180–182 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.14 (s, 1H), 10.84 (s, 1H), 8.99–8.93 (m, 1H), 8.90 (d, <i>J</i> = 8.2 Hz, 1H), 8.67 (s, 2H), 8.50–8.42 (m, 1H), 8.29 (s, 1H), 8.01 (d, <i>J</i> = 7.6 Hz, 1H), 7.84–7.71 (m, 4H), 5.06–4.92 (m, 2H), 3.90 (m, 2H), 3.78 (m, 1H), 3.72–3.64 (m, 1H), 3.63–3.45 (m, 3H), 3.23 (m, 1H), 2.15–2.07 (m, 1H), 1.91 (m, 1H), 1.81–1.62 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.86, 159.04, 156.47, 130.80, 129.73, 129.64, 129.55, 129.19, 128.34, 127.40, 126.69, 126.59, 125.35, 124.19, 122.98, 122.33, 111.82, 61.90, 53.77, 52.14, 40.51, 40.39, 39.96, 34.58, 34.38, 33.39; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>28</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 468.2400, found 468.2401; purity: 100% (254 nm, RT = 5.082 min).</div></div><div id="sec4_8_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-Hydroxy-2-(2-(pyren-1-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)pyrimidine-5-carboxamide Hydrochloride (<b>31</b>)</h4><div class="NLM_p last">Compound <b>31</b> was synthesized according to the above general synthetic method. 106 mg (20% yield from <b>39</b>); mp 211–213 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (s, 1H), 8.74 (d, <i>J</i> = 9.4 Hz, 1H), 8.68 (s, 2H), 8.54 (d, <i>J</i> = 7.9 Hz, 1H), 8.43–8.34 (m, 4H), 8.29 (d, <i>J</i> = 9.0 Hz, 1H), 8.24 (d, <i>J</i> = 9.0 Hz, 1H), 8.14 (t, <i>J</i> = 7.6 Hz, 1H), 5.26–5.14 (m, 2H), 3.93–3.82 (m, 2H), 3.76 (m, 1H), 3.66 (m, 1H), 3.48 (m, 3H), 3.23 (m, 1H), 2.09 (m, 1H), 1.99–1.88 (m, 1H), 1.71 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.83, 158.97, 156.40, 130.97, 130.08, 129.53, 129.38, 129.28, 127.79, 127.71, 126.68, 125.99, 125.28, 125.04, 124.31, 124.22, 123.36, 123.04, 122.82, 111.81, 61.39, 53.00, 51.71, 40.52, 40.37, 39.89, 34.57, 34.39, 33.38; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>30</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 492.2400, found 492.2401; purity: 95.4% (254 nm, RT = 5.140 min).</div></div><div id="sec4_8_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(2-([1,1′-Biphenyl]-4-ylmethyl)-2,8-diazaspiro[4.5]decan-8-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide Hydrochloride (<b>32</b>)</h4><div class="NLM_p last">Compound <b>32</b> was synthesized according to the above general synthetic method. 134 mg (28% yield from <b>39</b>); mp 169–171 °C (CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ11.56 (s, 1H), 8.68 (s, 2H), 7.79–7.69 (m, 6H), 7.49 (d, <i>J</i> = 7.4 Hz, 2H), 7.40 (t, <i>J</i> = 7.4 Hz, 1H), 4.41 (m, 2H), 3.98–3.85 (m, 2H), 3.70 (m, 2H), 3.48 (m, 1H), 3.28 (m, 2H), 3.01 (m, 1H), 2.05 (m, 1H), 1.94 (m, 1H), 1.67 (m, 4H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.12, 160.33, 156.45, 140.23, 138.74, 130.75, 129.87, 128.41, 127.20, 126.28, 126.14, 113.70, 60.97, 56.22, 51.36, 40.44, 40.25, 39.98, 39.31, 34.38, 34.21, 33.20; HRMS (ESI) <i>m</i>/<i>z</i> calcd. for C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>, [M + H]<sup>+</sup> 444.2400, found 444.2401; purity: 99.2% (254 nm, RT = 5.120 min).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Parasite Culture and Transfection</h3><div class="NLM_p last"><i>P. falciparum</i> was cultured based on a standard protocol.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> For simplification, all parasites were cultivated in an atmosphere consisting of 5% CO<sub>2</sub>, 5% O<sub>2</sub>, and 90% N<sub>2</sub> with a completed medium (CM) consisting of RPMI (10.44 g/L), HEPES (5.94 g/L), Albumax (5 g/L), and sodium bicarbonate (2.2 g/L) and supplemented with hypoxanthine (50 mg/L) and gentamycin (50 mg/L). Fifty micrograms of the plasmid was used for electroporation transfection in the ring phase of 7% parasitemia as reported previously.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Transfected parasites were screened with 5 nM WR99210 (Jacobus Pharmaceuticals) or 2.5 μg/mL blasticidin-S deaminase (Life Technologies), and the clones were diluted to specified concentrations. Parasite genomic DNAs were extracted for verification of gene editing by PCRR.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>In Vitro</i> Antiplasmodium Activity Assay</h3><div class="NLM_p last">A 72 h parasite growth inhibitory assay was performed as described previously.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Briefly, highly synchronized ring-stage parasites (1% parasitemia and 2% hematocrit) were cultured with the compound of interest in 96-well plates of 200 μL per well. The compound was diluted serially from an initial concentration of 200 nM. The parasites were cultured for 72 h followed by lysis as described above. The inhibition of each compound was normalized to the DMSO negative control, and IC<sub>50</sub> values were calculated by GraphPad Prism 7.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>In Vitro</i> Cytotoxicity Assay</h3><div class="NLM_p last">Mammalian cell lines HepG2 and 293T were cultured in 10 cm dishes with Dulbecco’s modified Eagle medium (DMEM) consisting of 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S) at 37 °C in an atmosphere consisting of 5% CO<sub>2</sub>. For the cytotoxicity assay, 10,000 cells were seeded into each well of a white 96-well plate, and the total volume was 100 μL. After 24 h, the medium was replaced with the new medium containing the test compounds. The compound was diluted serially from an initial concentration of 100 μM. After 72 h of cultivation, a cell viability assay was performed on CellTiter-Glo (Promega cat. no. G7572). The inhibition of each compound was normalized to that of the DMSO negative control, and IC<sub>50</sub> values were calculated by GraphPad Prism 7.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Liver Microsome Metabolism Assay</h3><div class="NLM_p last">Liver microsomes (0.5 mg/mL) were purchased from Corning Corporation. Ketanserin was used as a positive control. The test compounds were first dissolved in DMSO to a concentration of 10 mM and then diluted to 0.5 mM with acetonitrile. The compound was diluted to a working concentration of 1.5 μM using liver microsome buffer, and then 30 μL of the above mixture was mixed with 15 μL of 6 mM NADPH at 37 °C. At 0, 5, 15, 30, and 45 min after incubation, 135 μL of acetonitrile was added to extinguish the reaction. The mixture was shaken on a shaker (IKA, MTS 2/4) at 600 rpm for 10 min and then centrifuged at 5600×<i>g</i> for 15 min (Thermo Multifuge×3R). The supernatant was diluted to distilled water by 1:1 and analyzed by LC–MS/MS.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Preparation of Test Compound Solutions</h3><div class="NLM_p last">The solvents were DMSO (<b>A</b>) and 20 wt % aqueous 2-hydroxypropyl-β-cyclodextrin solution (<b>B</b>). The compounds were first dissolved in 5 v/v% <b>A</b> and then diluted with 95 v/v% <b>B</b> to the indicated concentration. Unless otherwise noted, in animal experiments, the injected volume was 15 μL/g based on the average body weight of the mice in each group (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information), and the concentration was calculated accordingly. The solution was freshly prepared before administration.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>In Vivo</i> Erythrocytic Antimalarial Assay</h3><div class="NLM_p last">All animal experimental procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals under the supervision of Animal Welfare and Committee of Institute Pasteur of shanghai, Chinese Academy of Sciences (IACUC issue no. A2018009). An <i>in vivo</i> erythrocytic antimalarial assay was conducted in a female Balb/c mouse-<i>P. yoelii</i> rodent malaria model. Each group contained five mice. On day 0, each mouse (6–8 weeks old) was inoculated with 10<sup>5</sup> parasites via intraperitoneal injection (i.p.).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> After 24 h, the solution of compounds or solvent (for the blank group) was delivered at the indicated dose via i.p. once daily for 5 successive days. Piperaquine phosphate (PPQ) was used as a positive control. Tail vein blood smears were collected on the indicated days, and the percentage of parasitemia was determined via microscopic examination of 5000 RBCs and expressed as the mean ± SD.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>In Vivo</i> Liver-Stage Antimalarial Assay</h3><div class="NLM_p last">An <i>in vivo</i> liver-stage antimalarial assay was conducted in a female Balb/c mouse-<i>P. berghei</i> ANKA rodent malaria parasite model. Each group contained five female Balb/c mice (6–8 weeks old). On day 0, each mouse was inoculated with 5000 <i>P. berghei</i>-<i>ANKA-GFP-luc</i> sporozoites via intravenous injection (i.v.) after which the solution of test compound or the solvent (for the blank group) was delivered at a single indicated dose via i.v. (day 0). KDU691 was used as a positive control. Three milligrams of <span class="smallcaps smallerCapital">d</span>-luciferin sodium (SinoChrom BC-220-10) in 100 μL of ddH<sub>2</sub>O was administered to each mouse via intraperitoneal injection for parasite fluorescence detection. The fluorescence signals were visualized by IVIS Lumina series and detected on days 1–4 after infection.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Erythrocytic Stage-Specific Parasite Inhibition Assay</h3><div class="NLM_p last">To analyze stage-specific parasite inhibition, highly synchronized 3D7 parasites were cultured in 24-well plates with an initial parasitemia of 1% and hematocrit of 2%. After incubation with the test compound at a concentration of 10 × IC<sub>50</sub> (3D7) for the indicated 12 h, the parasites were washed three times to remove the compound and diluted with CM to a ratio of 1:40. DMSO was used as a blank control. Morphological analysis of parasites was conducted by microscopic examination of a Giemsa-staining smear. Parasitemia was counted by flow cytometry (MoFlo Astrios EQ; BECKMAN COULTER).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> RSA Assay</h3><div class="NLM_p last">A ring-stage survival assay (RSA) was performed to evaluate the potency of compounds against artemisinin-resistant <i>P. falciparum</i> clinical isolates 6218 and 6320 carrying kelch 13 mutation C580Y as described previously.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Briefly, parasites were treated with 5% <span class="smallcaps smallerCapital">d</span>-sorbitol after being highly synchronized at 0–3 h post invasion by 60%/40% Percoll gradient separation. Parasite mixed liquor (0.5–1% parasitemia, hematocrit 2%) was seeded into each well of the 48-well plate with the compound treatment at a final concentration of 700 nM for 6 h. Parasites were cultured for 66 h with CM after three washes with 15 mL of CM each time. Parasitemia was calculated for at least 10,000 RBCs from a blood smear. The survival rate of the DMSO control was counted to calculate the percentage. Dihydroartemisinin (DHA) was used as a positive control.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Flow Cytometry</h3><div class="NLM_p last">Flow cytometry was performed as previously described.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Briefly, RBCs infected with parasites were fixed in 4% formaldehyde/0.015% glutaraldehyde for 30 min at room temperature and then mixed with 500 μL of SYBR green staining solution (Invitrogen) (1:5000) in 1 × PBS (phosphate-buffered in saline, pH 7.4, free of calcium and magnesium) solution. Prior to flow cytometry analysis on the MoFlo Astrios EQ instrument (BECKMAN COULTER), the cells were washed three times with 1 × PBS. RBCs (excitation 488 nm; emission detection FL1 513 ± 26 nm, 5 × 10<sup>5</sup>) were measured, and the 5 (SYBR green intensity) value on FL1 was used as a threshold to identify (gated) infected RBCs. FlowJo software (v.10.0.5) was used to process the acquired data.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Plasmid Construction for Conditional Knock-Down of <i>Pf</i>HDAC1/2</h3><div class="NLM_p last">The gene conditional knock-down strategy was based on the <i>glmS</i> system.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The <i>glmS</i> sequence was inserted into the C-terminus of the targeted genes by using the CRISPR/Cas9 system.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Briefly, the C-terminus of <i>PfHDAC1</i> or <i>PfHDAC2</i> was fused with 3 × TY1 or 3 × TY1 plus <i>glmS</i>. Primers 1/2 and 3/4 and primers 5/6 and 7/8 were used to amplify the homologous arms of <i>PfHDAC1</i> and <i>PfHDAC2</i>, respectively. Primers 9/10 and 11/12 were used to amplify the 3 × TY1 tag and <i>glmS</i> sequences for <i>Pf</i>HDAC2 editing and primers 13/14 and 15/16 for <i>Pf</i>HDAC1, respectively. Primers 1/4 for <i>PfHDAC2</i> and primers 5/8 for <i>PfHDAC1</i> were used for overlap PCR to get the full donor sequences. All molecular clones were completed by the ClonExpress II One Step Cloning Kit (Vazyme C112-02). The purified PCR products were inserted into pL6CS at the ASC I/Afl II sites. The sgRNA (single guide RNA) was made by annealing primers 21/22 with its antisense strand for <i>Pf</i>HDAC1 and <i>Pf</i>HDAC2, respectively, and was inserted into pL6CS at the Xho I/Avr II sites. The successful plasmids were used to do the Parasite transfections, which was performed by electroporation at the ring stage of 7% parasitemia by using 50 μg of the plasmid as reported previously. Transfected parasites were selected by blasticidin-S deaminase (Life Technologies) at 2.5 μg/mL or 5 nM WR99210 (Jacobus Pharmaceuticals) and cloned by limiting dilution. Parasite genomic DNAs were extracted for validation of gene-editing by PCR. Gene knock-in was validated by PCR using primers 17/18 and 19/20, followed by DNA sequencing. The schematic explanation, PCR, and western blot identification of the strategy is displayed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Figures S2 and S3</a> in the Supporting Information.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Western Blot Assay</h3><div class="NLM_p">For identification of parasite histone hyperacetylation: Parasite samples were first treated with 0.15% saponin to remove the RBC proteins and then sonicated in 1% NP40 separation buffer. After centrifugation at 12,000×<i>g</i> for 15 min, the supernatant was resuspended in conventional SDS loading buffer. Parasite proteins were separated by 10% SDS-PAGE and transferred onto PVDF membranes (Millipore). Immunodetection was performed using anti-histone H3 antibody (ABclonal, A2348) or anti-histone H3 acetylated antibody (Millipore, 06-599) and secondary antibody that binds to HRP (Jackson ImmunoResearch Laboratories). The chemiluminescent HRP substrate Immobilon Western Kit (Millipore) was used for signal detection.</div><div class="NLM_p last">For identification of <i>Pf</i>HDAC1 downregulation: The 3D7<sup>HDAC1-TY1</sup> and 3D7<sup>HDAC1-<i>glmS</i></sup> parasites in the schizont stage were cultivated for 48 h with 2.5 mM glucosamine (GlcN). The parasite samples were collected and first treated with 0.15% saponin followed by sonicating in 1% NP40 separation buffer. After centrifugation at 12,000×<i>g</i> for 15 min, the supernatant was resuspended in conventional SDS loading buffer. Parasite proteins were separated by 10% SDS-PAGE and transferred onto PVDF membranes (Millipore). Immunodetection was performed using anti-TY1 antibody (diagenode, c15200054) and secondary antibody that binds to HRP (Jackson ImmunoResearch Laboratories). The chemiluminescent HRP substrate Immobilon Western Kit (Millipore) was used for signal detection. Actin was used as loading control.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> RT-qPCR Assay</h3><div class="NLM_p last">Parasite total RNA was extracted according to the manufacturer’s instructions for the TRIzol Kit (Life Technologies). According to the product manual, the complementary DNAs were synthesized using a HiScript II Q Select RT SuperMix Kit for qPCR (Vazyme, R223-01). QPCR was performed on the ABI 7900 system with the following procedure: initial denaturation was performed at 95 °C for 5 min, and then 40 cycles of 10 s were performed at 95 °C, 50 °C for 20 s, and 60 °C for 30 s. The housekeeping gene seryl-tRNA synthetase (PF3D7_0717700) was used as an internal control. Primers used in <i>PfHDAC1/2</i> gene knock-down study are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">Table S2</a> in the Supporting Information.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>In Vitro</i> Sensitivity Assay of Compounds toward <i>Pf</i>HDAC1/2 Knock-Down Parasites</h3><div class="NLM_p last">The assay was performed as described previously.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> After highly synchronized, schizont-stage 3D7<sup>HDAC1/2-<i>glmS</i></sup> or 3D7<sup>HDAC1/2-TY1</sup> parasites were pretreated with 2.5 mM glucosamine (GlcN) until the next ring-stage to knockdown the expression of <i>PfHDAC1/2</i>, the parasites were then incubated in a 96-well plate (1% parasitemia, and 2% hematocrit) with compounds from an initial concentration of 1 μM with a gradient dilution in the total volume of 200 μL. After 4 h incubation, the parasites were washed three times by an in-completed medium to remove compounds and continued culture for 68 h before SYBR Green I-staining as described above. The IC<sub>50</sub> values were calculated by GraphPad Prism 7.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>In Vitro</i> Recombinant Human HDAC Inhibition Assay</h3><div class="NLM_p">Human HDAC 1–3, 6, and 8 and Sirt 2 were purchased from BPS. SAHA and Suramin were selected as positive control. Tested compound were dissolved into 20 mM stock in 100% DMSO.</div><div class="NLM_p">HDAC 1–3 and 6 inhibition: In the 96-well plate, compound at test concentrations (10, 3.33, 1.11, 0.37, 0.12, 0.041, 0.014, 0.0046, 0.0015, 0.005 μM) was incubated with enzyme/Tris buffer solution (15 μL) at 25 °C for 15 min. To each well, trypsin and Ac-peptide substrate/Tris buffer solution (10 μL) were added to start reaction. The plates were incubated at 25 °C for 60 min and then analyzed on Synergy MX (excitation 355 nm, emission 460 nm).</div><div class="NLM_p">HDAC 8 inhibition: In the 96-well plate, compound at test concentrations (10, 3.33, 1.11, 0.37, 0.12, 0.041, 0.014, 0.0046, 0.0015, 0.005 μM) was incubated with enzyme/Tris buffer solution (15 μL) at 25 °C for 15 min. To each well, Ac-peptide substrate/Tris buffer solution (10 μL) was added to start reaction. The plates were incubated at 25 °C for 240 min; then trypsin solution was added and the incubation was continued for further 120 min. The plate was analyzed on Synergy MX (excitation 355 nm, emission 460 nm).</div><div class="NLM_p last">Sirt 2 inhibition: In the 96-well plate, compound at test concentrations (10, 3.33, 1.11, 0.37, 0.12, 0.041, 0.014, 0.0046, 0.0015, 0.005 μM) was incubated with enzyme/Tris buffer solution (15 μL) at 25 °C for 15 min. To each well, Ac-peptide substrate/Tris buffer solution (10 μL) was added to start reaction. The plates were incubated at 25 °C for 240 min, trypsin solution was added, and then the incubation was continued for further 120 min. The plate was analyzed on Synergy MX (excitation 355 nm, emission 460 nm).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>In Vitro</i> Recombinant <i>Pf</i>HDAC1 Inhibition Assay</h3><div class="NLM_p last"><i>In vitro</i> inhibition assay of <i>Pf</i>HDAC1 sample was performed according to previous report.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The recombinant <i>Pf</i>HDAC1 (BPS bioscience, 50063) and the HDAC-Glo I/II Assays and Screening System (Promega, G6431) were all commercially available. Briefly, in a 96-well plate, compounds <b>1</b> and <b>11</b> were diluted with a 3-fold gradient from an initial concentration of 50 and 200 μM, respectively, to 14 wells in the total volume of 100 μL in HDAC-Glo I/II Buffer. An amount of 200 ng of <i>Pf</i>HDAC1 was then added to each well. After incubation for 1.5 h, 100 μL of the HDAC-Glo I/II substrate with a developer regent was added to each well. After incubation 30 min, luminous values were detected by a microplate reader (bioteck). Positive control contained no compound, negative control contained no compound, and no <i>Pf</i>HDAC1. IC<sub>50</sub> was calculated by GraphPad Prism 7.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Pharmacokinetic Assay</h3><div class="NLM_p last">Female Balb/c mice (18–19 g, 6–8 weeks) were purchased from Beijing Vital River Biotechnology Co., Ltd. All mice were kept at controlled temperature and humidity and were given access to sterilized water and diet <i>ad libitum</i>. Solutions of the test compounds were prepared at concentrations of 0.4 mg/mL for i.v. and 1 mg/mL for i.p. Each mouse received one compound solution at the indicated dose and mode of administration. At 0.25, 0.5, 1, 2, 4, 8, and 24 h after administration, blood samples were collected into K<sub>2</sub>EDTA-containing test tubes and centrifuged at 82,000 rpm for 6 min at 4 °C. LC–MS/MS analysis of plasma was performed on a Shimadzu LC30AD and API 5000 equipped with a Phenomenex Luna Omega C18 1.6 μm column (2.1 × 50 mm). The mobile phase was a mixture of phase A (0.1% formic acid in water) and phase B (0.1% formic acid in acetonitrile), running at a flow rate gradient of 0.6 mL/min at 60 °C. The mass spectrum was obtained on an API 5000 triple quadrupole equipped with an ESI source. Propranolol was used as an internal standard. The plasma concentration of the compound was analyzed, and the pharmacokinetic parameters were calculated by WinNonlin.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Statistical Analysis</h3><div class="NLM_p last">The results are shown as the mean ± SEM from three independent experiments or the mean ± SD from two independent experiments. Graphical representation and statistical analyses were conducted using GraphPad Prism 7 software. Differences were tested for statistical significance using two-tailed Student’s <i>t</i>-test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02104" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02104?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02104</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC analysis data and purity spectra of compounds <b>2–32</b>, Body weight date of <i>in vivo</i> erythrocytic antimalarial assay, schematic diagram, and PCR identification and primers of <i>Pf</i>HDAC1 and <i>Pf</i>HDAC2 gene editing (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf">jm0c02104_si_001.pdf (1.67 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_002.csv">jm0c02104_si_002.csv (4.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02104" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaokang Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7800131411381d1b0d0b0c561d1c0d561b16"><span class="__cf_email__" data-cfemail="176f7c7b7e57727462646339727362397479">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lubin Jiang</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Virology and Immunology, Institut Pasteur
of Shanghai, University of Chinese Academy
of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Life Science and Technology, ShanghaiTech
University, Shanghai 201210, P.R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c9a5aba3a0a8a7ae89a0b9bae7a8aae7aaa7"><span class="__cf_email__" data-cfemail="432f21292a222d24032a33306d22206d202d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Pharmacy and Chemistry, Dali University, 5 Xue Ren Road, Dali 671000, China</span>; 
    <span class="hlFld-Affiliation affiliation">Frontiers
Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#13797a727d7f7a5376706660673d7677663d707d"><span class="__cf_email__" data-cfemail="e08a89818e8c89a08583959394ce858495ce838e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruoxi Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dazheng Ling</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tongke Tang</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Virology and Immunology, Institut Pasteur
of Shanghai, University of Chinese Academy
of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Life Science and Technology, ShanghaiTech
University, Shanghai 201210, P.R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenghui Huang</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Virology and Immunology, Institut Pasteur
of Shanghai, University of Chinese Academy
of Sciences, Chinese Academy of Sciences, Shanghai 200031, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manjiong Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Ding</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathogenic Biology, Army Medical University, Chongqing 400038, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taiping Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathogenic Biology, Army Medical University, Chongqing 400038, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanwen Wei</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenyue Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathogenic Biology, Army Medical University, Chongqing 400038, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Mao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5871-6878" title="Orcid link">http://orcid.org/0000-0001-5871-6878</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Zhu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3934-0312" title="Orcid link">http://orcid.org/0000-0003-3934-0312</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.L., D.L., and T.T. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Didier Ménard for providing the artemisinin-resistant field isolates. This work was supported by the National Key R&D Program of China (2017YFB0202600, 2018YFA0507300), the National Natural Science Foundation of China (81872747, 81903457), the National Science and Technology Major Project (2018ZX10101004003001), the Innovative Research Team of High-level Local Universities in Shanghai, the Chinese Special Fund for State Key Laboratory of Bioreactor Engineering (2060204), the Pu’er Municipal Expert Workstation of L. J., the Chinese Postdoctoral Science Foundation (2018M641946), the Shanghai Sailing Program (19YF1412600), and the Shanghai Morning Light Program (18CG33).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACT</td><td class="NLM_def"><p class="first last">artemisinin-based combination therapy</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">dihydroartemisinin</p></td></tr><tr><td class="NLM_term">GlcN</td><td class="NLM_def"><p class="first last">2-amino-2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">hpi</td><td class="NLM_def"><p class="first last">hour post infection</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneally</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenously</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term"><i>Pf</i></td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i></p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPQ</td><td class="NLM_def"><p class="first last">piperaquine phosphate</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cell</p></td></tr><tr><td class="NLM_term">RSA</td><td class="NLM_def"><p class="first last">ring-stage survival assay</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Sir</td><td class="NLM_def"><p class="first last">sirtuin</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc-binding group</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Malaria%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherbuin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Drug Discovery – the Path towards Eradication</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1017/S0031182013000826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1017%2FS0031182013000826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23863111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=128-139&author=J.+N.+Burrowsauthor=E.+Burlotauthor=B.+Campoauthor=S.+Cherbuinauthor=S.+Jeanneretauthor=D.+Leroyauthor=T.+Spangenbergauthor=D.+Watersonauthor=T.+N.+Wellsauthor=P.+Willis&title=Antimalarial+Drug+Discovery+%E2%80%93+the+Path+towards+Eradication&doi=10.1017%2FS0031182013000826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - the path towards eradication</span></div><div class="casAuthors">Burrows Jeremy N; Burlot Emilie; Campo Brice; Cherbuin Stephanie; Jeanneret Sarah; Leroy Didier; Spangenberg Thomas; Waterson David; Wells Timothy Nc; Willis Paul</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a disease that still affects a significant proportion of the global human population.  Whilst advances have been made in lowering the numbers of cases and deaths, it is clear that a strategy based solely on disease control year on year, without reducing transmission and ultimately eradicating the parasite, is unsustainable.  This article highlights the current mainstay treatments alongside a selection of emerging new clinical molecules from the portfolio of Medicines for Malaria Venture (MMV) and our partners.  In each case, the key highlights from each research phase are described to demonstrate how these new potential medicines were discovered.  Given the increased focus of the community on eradicating the disease, the strategy for next generation combination medicines that will provide such potential is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3YKOgrIcfkIvKgEt20y1XfW6udTcc2eYKRdpisncHsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D&md5=24b1b3b746eb152a54f68c090cad3421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS0031182013000826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182013000826%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBurlot%26aufirst%3DE.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DCherbuin%26aufirst%3DS.%26aulast%3DJeanneret%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3DWillis%26aufirst%3DP.%26atitle%3DAntimalarial%2520Drug%2520Discovery%2520%25E2%2580%2593%2520the%2520Path%2520towards%2520Eradication%26jtitle%3DParasitology%26date%3D2014%26volume%3D141%26spage%3D128%26epage%3D139%26doi%3D10.1017%2FS0031182013000826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Guidelines for the Treatment of Malaria,
Third Edition</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=World+Health+Organization&title=Guidelines+for+the+Treatment+of+Malaria%2C%0AThird+Edition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DGuidelines%2520for%2520the%2520Treatment%2520of%2520Malaria%252C%250AThird%2520Edition%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Drug Resistance: Linking <i>Plasmodium Falciparum</i> Parasite Biology to the Clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nm.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnm.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=28777791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=917-928&author=B.+Blascoauthor=D.+Leroyauthor=D.+A.+Fidock&title=Antimalarial+Drug+Resistance%3A+Linking+Plasmodium+Falciparum+Parasite+Biology+to+the+Clinic&doi=10.1038%2Fnm.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span></div><div class="casAuthors">Blasco, Benjamin; Leroy, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-928</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria.  However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivs. and ACT partner drugs, resulting in increasing rates of treatment failures.  Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combating resistance, optimizing treatment and advancing the global campaign to eliminate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN71qlYUi97Vg90H21EOLACvtfcHk0lgUIktUt69H2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO&md5=832e6fdea00ba5ddc25308c682758eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4381%26sid%3Dliteratum%253Aachs%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DAntimalarial%2520Drug%2520Resistance%253A%2520Linking%2520Plasmodium%2520Falciparum%2520Parasite%2520Biology%2520to%2520the%2520Clinic%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D917%26epage%3D928%26doi%3D10.1038%2Fnm.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Status Report on Artemisinin Resistance
and ACT Efficacy</i>; <span class="NLM_publisher-name">World Health Organization</span>, December, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Status+Report+on+Artemisinin+Resistance%0Aand+ACT+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DStatus%2520Report%2520on%2520Artemisinin%2520Resistance%250Aand%2520ACT%2520Efficacy%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span> <span> </span><span class="NLM_article-title">A Temporizing Solution to ″Artemisinin Resistance″</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1056/NEJMp1901233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1056%2FNEJMp1901233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=31018065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FoslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=2087-2089&author=J.+Wangauthor=C.+Xuauthor=F.+L.+Liaoauthor=T.+Jiangauthor=S.+Krishnaauthor=Y.+Tu&title=A+Temporizing+Solution+to+%E2%80%B3Artemisinin+Resistance%E2%80%B3&doi=10.1056%2FNEJMp1901233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Temporizing Solution to "Artemisinin Resistance"</span></div><div class="casAuthors">Wang Jigang; Xu Chengchao; Liao Fu Long; Jiang Tingliang; Krishna Sanjeev; Tu Youyou</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2087-2089</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9xWJtaaze2v3jf77P2BG3fW6udTcc2ebjEmymsavuO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FoslamtA%253D%253D&md5=214cbb6f2ef0a4b51a728e974c8d5975</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1901233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1901233%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DF.%2BL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DY.%26atitle%3DA%2520Temporizing%2520Solution%2520to%2520%25E2%2580%25B3Artemisinin%2520Resistance%25E2%2580%25B3%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D2087%26epage%3D2089%26doi%3D10.1056%2FNEJMp1901233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimondo, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rots, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeronimo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdasco, M.</span></span> <span> </span><span class="NLM_article-title">The Timeline of Epigenetic Drug Discovery: from Reality to Dreams</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1186/s13148-019-0776-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1186%2Fs13148-019-0776-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=31791394" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=174-190&author=A.+Ganesanauthor=P.+B.+Arimondoauthor=M.+G.+Rotsauthor=C.+Jeronimoauthor=M.+Berdasco&title=The+Timeline+of+Epigenetic+Drug+Discovery%3A+from+Reality+to+Dreams&doi=10.1186%2Fs13148-019-0776-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2Fs13148-019-0776-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-019-0776-0%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DArimondo%26aufirst%3DP.%2BB.%26aulast%3DRots%26aufirst%3DM.%2BG.%26aulast%3DJeronimo%26aufirst%3DC.%26aulast%3DBerdasco%26aufirst%3DM.%26atitle%3DThe%2520Timeline%2520of%2520Epigenetic%2520Drug%2520Discovery%253A%2520from%2520Reality%2520to%2520Dreams%26jtitle%3DClin.%2520Epigenet.%26date%3D2019%26volume%3D11%26spage%3D174%26epage%3D190%26doi%3D10.1186%2Fs13148-019-0776-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailu, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4780</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4780-4804&author=G.+S.+Hailuauthor=D.+Robaaauthor=M.+Forgioneauthor=W.+Sipplauthor=D.+Rotiliauthor=A.+Mai&title=Lysine+Deacetylase+Inhibitors+in+Parasites%3A+Past%2C+Present%2C+and+Future+Perspectives&doi=10.1021%2Facs.jmedchem.6b01595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives</span></div><div class="casAuthors">Hailu, Gebremedhin S.; Robaa, Dina; Forgione, Mariantonietta; Sippl, Wolfgang; Rotili, Dante; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4780-4804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current therapies for human parasite infections rely on a few drugs, most of which have severe side effects, and their helpfulness is being seriously compromised by the drug resistance problem.  Globally, this is pushing discovery research of antiparasitic drugs toward new agents endowed with new mechanisms of action.  By using a "drug repurposing" strategy, histone deacetylase inhibitors (HDACi), which are presently clin. approved for cancer use, are now under investigation for various parasite infections.  Because parasitic Zn2+- and NAD+-dependent HDACs play crucial roles in the modulation of parasite gene expression and many of them are pro-survival for several parasites under various conditions, they are now emerging as novel potential antiparasitic targets.  This Perspective summarizes the state of knowledge of HDACi (both class I/II HDACi and sirtuin inhibitors) targeted to the main human parasitic diseases (schistosomiasis, malaria, trypanosomiasis, leishmaniasis, and toxoplasmosis) and provides visions into the main issues that challenge their development as antiparasitic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHB7ia90mr4LVg90H21EOLACvtfcHk0lgAMQ0NnRH8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaksr4%253D&md5=7969f188d68e38d6254e98feb771613d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01595%26sid%3Dliteratum%253Aachs%26aulast%3DHailu%26aufirst%3DG.%2BS.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DLysine%2520Deacetylase%2520Inhibitors%2520in%2520Parasites%253A%2520Past%252C%2520Present%252C%2520and%2520Future%2520Perspectives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4780%26epage%3D4804%26doi%3D10.1021%2Facs.jmedchem.6b01595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancio-Silva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Meza, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Rivas, R.</span></span> <span> </span><span class="NLM_article-title">Differential Association of Orc1 and Sir2 Proteins to Telomeric Domains in <i>Plasmodium Falciparum</i></span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2046</span>– <span class="NLM_lpage">2053</span>, <span class="refDoi"> DOI: 10.1242/jcs.026427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1242%2Fjcs.026427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=18525026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=2046-2053&author=L.+Mancio-Silvaauthor=A.+P.+Rojas-Mezaauthor=M.+Vargasauthor=A.+Scherfauthor=R.+Hernandez-Rivas&title=Differential+Association+of+Orc1+and+Sir2+Proteins+to+Telomeric+Domains+in+Plasmodium+Falciparum&doi=10.1242%2Fjcs.026427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differential association of Orc1 and Sir2 proteins to telomeric domains in Plasmodium falciparum</span></div><div class="casAuthors">Mancio-Silva, Liliana; Rojas-Meza, Ana Paola; Vargas, Miguel; Scherf, Artur; Hernandez-Rivas, Rosaura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2046-2053</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Telomeres have the capacity to recruit proteins that facilitate the spreading of heterochromatin into subtelomeric DNA regions.  In the human protozoan pathogen Plasmodium falciparum, the telomere-assocd. protein Sir2 has been shown to control the silencing of members of virulence genes at some, but not all, chromosome-end loci, indicating that addnl. proteins are involved in telomere position effect.  Here, we identified, in P. falciparum, a novel telomere-assocd. protein that displays homol. with the origin-of-recognition-complex 1 protein Orc1.  Antibodies raised against this P. falciparum protein localized to telomeric clusters in the nuclear periphery and the nucleolus.  It was found that, prior to DNA replication, P. falciparum Orc1 and Sir2 undergo drastic subcellular reorganization, such as dissocn. from the telomere cluster and spreading into the nucleus and parasite cytoplasm.  Relocation of Orc1 and Sir2 was also linked to the partial dissocn. of telomere clusters.  Super gel-shift and chromatin-immunopptn. expts. showed the phys. assocn. of Orc1 with telomere repeats but revealed a differential assocn. with adjacent non-coding repeat DNA elements.  The data suggest that Plasmodium telomeres might fold back and that Orc1 cooperates with Sir2 in telomeric silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNibQxom2UrVg90H21EOLACvtfcHk0lgAMQ0NnRH8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFakt70%253D&md5=203e4cdef40fe30a145ef262a023c95e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1242%2Fjcs.026427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.026427%26sid%3Dliteratum%253Aachs%26aulast%3DMancio-Silva%26aufirst%3DL.%26aulast%3DRojas-Meza%26aufirst%3DA.%2BP.%26aulast%3DVargas%26aufirst%3DM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DHernandez-Rivas%26aufirst%3DR.%26atitle%3DDifferential%2520Association%2520of%2520Orc1%2520and%2520Sir2%2520Proteins%2520to%2520Telomeric%2520Domains%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2008%26volume%3D121%26spage%3D2046%26epage%3D2053%26doi%3D10.1242%2Fjcs.026427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carret, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span> <span> </span><span class="NLM_article-title">Sir2 Paralogues Cooperate to Regulate Virulence Genes and Antigenic Variation in <i>Plasmodium Falciparum</i></span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pbio.1000084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=771-779&author=C.+J.+Tonkinauthor=C.+K.+Carretauthor=M.+T.+Duraisinghauthor=T.+S.+Vossauthor=S.+A.+Ralphauthor=M.+Hommelauthor=M.+F.+Duffyauthor=L.+M.+da+Silvaauthor=A.+Scherfauthor=A.+Ivensauthor=T.+P.+Speedauthor=J.+G.+Beesonauthor=A.+F.+Cowman&title=Sir2+Paralogues+Cooperate+to+Regulate+Virulence+Genes+and+Antigenic+Variation+in+Plasmodium+Falciparum&doi=10.1371%2Fjournal.pbio.1000084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000084%26sid%3Dliteratum%253Aachs%26aulast%3DTonkin%26aufirst%3DC.%2BJ.%26aulast%3DCarret%26aufirst%3DC.%2BK.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26aulast%3DVoss%26aufirst%3DT.%2BS.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DHommel%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DM.%2BF.%26aulast%3Dda%2BSilva%26aufirst%3DL.%2BM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DIvens%26aufirst%3DA.%26aulast%3DSpeed%26aufirst%3DT.%2BP.%26aulast%3DBeeson%26aufirst%3DJ.%2BG.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26atitle%3DSir2%2520Paralogues%2520Cooperate%2520to%2520Regulate%2520Virulence%2520Genes%2520and%2520Antigenic%2520Variation%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D771%26epage%3D779%26doi%3D10.1371%2Fjournal.pbio.1000084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaal, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastuwidyaningtyas, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luah, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylases Play a Major Role in the Transcriptional Regulation of the <i>Plasmodium Falciparum</i> Life Cycle</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000737</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.ppat.1000737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20107518" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&author=B.+K.+Chaalauthor=A.+P.+Guptaauthor=B.+D.+Wastuwidyaningtyasauthor=Y.+H.+Luahauthor=Z.+Bozdech&title=Histone+Deacetylases+Play+a+Major+Role+in+the+Transcriptional+Regulation+of+the+Plasmodium+Falciparum+Life+Cycle&doi=10.1371%2Fjournal.ppat.1000737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000737%26sid%3Dliteratum%253Aachs%26aulast%3DChaal%26aufirst%3DB.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BP.%26aulast%3DWastuwidyaningtyas%26aufirst%3DB.%2BD.%26aulast%3DLuah%26aufirst%3DY.%2BH.%26aulast%3DBozdech%26aufirst%3DZ.%26atitle%3DHistone%2520Deacetylases%2520Play%2520a%2520Major%2520Role%2520in%2520the%2520Transcriptional%2520Regulation%2520of%2520the%2520Plasmodium%2520Falciparum%2520Life%2520Cycle%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26doi%3D10.1371%2Fjournal.ppat.1000737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobert, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span> <span> </span><span class="NLM_article-title">Comparative Gene Expression Profiling of <i>P falciparum Malaria Parasites Exposed to Three Different Histone Deacetylase Inhibitors</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31847</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pone.0031847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22384084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFylsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+T.+Andrewsauthor=A.+P.+Guptaauthor=T.+N.+Tranauthor=D.+P.+Fairlieauthor=G.+N.+Gobertauthor=Z.+Bozdech&title=Comparative+Gene+Expression+Profiling+of+P+falciparum+Malaria+Parasites+Exposed+to+Three+Different+Histone+Deacetylase+Inhibitors&doi=10.1371%2Fjournal.pone.0031847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors</span></div><div class="casAuthors">Andrews, Katherine T.; Gupta, Archna P.; Tran, Thanh N.; Fairlie, David P.; Gobert, Geoffrey N.; Bozdech, Zbynek</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31847</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors are being intensively pursued as potential new drugs for a range of diseases, including malaria.  HDAC inhibitors are also important tools for the study of epigenetic mechanisms, transcriptional control, and other important cellular processes.  In this study the effects of three structurally related antimalarial HDAC inhibitors on P. falciparum malaria parasite gene expression were compared.  The three hydroxamate-based compds., trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA; Vorinostat) and a 2-aminosuberic acid deriv. (2-ASA-9), all caused profound transcriptional effects, with ∼ 2-21% of genes having >2-fold altered expression following 2 h exposure to the compds.  Only two genes, alpha tubulin II and a hydrolase, were up-regulated by all three compds. after 2 h exposure in all biol. replicates examd.  The transcriptional changes obsd. after 2 h exposure to HDAC inhibitors were found to be largely transitory, with only 1-5 % of genes being regulated after removing the compds. and culturing for a further 2 h.  Despite some structural similarity, the three inhibitors caused quite diverse transcriptional effects, possibly reflecting subtle differences in mode of action or cellular distribution.  This dataset represents an important contribution to our understanding of how HDAC inhibitors act on malaria parasites and identifies alpha tubulin II as a potential transcriptional marker of HDAC inhibition in malaria parasites that may be able to be exploited for future development of HDAC inhibitors as new antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6BwfqS4RO_rVg90H21EOLACvtfcHk0lgucQvNBMONdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFylsLs%253D&md5=3b1d97984e1f643427ff6278e3804545</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031847%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DGupta%26aufirst%3DA.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DGobert%26aufirst%3DG.%2BN.%26aulast%3DBozdech%26aufirst%3DZ.%26atitle%3DComparative%2520Gene%2520Expression%2520Profiling%2520of%2520P%2520falciparum%2520Malaria%2520Parasites%2520Exposed%2520to%2520Three%2520Different%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. K.</span></span> <span> </span><span class="NLM_article-title">HDAC Inhibitors in Parasitic Diseases</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/icb.2011.97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Ficb.2011.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22124373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=66-77&author=K.+T.+Andrewsauthor=A.+Haqueauthor=M.+K.+Jones&title=HDAC+Inhibitors+in+Parasitic+Diseases&doi=10.1038%2Ficb.2011.97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitors in parasitic diseases</span></div><div class="casAuthors">Andrews, Katherine T.; Haque, Ashraful; Jones, Malcolm K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Parasitic diseases cause significant global morbidity and mortality, particularly in underdeveloped regions of the world.  Malaria alone causes ∼800 000 deaths each year, with children and pregnant women being at highest risk.  There is no licensed vaccine available for any human parasitic disease and drug resistance is compromising the efficacy of many available anti-parasitic drugs.  This is driving drug discovery research on new agents with novel modes of action.  Histone deacetylase (HDAC) inhibitors are being investigated as drugs for a range of diseases, including cancers and infectious diseases such as HIV/AIDS, and several parasitic diseases.  This review focuses on the current state of knowledge of HDAC inhibitors targeted to the major human parasitic diseases malaria, schistosomiasis, trypanosomiasis, toxoplasmosis and leishmaniasis.  Insights are provided into the unique challenges that will need to be considered if HDAC inhibitors are to be progressed towards clin. development as potential new anti-parasitic drugs.  Immunol. and Cell Biol. (2012) 90, 66-77; doi:10.1038/icb.2011.97; published online 29 Nov. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkvVI4Oq1MYbVg90H21EOLACvtfcHk0lgucQvNBMONdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslyltA%253D%253D&md5=dfddf07627e40d37df311c5b4ef8a29d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Ficb.2011.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2011.97%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DHaque%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DM.%2BK.%26atitle%3DHDAC%2520Inhibitors%2520in%2520Parasitic%2520Diseases%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D90%26spage%3D66%26epage%3D77%26doi%3D10.1038%2Ficb.2011.97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs</span>. <i>Curr. Pharm. Design</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3479</span>, <span class="refDoi"> DOI: 10.2174/138161212801327257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.2174%2F138161212801327257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22607140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KltrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=3467-3479&author=K.+T.+Andrewsauthor=T.+N.+Tranauthor=D.+P.+Fairlie&title=Towards+Histone+Deacetylase+Inhibitors+as+New+Antimalarial+Drugs&doi=10.2174%2F138161212801327257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Towards histone deacetylase inhibitors as new antimalarial drugs</span></div><div class="casAuthors">Andrews, Katherine T.; Tran, Thanh N.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3467-3479</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are important enzymes that effect post-translational modifications of proteins by altering the acetylation state of lysine residues.  HDACs control epigenetic changes that trigger cell transformation and proliferation of transformed cells assocd. with many diseases.  These enzymes are validated drug targets for some types of cancer and are promising therapeutic targets for a range of other diseases, including malaria.  Annually, there are ∼500 million clin. cases of malaria and ∼0.8-1.2 million deaths.  There is no licensed vaccine for preventing malaria, and parasites that cause malaria are becoming resistant to current drugs, necessitating the search for new therapies.  HDAC inhibitors are emerging as a promising new class of antimalarial drugs with potent and selective action against Plasmodium parasites in vitro.  Recent studies on the effects of HDAC inhibitors on the growth and development of P. falciparum have provided important new information on transcriptional regulation in malaria parasites and have validated the potential of this class of inhibitors for malaria therapy.  To realize effective HDAC inhibitors for clin. trials, next generation inhibitors must not inhibit other human HDACs or proteins required for normal human physiol., be highly selective in killing parasites in vivo without killing normal host cells, and have improved bioavailability and pharmacokinetic profiles.  This review summarizes current knowledge about malaria parasite HDACs and HDAC inhibitors with antimalarial properties, and provides insights for their development into new drugs for treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-TC7XQUTlLVg90H21EOLACvtfcHk0lgucQvNBMONdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KltrfK&md5=8499726373358c2b61e28639c53cedba</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161212801327257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212801327257%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DTowards%2520Histone%2520Deacetylase%2520Inhibitors%2520as%2520New%2520Antimalarial%2520Drugs%26jtitle%3DCurr.%2520Pharm.%2520Design%26date%3D2012%26volume%3D18%26spage%3D3467%26epage%3D3479%26doi%3D10.2174%2F138161212801327257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancio-Silva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rubio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span> <span> </span><span class="NLM_article-title">Si2a Regulates rDNA Transcription and Multiplication Rate in the Human Malaria Parasite <i>Plasmodium Falciparum</i></span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1530</span>, <span class="refDoi"> DOI: 10.1038/ncomms2539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fncomms2539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23443558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC3svhslersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1530&author=L.+Mancio-Silvaauthor=J.+J.+Lopez-Rubioauthor=A.+Claesauthor=A.+Scherf&title=Si2a+Regulates+rDNA+Transcription+and+Multiplication+Rate+in+the+Human+Malaria+Parasite+Plasmodium+Falciparum&doi=10.1038%2Fncomms2539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sir2a regulates rDNA transcription and multiplication rate in the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Mancio-Silva Liliana; Lopez-Rubio Jose Juan; Claes Aurelie; Scherf Artur</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1530</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Plasmodium falciparum histone deacetylase Sir2a localizes at telomeric regions where it contributes to epigenetic silencing of clonally variant virulence genes.  Apart from telomeres, PfSir2a also accumulates in the nucleolus, which harbours the developmentally regulated ribosomal RNA genes.  Here we investigate the nucleolar function of PfSir2a and demonstrate that PfSir2a fine-tunes ribosomal RNA gene transcription.  Using a parasite line in which PfSir2a has been disrupted, we observe that histones near the transcription start sites of all ribosomal RNA genes are hyperacetylated and that transcription of ribosomal RNA genes is upregulated.  Complementation of the PfSir2a-disrupted parasites restores the ribosomal RNA levels, whereas PfSir2a overexpression in wild-type parasites decreases ribosomal RNA synthesis.  Furthermore, we observe that PfSir2a modulation of ribosomal RNA synthesis is linked to an altered number of daughter merozoites and the parasite multiplication rate.  These findings provide new insights into an epigenetic mechanism that controls malaria parasite proliferation and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNNvXEU0QC0IUSrryheKE6fW6udTcc2eaKVr5ec58F1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svhslersA%253D%253D&md5=01ae424a0abe3467de29481a50f97266</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms2539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2539%26sid%3Dliteratum%253Aachs%26aulast%3DMancio-Silva%26aufirst%3DL.%26aulast%3DLopez-Rubio%26aufirst%3DJ.%2BJ.%26aulast%3DClaes%26aufirst%3DA.%26aulast%3DScherf%26aufirst%3DA.%26atitle%3DSi2a%2520Regulates%2520rDNA%2520Transcription%2520and%2520Multiplication%2520Rate%2520in%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1530%26doi%3D10.1038%2Fncomms2539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childs, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenhofen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldowitz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafsack, B. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckee, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span> <span> </span><span class="NLM_article-title">A <i>Plasmodium Falciparum</i> Histone Deacetylase Regulates Antigenic Variation and Gametocyte Conversion</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2014.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.chom.2014.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25121747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OjtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=177-186&author=B.+I.+Colemanauthor=K.+M.+Skillmanauthor=R.+H.+Y.+Jiangauthor=L.+M.+Childsauthor=L.+M.+Altenhofenauthor=M.+Ganterauthor=Y.+Leungauthor=I.+Goldowitzauthor=B.+F.+C.+Kafsackauthor=M.+Martiauthor=M.+Llin%C3%A1sauthor=C.+O.+Buckeeauthor=M.+T.+Duraisingh&title=A+Plasmodium+Falciparum+Histone+Deacetylase+Regulates+Antigenic+Variation+and+Gametocyte+Conversion&doi=10.1016%2Fj.chom.2014.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Plasmodium falciparum Histone Deacetylase Regulates Antigenic Variation and Gametocyte Conversion</span></div><div class="casAuthors">Coleman, Bradley I.; Skillman, Kristen M.; Jiang, Rays H. Y.; Childs, Lauren M.; Altenhofen, Lindsey M.; Ganter, Markus; Leung, Yvette; Goldowitz, Ilana; Kafsack, Bjorn F. C.; Marti, Matthias; Llinas, Manuel; Buckee, Caroline O.; Duraisingh, Manoj T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The asexual forms of the malaria parasite Plasmodium falciparum are adapted for chronic persistence in human red blood cells, continuously evading host immunity using epigenetically regulated antigenic variation of virulence-assocd. genes.  Parasite survival on a population level also requires differentiation into sexual forms, an obligatory step for further human transmission.  We reveal that the essential nuclear gene, P. falciparum histone deacetylase 2 (PfHda2), is a global silencer of virulence gene expression and controls the frequency of switching from the asexual cycle to sexual development.  PfHda2 depletion leads to dysregulated expression of both virulence-assocd. var genes and PfAP2-g, a transcription factor controlling sexual conversion, and is accompanied by increases in gametocytogenesis.  Math. modeling further indicates that PfHda2 has likely evolved to optimize the parasite's infectious period by achieving low frequencies of virulence gene expression switching and sexual conversion.  This common regulation of cellular transcriptional programs mechanistically links parasite transmissibility and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7_de7f4ySrVg90H21EOLACvtfcHk0lhv7yw2jrs3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OjtLvO&md5=fc0b76408ac427d0b3489ede96b9ac31</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2014.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2014.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DB.%2BI.%26aulast%3DSkillman%26aufirst%3DK.%2BM.%26aulast%3DJiang%26aufirst%3DR.%2BH.%2BY.%26aulast%3DChilds%26aufirst%3DL.%2BM.%26aulast%3DAltenhofen%26aufirst%3DL.%2BM.%26aulast%3DGanter%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DY.%26aulast%3DGoldowitz%26aufirst%3DI.%26aulast%3DKafsack%26aufirst%3DB.%2BF.%2BC.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DBuckee%26aufirst%3DC.%2BO.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26atitle%3DA%2520Plasmodium%2520Falciparum%2520Histone%2520Deacetylase%2520Regulates%2520Antigenic%2520Variation%2520and%2520Gametocyte%2520Conversion%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2014%26volume%3D16%26spage%3D177%26epage%3D186%26doi%3D10.1016%2Fj.chom.2014.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darkin-Rattray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurnett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulski, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumley, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allocco, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombrowski, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polishook, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmatz, D. M.</span></span> <span> </span><span class="NLM_article-title">Apicidin: a Novel Antiprotozoal Agent that Inhibits Parasite Histone Deacetylase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">13143</span>– <span class="NLM_lpage">13147</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.23.13143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1073%2Fpnas.93.23.13143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=8917558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADyaK28XmvV2qtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=13143-13147&author=S.+J.+Darkin-Rattrayauthor=A.+M.+Gurnettauthor=R.+W.+Myersauthor=P.+M.+Dulskiauthor=T.+M.+Crumleyauthor=J.+J.+Alloccoauthor=C.+Cannovaauthor=P.+T.+Meinkeauthor=S.+L.+Collettiauthor=M.+A.+Bednarekauthor=S.+B.+Singhauthor=M.+A.+Goetzauthor=A.+W.+Dombrowskiauthor=J.+D.+Polishookauthor=D.+M.+Schmatz&title=Apicidin%3A+a+Novel+Antiprotozoal+Agent+that+Inhibits+Parasite+Histone+Deacetylase&doi=10.1073%2Fpnas.93.23.13143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase</span></div><div class="casAuthors">Darkin-Rattray, Sandra J.; Gurnett, Anne M.; Myers, Robert W.; Dulski, Paula M.; Crumley, Tami M.; Allocco, John J.; Cannova, Christine; Meinke, Peter T.; Colletti, Steven L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13143-13147</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel fungal metabolite, apicidin [cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)], that exhibits potent, broad spectrum antiprotozoal activity in vitro against Apicomplexan parasites has been identified.  It is also orally and parenterally active in vivo against Plasmodium berghei malaria in mice.  Many Apicomplexan parasites cause serious, life-threatening human and animal diseases, such as malaria, cryptosporidiosis, toxoplasmosis, and coccidiosis, and new therapeutic agents are urgently needed.  Apicidin's antiparasitic activity appears to be due to low nanomolar inhibition of Apicomplexan histone deacetylase (HDA), which induces hyperacetylation of histones in treated parasites.  The acetylation-deacetylation of histones is thought to play a central role in transcriptional control in eukaryotic cells.  Other known HDA inhibitors were also evaluated and found to possess antiparasitic activity, suggesting that HDA is an attractive target for the development of novel antiparasitic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqub6fPyIvFQrVg90H21EOLACvtfcHk0lhv7yw2jrs3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvV2qtrk%253D&md5=3738f88674b6e5856d55bab7a0701e22</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.23.13143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.23.13143%26sid%3Dliteratum%253Aachs%26aulast%3DDarkin-Rattray%26aufirst%3DS.%2BJ.%26aulast%3DGurnett%26aufirst%3DA.%2BM.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DDulski%26aufirst%3DP.%2BM.%26aulast%3DCrumley%26aufirst%3DT.%2BM.%26aulast%3DAllocco%26aufirst%3DJ.%2BJ.%26aulast%3DCannova%26aufirst%3DC.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DBednarek%26aufirst%3DM.%2BA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DGoetz%26aufirst%3DM.%2BA.%26aulast%3DDombrowski%26aufirst%3DA.%2BW.%26aulast%3DPolishook%26aufirst%3DJ.%2BD.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26atitle%3DApicidin%253A%2520a%2520Novel%2520Antiprotozoal%2520Agent%2520that%2520Inhibits%2520Parasite%2520Histone%2520Deacetylase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D13143%26epage%3D13147%26doi%3D10.1073%2Fpnas.93.23.13143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walduck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, P. G.</span></span> <span> </span><span class="NLM_article-title">Anti-malarial Effect of Histone Deacetylation Inhibitors and Mammalian Tumour Cytodifferentiating Agents</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1016/S0020-7519(00)00043-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2FS0020-7519%2800%2900043-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10856511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslyrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=761-768&author=K.+T.+Andrewsauthor=A.+Walduckauthor=M.+J.+Kelsoauthor=D.+P.+Fairlieauthor=A.+Saulauthor=P.+G.+Parsons&title=Anti-malarial+Effect+of+Histone+Deacetylation+Inhibitors+and+Mammalian+Tumour+Cytodifferentiating+Agents&doi=10.1016%2FS0020-7519%2800%2900043-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents</span></div><div class="casAuthors">Andrews, Kathy T.; Walduck, Anna; Kelso, Mike J.; Fairlie, David P.; Saul, Allan; Parsons, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The histones of Plasmodium falciparum represent a potential new target for anti-malarial compds.  A naturally occurring compd., apicidin, has recently been shown to inhibit the in vitro growth of P. falciparum.  Apicidin was shown to hyperacetylate histones, suggesting that its mode of action is through histone deacetylase inhibition.  We have tested the ability of known histone deacetylase inhibitors, mammalian tumor suppressor compds., and cytodifferentiating agents to inhibit the in vitro growth of a drug sensitive and resistant strain of P. falciparum.  Seven of the tested compds. had μM IC50 values, and trichostatin A, a histone deacetylation inhibitor and cytodifferentiating agent, was active at low nM concns.  One compd., suberic acid bisdimethylamide, which selectively arrests tumor cells as opposed to normal mammalian cells, had an in vivo cytostatic effect against the acute murine malaria Plasmodium berghei, and one round of treatment with the compd. failed to select for resistant mutations.  These results suggest a promising role for histone deacetylase inhibitors and cytodifferentiating agents as antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRESA5UQICWLVg90H21EOLACvtfcHk0lgCjUoo_mPdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslyrtr4%253D&md5=74f82add94f7167d8953ddcdd87ab619</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2800%2900043-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252800%252900043-6%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DWalduck%26aufirst%3DA.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DP.%2BG.%26atitle%3DAnti-malarial%2520Effect%2520of%2520Histone%2520Deacetylation%2520Inhibitors%2520and%2520Mammalian%2520Tumour%2520Cytodifferentiating%2520Agents%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2000%26volume%3D30%26spage%3D761%26epage%3D768%26doi%3D10.1016%2FS0020-7519%2800%2900043-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Activity of Phenylthiazolyl-bearing Hydroxamate-based Histone Deacetylase Inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3477</span>, <span class="refDoi"> DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+Activity+of+Phenylthiazolyl-bearing+Hydroxamate-based+Histone+Deacetylase+Inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 μM.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0lgCjUoo_mPdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520Activity%2520of%2520Phenylthiazolyl-bearing%2520Hydroxamate-based%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sumanadasa, S. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3849</span>– <span class="NLM_lpage">3856</span>, <span class="refDoi"> DOI: 10.1128/AAC.00030-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.00030-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22508312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2isbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3849-3856&author=S.+D.+M.+Sumanadasaauthor=C.+D.+Goodmanauthor=A.+J.+Luckeauthor=T.+Skinner-Adamsauthor=I.+Sahamaauthor=A.+Haqueauthor=T.+A.+Doauthor=G.+I.+McFaddenauthor=D.+P.+Fairlieauthor=K.+T.+Andrews&title=Antimalarial+Activity+of+the+Anticancer+Histone+Deacetylase+Inhibitor+SB939&doi=10.1128%2FAAC.00030-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of the anticancer histone deacetylase inhibitor SB939</span></div><div class="casAuthors">Sumanadasa, Subathdrage D. M.; Goodman, Christopher D.; Lucke, Andrew J.; Skinner-Adams, Tina; Sahama, Ishani; Haque, Ashraful; Do, Tram Anh; McFadden, Geoffrey I.; Fairlie, David P.; Andrews, Katherine T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3849-3856</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymes posttranslationally modify lysines on histone and nonhistone proteins and play crucial roles in epigenetic regulation and other important cellular processes.  HDAC inhibitors (e.g., suberoylanilide hydroxamic acid [SAHA; also known as vorinostat]) are used clin. to treat some cancers and are under investigation for use against many other diseases.  Development of new HDAC inhibitors for noncancer indications has the potential to be accelerated by piggybacking onto cancer studies, as several HDAC inhibitors have undergone or are undergoing clin. trials.  One such compd., SB939, is a new orally active hydroxamate-based HDAC inhibitor with an improved pharmacokinetic profile compared to that of SAHA.  In this study, the in vitro and in vivo antiplasmodial activities of SB939 were investigated.  SB939 was found to be a potent inhibitor of the growth of Plasmodium falciparum asexual-stage parasites in vitro (50% inhibitory concn. [IC50], 100 to 200 nM), causing hyperacetylation of parasite histone and nonhistone proteins.  In combination with the aspartic protease inhibitor lopinavir, SB939 displayed additive activity.  SB939 also potently inhibited the in vitro growth of exoerythrocytic-stage Plasmodium parasites in liver cells (IC50, ∼150 nM), suggesting that inhibitor targeting to multiple malaria parasite life cycle stages may be possible.  In an exptl. in vivo murine model of cerebral malaria, orally administered SB939 significantly inhibited P. berghei ANKA parasite growth, preventing development of cerebral malaria-like symptoms.  These results identify SB939 as a potent new antimalarial HDAC inhibitor and underscore the potential of investigating next-generation anticancer HDAC inhibitors as prospective new drug leads for treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9VOh-rgoatLVg90H21EOLACvtfcHk0lgCjUoo_mPdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2isbk%253D&md5=39b3013e97dec44eb326bd8d86101519</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.00030-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00030-12%26sid%3Dliteratum%253Aachs%26aulast%3DSumanadasa%26aufirst%3DS.%2BD.%2BM.%26aulast%3DGoodman%26aufirst%3DC.%2BD.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DSahama%26aufirst%3DI.%26aulast%3DHaque%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DT.%2BA.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26atitle%3DAntimalarial%2520Activity%2520of%2520the%2520Anticancer%2520Histone%2520Deacetylase%2520Inhibitor%2520SB939%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3849%26epage%3D3856%26doi%3D10.1128%2FAAC.00030-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignola, D.</span></span> <span> </span><span class="NLM_article-title">Hydroxamic Acid Based Histone Deacetylase Inhibitors with Confirmed Activity against the Malaria Parasite</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.bmcl.2014.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25563890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=459-461&author=G.+Gianniniauthor=G.+Battistuzziauthor=D.+Vignola&title=Hydroxamic+Acid+Based+Histone+Deacetylase+Inhibitors+with+Confirmed+Activity+against+the+Malaria+Parasite&doi=10.1016%2Fj.bmcl.2014.12.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite</span></div><div class="casAuthors">Giannini, Giuseppe; Battistuzzi, Gianfranco; Vignola, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-461</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies have highlighted a key role in regulating gene transcription, in both eukaryotes and prokaryotes, by enzymes that control the acetylation and deacetylation of histones.  In particular, inhibitors of histone deacetylases (HDAC-Is) have been shown effective in controlling the development of many parasites, such as the plasmodium of malaria.  Here we report the results of a study aimed at evaluating antiparasitic effect of two classes of HDAC-Is bearing different zinc binding group (hydroxamic acid vs thiol).  The study showed that only the hydroxamic acid based HDAC inhibitors were active, with Plasmodium falciparum being the most sensitive parasite, having from low double-digit to single-digit nanomolar range in vitro activities.  Among three derivs. evaluated also in vivo, ST8086AA1 (8) effectively inhibited 88% of the development of Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvc4vbdguDrVg90H21EOLACvtfcHk0liGD47uZEnWXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWgsw%253D%253D&md5=368003ce13e438d7d20eeefe2c232aec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DVignola%26aufirst%3DD.%26atitle%3DHydroxamic%2520Acid%2520Based%2520Histone%2520Deacetylase%2520Inhibitors%2520with%2520Confirmed%2520Activity%2520against%2520the%2520Malaria%2520Parasite%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D459%26epage%3D461%26doi%3D10.1016%2Fj.bmcl.2014.12.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, M. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancelot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Späth, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span> <span> </span><span class="NLM_article-title">Effect of Clinically Approved HDAC Inhibitors on <i>Plasmodium</i>, <i>Leishmania</i> and <i>Schistosoma</i> Parasite Growth</span>. <i>Int. J. Parasitol. Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2016.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.ijpddr.2016.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=28107750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nslOgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=42-50&author=M.+J.+Chuaauthor=M.+S.+J.+Arnoldauthor=W.+Xuauthor=J.+Lancelotauthor=S.+Lamotteauthor=G.+F.+Sp%C3%A4thauthor=E.+Prinaauthor=R.+J.+Pierceauthor=D.+P.+Fairlieauthor=T.+S.+Skinner-Adamsauthor=K.+T.+Andrews&title=Effect+of+Clinically+Approved+HDAC+Inhibitors+on+Plasmodium%2C+Leishmania+and+Schistosoma+Parasite+Growth&doi=10.1016%2Fj.ijpddr.2016.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth</span></div><div class="casAuthors">Chua Ming Jang; Arnold Megan S J; Skinner-Adams Tina S; Xu Weijun; Fairlie David P; Lancelot Julien; Pierce Raymond J; Lamotte Suzanne; Spath Gerald F; Prina Eric; Andrews Katherine T</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria, schistosomiasis and leishmaniases are among the most prevalent tropical parasitic diseases and each requires new innovative treatments.  Targeting essential parasite pathways, such as those that regulate gene expression and cell cycle progression, is a key strategy for discovering new drug leads.  In this study, four clinically approved anti-cancer drugs (Vorinostat, Belinostat, Panobinostat and Romidepsin) that target histone/lysine deacetylase enzymes were examined for in vitro activity against Plasmodium knowlesi, Schistosoma mansoni, Leishmania amazonensis and L. donovani parasites and two for in vivo activity in a mouse malaria model.  All four compounds were potent inhibitors of P. knowlesi malaria parasites (IC50 9-370 nM), with belinostat, panobinostat and vorinostat having 8-45 fold selectivity for the parasite over human neonatal foreskin fibroblast (NFF) or human embryonic kidney (HEK 293) cells, while romidepsin was not selective.  Each of the HDAC inhibitor drugs caused hyperacetylation of P. knowlesi histone H4.  None of the drugs was active against Leishmania amastigote or promastigote parasites (IC50 > 20 μM) or S. mansoni schistosomula (IC50 > 10 μM), however romidepsin inhibited S. mansoni adult worm parings and egg production (IC50 ∼10 μM).  Modest in vivo activity was observed in P. berghei infected mice dosed orally with vorinostat or panobinostat (25 mg/kg twice daily for four days), with a significant reduction in parasitemia observed on days 4-7 and 4-10 after infection (P < 0.05), respectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4PFWYnE_iRT69zv1FsJFMfW6udTcc2eYHMCz4kMhPRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nslOgsw%253D%253D&md5=699b8901c27dd849096a3b728c0de891</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DM.%2BJ.%26aulast%3DArnold%26aufirst%3DM.%2BS.%2BJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DS.%26aulast%3DSp%25C3%25A4th%26aufirst%3DG.%2BF.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26atitle%3DEffect%2520of%2520Clinically%2520Approved%2520HDAC%2520Inhibitors%2520on%2520Plasmodium%252C%2520Leishmania%2520and%2520Schistosoma%2520Parasite%2520Growth%26jtitle%3DInt.%2520J.%2520Parasitol.%2520Drugs%2520Drug%2520Resist.%26date%3D2017%26volume%3D7%26spage%3D42%26epage%3D50%26doi%3D10.1016%2Fj.ijpddr.2016.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urgaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from <i>Plasmodium Falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2185</span>– <span class="NLM_lpage">2187</span>, <span class="refDoi"> DOI: 10.1021/jm801654y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801654y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Gmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2185-2187&author=V.+Patelauthor=R.+Mazitschekauthor=B.+Colemanauthor=C.+Nguyenauthor=S.+Urgaonkarauthor=J.+Corteseauthor=R.+H.+Barkerauthor=E.+Greenbergauthor=W.+Tangauthor=J.+E.+Bradnerauthor=S.+L.+Schreiberauthor=M.+T.+Duraisinghauthor=D.+F.+Wirthauthor=J.+Clardy&title=Identification+and+Characterization+of+Small+Molecule+Inhibitors+of+a+Class+I+Histone+Deacetylase+from+Plasmodium+Falciparum&doi=10.1021%2Fjm801654y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparum</span></div><div class="casAuthors">Patel, Vishal; Mazitschek, Ralph; Coleman, Bradley; Nguyen, Cokey; Urgaonkar, Sameer; Cortese, Joseph; Barker, Robert H., Jr.; Greenberg, Edward; Tang, Weiping; Bradner, James E.; Schreiber, Stuart L.; Duraisingh, Manoj T.; Wirth, Dyann F.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2185-2187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of approx. 2000 small mols. biased toward inhibition of histone deacetylases was assayed for antimalarial activity in a high-throughput P. falciparum viability assay.  Active compds. were cross-analyzed for induction of histone hyperacetylation in a human myeloma cell line to identify HDAC inhibitors with selectivity for P. falciparum over the human host.  To verify on-target selectivity, pfHDAC-1 was expressed and purified and a biochem. assay for pfHDAC-1 activity was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2aI4Y1nc2M7Vg90H21EOLACvtfcHk0lgPVWJv9Sso_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Gmurk%253D&md5=0cee47c16047222dc6283f98ee2961fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm801654y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801654y%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DColeman%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DUrgaonkar%26aufirst%3DS.%26aulast%3DCortese%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DR.%2BH.%26aulast%3DGreenberg%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520a%2520Class%2520I%2520Histone%2520Deacetylase%2520from%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2185%26epage%3D2187%26doi%3D10.1021%2Fjm801654y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwakwari, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">A Structure–activity Relationship Study of the Antimalarial and Antileishmanial Activities of Nonpeptide Macrocyclic Histone Deacetylase Inhibitors</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1002%2Fcmdc.201000087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20533500" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1232-1235&author=W.+Guerrantauthor=S.+C.+Mwakwariauthor=P.+C.+Chenauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=A.+K.+Oyelere&title=A+Structure%E2%80%93activity+Relationship+Study+of+the+Antimalarial+and+Antileishmanial+Activities+of+Nonpeptide+Macrocyclic+Histone+Deacetylase+Inhibitors&doi=10.1002%2Fcmdc.201000087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000087%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DA%2520Structure%25E2%2580%2593activity%2520Relationship%2520Study%2520of%2520the%2520Antimalarial%2520and%2520Antileishmanial%2520Activities%2520of%2520Nonpeptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2010%26volume%3D5%26spage%3D1232%26epage%3D1235%26doi%3D10.1002%2Fcmdc.201000087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mwakwari, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurard-Levin, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrksich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">Non-peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6100</span>– <span class="NLM_lpage">6111</span>, <span class="refDoi"> DOI: 10.1021/jm100507q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsV2mtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-peptide+Macrocyclic+Histone+Deacetylase+Inhibitors+Derived+from+Tricyclic+Ketolide+Skeleton&doi=10.1021%2Fjm100507q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span></div><div class="casAuthors">Mwakwari, Sandra C.; Guerrant, William; Patil, Vishal; Khan, Shabana I.; Tekwani, Babu L.; Gurard-Levin, Zachary A.; Mrksich, Milan; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6100-6111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of histone deacetylase (HDAC) function is a validated therapeutic strategy for cancer treatment.  Of the several structurally distinct small mol. histone deacetylase inhibitors (HDACi) reported, macrocyclic depsipeptides possess the most complex cap groups and have demonstrated excellent HDAC inhibition potency and isoform selectivity.  Unfortunately, the development of macrocyclic depsipeptides has been hampered in part because of development problems characteristic of large peptides and the complex reaction schemes required for their synthesis.  Herein we report that tricyclic ketolide TE-802 is an excellent mimetic for the peptide backbone of macrocyclic HDACi.  Compds. derived from this template are particularly selective against HDACs 1 and 2 with nanomolar inhibitory activity.  Interrogation of the assocn. between a subset of these compds. and key HDAC isoforms, using AutoDock, enables a mol. description of the interaction between the HDAC enzyme's outer rim and the inhibitors' macrocyclic cap group that are responsible for compd. affinity and presumably isoform selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt9QPKI33jvbVg90H21EOLACvtfcHk0lgPVWJv9Sso_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsV2mtLk%253D&md5=6407dc82e9fb2dab6313d32956600659</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%2520Derived%2520from%2520Tricyclic%2520Ketolide%2520Skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6100%26epage%3D6111%26doi%3D10.1021%2Fjm100507q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumanadasa, S. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenzel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmetter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordmüller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of HDAC Inhibitors with Potent Activity against Multiple Malaria Parasite Life Cycle Stages</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.ejmech.2014.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24904967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=204-213&author=F.+K.+Hansenauthor=S.+D.+M.+Sumanadasaauthor=K.+Stenzelauthor=S.+Duffyauthor=S.+Meisterauthor=L.+Marekauthor=R.+Schmetterauthor=K.+Kunaauthor=A.+Hamacherauthor=B.+Mordm%C3%BCllerauthor=M.+U.+Kassackauthor=E.+A.+Winzelerauthor=V.+M.+Averyauthor=K.+T.+Andrewsauthor=T.+Kurz&title=Discovery+of+HDAC+Inhibitors+with+Potent+Activity+against+Multiple+Malaria+Parasite+Life+Cycle+Stages&doi=10.1016%2Fj.ejmech.2014.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages</span></div><div class="casAuthors">Hansen, Finn K.; Sumanadasa, Subathdrage D. M.; Stenzel, Katharina; Duffy, Sandra; Meister, Stephan; Marek, Linda; Schmetter, Rebekka; Kuna, Krystina; Hamacher, Alexandra; Mordmueller, Benjamin; Kassack, Matthias U.; Winzeler, Elizabeth A.; Avery, Vicky M.; Andrews, Katherine T.; Kurz, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-213</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this work the authors investigated the antiplasmodial activity of a series of HDAC inhibitors contg. an alkoxyamide connecting-unit linker region.  HDAC inhibitor LMK235, previously shown to be a novel and specific inhibitor of human HDAC4 and 5, was used as a starting point to rapidly construct a mini-library of HDAC inhibitors using a straightforward solid-phase supported synthesis.  Several of these novel HDAC inhibitors were found to have potent in vitro activity against asexual stage Plasmodium falciparum malaria parasites.  Representative compds. were shown to hyperacetylate P. falciparum histones and to inhibit deacetylase activity of recombinant PfHDAC1 and P. falciparum nuclear exts.  All compds. were also screened in vitro for activity against Plasmodium berghei exo-erythrocytic stages and selected compds. were further tested against late stage (IV and V) P. falciparum gametocytes.  Of note, some compds. showed nanomolar activity against all three life cycle stages tested (asexual, exo-erythrocytic and gametocyte stages) and several compds. displayed significantly increased parasite selectivity compared to the ref. HDAC inhibitor suberoylanilide hydroxamic acid (SAHA).  These data suggest that it may be possible to develop HDAC inhibitors that target multiple malaria parasite life cycle stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyJ3jTxcuXi7Vg90H21EOLACvtfcHk0liiWXH1va2V2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu77P&md5=b0582421de08370dda4cb4bf6c370256</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DF.%2BK.%26aulast%3DSumanadasa%26aufirst%3DS.%2BD.%2BM.%26aulast%3DStenzel%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DL.%26aulast%3DSchmetter%26aufirst%3DR.%26aulast%3DKuna%26aufirst%3DK.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DMordm%25C3%25BCller%26aufirst%3DB.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DKurz%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520HDAC%2520Inhibitors%2520with%2520Potent%2520Activity%2520against%2520Multiple%2520Malaria%2520Parasite%2520Life%2520Cycle%2520Stages%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D204%26epage%3D213%26doi%3D10.1016%2Fj.ejmech.2014.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Haung, Z.</span></span> <span> </span><span class="NLM_article-title">Novel High-efficiency Antimalarial Drug, Quisinostat</span>. World Patent <span class="NLM_patent">WO2017143964A1</span>, August 31, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Jiang&author=Z.+Haung&title=Novel+High-efficiency+Antimalarial+Drug%2C+Quisinostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DNovel%2520High-efficiency%2520Antimalarial%2520Drug%252C%2520Quisinostat%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsuno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmatz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slingsby, B. T.</span></span> <span> </span><span class="NLM_article-title">Hit and Lead Criteria in Drug Discovery for Infectious Diseases of the Developing World</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1038/nrd4683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnrd4683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=26435527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SitL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=751-758&author=K.+Katsunoauthor=J.+N.+Burrowsauthor=K.+Duncanauthor=R.+H.+van+Huijsduijnenauthor=T.+Kanekoauthor=K.+Kitaauthor=C.+E.+Mowbrayauthor=D.+Schmatzauthor=P.+Warnerauthor=B.+T.+Slingsby&title=Hit+and+Lead+Criteria+in+Drug+Discovery+for+Infectious+Diseases+of+the+Developing+World&doi=10.1038%2Fnrd4683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hit and lead criteria in drug discovery for infectious diseases of the developing world</span></div><div class="casAuthors">Katsuno, Kei; Burrows, Jeremy N.; Duncan, Ken; van Huijsduijnen, Rob Hooft; Kaneko, Takushi; Kita, Kiyoshi; Mowbray, Charles E.; Schmatz, Dennis; Warner, Peter; Slingsby, B. T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">751-758</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reducing the burden of infectious diseases that affect people in the developing world requires sustained collaborative drug discovery efforts.  The quality of the chem. starting points for such projects is a key factor in improving the likelihood of clin. success, and so it is important to set clear go/no-go criteria for the progression of hit and lead compds.  With this in mind, the Japanese Global Health Innovative Technol. (GHIT) Fund convened with experts from the Medicines for Malaria Venture, the Drugs for Neglected Diseases initiative and the TB Alliance, together with representatives from the Bill & Melinda Gates Foundation, to set disease-specific criteria for hits and leads for malaria, tuberculosis, visceral leishmaniasis and Chagas disease.  Here, we present the agreed criteria and discuss the underlying rationale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFQHFz6z3D_rVg90H21EOLACvtfcHk0liiWXH1va2V2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SitL7O&md5=6cd6d7c8ca3a85d64f24915da8e1120c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrd4683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4683%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuncan%26aufirst%3DK.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DSchmatz%26aufirst%3DD.%26aulast%3DWarner%26aufirst%3DP.%26aulast%3DSlingsby%26aufirst%3DB.%2BT.%26atitle%3DHit%2520and%2520Lead%2520Criteria%2520in%2520Drug%2520Discovery%2520for%2520Infectious%2520Diseases%2520of%2520the%2520Developing%2520World%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2015%26volume%3D14%26spage%3D751%26epage%3D758%26doi%3D10.1038%2Fnrd4683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span> <span> </span><span class="NLM_article-title">Small-molecule Targeting of a Diapophytoene Desaturase Inhibits <i>S, aureus Virulence</i></span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.+G.+Yangauthor=Y.+Xuauthor=H.+Jiangauthor=F.+Lianauthor=N.+Zhangauthor=J.+Liauthor=L.+Lan&title=Small-molecule+Targeting+of+a+Diapophytoene+Desaturase+Inhibits+S%2C+aureus+Virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0liiWXH1va2V2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLian%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DSmall-molecule%2520Targeting%2520of%2520a%2520Diapophytoene%2520Desaturase%2520Inhibits%2520S%252C%2520aureus%2520Virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Benzofuran-derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-resistant <i>Staphylococcus Aureus</i> (MRSA) Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3215</span>– <span class="NLM_lpage">3230</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3215-3230&author=Y.+Wangauthor=F.+Chenauthor=H.+Diauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=C.+Shengauthor=L.+Lanauthor=J.+Li&title=Discovery+of+Potent+Benzofuran-derived+Diapophytoene+Desaturase+%28CrtN%29+Inhibitors+with+Enhanced+Oral+Bioavailability+for+the+Treatment+of+Methicillin-resistant+Staphylococcus+Aureus+%28MRSA%29+Infections&doi=10.1021%2Facs.jmedchem.5b01984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections</span></div><div class="casAuthors">Wang, Youxin; Chen, Feifei; Di, Hongxia; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Sheng, Chunquan; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3215-3230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blocking the staphyloxanthin biosynthesis process has emerged as a new promising antivirulence strategy.  Previously, we first revealed that CrtN is a druggable target against infections caused by pigmented Staphylococcus aureus (S. aureus) and that naftifine was an effective CrtN inhibitor.  Here, we identify a new type of benzofuran-derived CrtN inhibitor with submicromolar IC50 values that is based on the naftifine scaffold.  The most potent analog, 5m, inhibits the pigment prodn. of S. aureus Newman and three MRSA strains, with IC50 values of 0.38-5.45 nM, without any impact on the survival of four strains (up to 200 μM).  Notably, compd. 5m (1 μM) could significantly sensitize four strains to immune clearance and could effectively attenuate the virulence of three strains in vivo.  Moreover, 5m was detd. to be a weak antifungal reagent (MIC > 16 μg/mL).  Combined with good oral bioavailability (F = 42.2%) and excellent safety profiles, these data demonstrate that 5m may be a good candidate for the treatment of MRSA infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahz7Kq8Z-k7Vg90H21EOLACvtfcHk0lhLg03z0lItYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D&md5=109908ff78289f118ced8c8883622f02</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01984%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Potent%2520Benzofuran-derived%2520Diapophytoene%2520Desaturase%2520%2528CrtN%2529%2520Inhibitors%2520with%2520Enhanced%2520Oral%2520Bioavailability%2520for%2520the%2520Treatment%2520of%2520Methicillin-resistant%2520Staphylococcus%2520Aureus%2520%2528MRSA%2529%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3215%26epage%3D3230%26doi%3D10.1021%2Facs.jmedchem.5b01984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-resistant <i>S. Aureus</i> (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4831</span>– <span class="NLM_lpage">4848</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XntFCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4831-4848&author=Y.+Wangauthor=H.+Diauthor=F.+Chenauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Discovery+of+Benzocycloalkane+Derivatives+Efficiently+Blocking+Bacterial+Virulence+for+the+Treatment+of+Methicillin-resistant+S.+Aureus+%28MRSA%29+Infections+by+Targeting+Diapophytoene+Desaturase+%28CrtN%29&doi=10.1021%2Facs.jmedchem.6b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN)</span></div><div class="casAuthors">Wang, Youxin; Di, Hongxia; Chen, Feifei; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4831-4848</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antivirulence strategies are now attracting interest for the inherent mechanism of action advantages.  In the previous work, diapophytoene desaturase (CrtN) was identified to be an attractive and drugable target for fighting pigmented S. aureus infections.  In this research, the authors developed a series of effective benzocycloalkane-derived CrtN inhibitors with submicromolar IC50.  Analog I blocked the pigment biosynthesis of three MRSA strains with a nanomolar IC50 value.  Corresponding to its mode of action, I did not function as a bactericidal agent. I could sensitize S. aureus to immune clearance.  In vivo, I was proven to be efficacious in an S. aureus Newman sepsis model and abscess formation model.  For two typical MRSAs, USA400 MW2 and Mu50, I significantly decreased the staphylococcal loads in the liver and kidneys.  Moreover, I showed minimal antifungal activity compared to that of NTF.  In summary, I has the potential to be developed as a therapeutic drug, esp. against intractable MRSA issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_zFIf63DmLVg90H21EOLACvtfcHk0lhLg03z0lItYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntFCjs78%253D&md5=f6065a8db5d957c4ea44d059ad58736f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Benzocycloalkane%2520Derivatives%2520Efficiently%2520Blocking%2520Bacterial%2520Virulence%2520for%2520the%2520Treatment%2520of%2520Methicillin-resistant%2520S.%2520Aureus%2520%2528MRSA%2529%2520Infections%2520by%2520Targeting%2520Diapophytoene%2520Desaturase%2520%2528CrtN%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4831%26epage%3D4848%26doi%3D10.1021%2Facs.jmedchem.6b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-resistant, Linezolid-resistant, and Vancomycin-intermediate <i>Staphylococcus Aureus</i> Infections In Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8145</span>– <span class="NLM_lpage">8159</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+Inhibitors+of+Staphyloxanthin+Virulence+Factor+in+Comparison+with+Linezolid+and+Vancomycin+versus+Methicillin-resistant%2C+Linezolid-resistant%2C+and+Vancomycin-intermediate+Staphylococcus+Aureus+Infections+In+Vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo</span></div><div class="casAuthors">Ni, Shuaishuai; Wei, Hanwen; Li, Baoli; Chen, Feifei; Liu, Yifu; Chen, Wenhua; Xu, Yixiang; Qiu, Xiaoxia; Li, Xiaokang; Lu, Yanli; Liu, Wenwen; Hu, Linhao; Lin, Dazheng; Wang, Manjiong; Zheng, Xinyu; Mao, Fei; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8145-8159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors' previous work (Wang, et al. J. Med. Chem. 2016, 59, 4831-4848) revealed that effective benzocycloalkane-derived staphyloxanthin inhibitors against methicillin-resistant Staphylococcus aureus (S. aureus) infections were accompanied by poor water soly. and high hERG inhibition and dosages (pre-administration).  In this study, ninety-two chroman and coumaran derivs. as novel inhibitors have been addressed for overcoming deficiencies above.  Derivs. 69 ((E)-N-(coumaran-5-methyl)-N-methyl-3-(4-biphenyl)prop-2-en-1-amine hydrochloride) and 105 ((E,E)-N-(chroman-7-methyl)-N-methyl-5-(4-biphenyl)pent-2,4-dien-1-amine hydrochloride) displayed the excellent pigment inhibitory activities and low hERG inhibition, along with the improvement of soly. by salt type selection.  The broad and significantly potent antibacterial spectra of 69 and 105 were displayed firstly with normal administration in the livers and hearts in mice against pigmented S. aureus Newman, Mu50 (vancomycin-intermediate S. aureus) and NRS271 (linezolid-resistant S. aureus), compared with linezolid and vancomycin.  In summary, both 69 and 105 have the potential to be developed as good antibacterial candidates targeting virulence factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcybrWG0xXSLVg90H21EOLACvtfcHk0lgZ0uCz8F2WIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN&md5=c29f6cf0efd0584034f623d62222a943</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520Inhibitors%2520of%2520Staphyloxanthin%2520Virulence%2520Factor%2520in%2520Comparison%2520with%2520Linezolid%2520and%2520Vancomycin%2520versus%2520Methicillin-resistant%252C%2520Linezolid-resistant%252C%2520and%2520Vancomycin-intermediate%2520Staphylococcus%2520Aureus%2520Infections%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel Terminal Bipheny-based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced <i>h</i>ERG Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01300</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01300" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=224-250&author=B.+Liauthor=S.+Niauthor=F.+Maoauthor=F.+Chenauthor=Y.+Liuauthor=H.+Weiauthor=W.+Chenauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+Terminal+Bipheny-based+Diapophytoene+Desaturases+%28CrtN%29+Inhibitors+as+Anti-MRSA%2FVISR%2FLRSA+Agents+with+Reduced+hERG+Activity&doi=10.1021%2Facs.jmedchem.7b01300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity</span></div><div class="casAuthors">Li, Baoli; Ni, Shuaishuai; Mao, Fei; Chen, Feifei; Liu, Yifu; Wei, Hanwen; Chen, Wenhua; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections.  More than 100 new compds. were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1 (I).  Analogs 23a ((E)-3-([1,1'-biphenyl]-4-yl)-N-(benzofuran-3-ylmethyl)-N-methylprop-2-en-1-amine hydrochloride) and 23b ((E)-N-((1H-indol-7-yl)methyl)-3-([1,1'-biphenyl]-4-yl)-N-methylprop-2-en-1-amine hydrochloride) demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02-10.5 nM), along with lower hERG inhibition (IC50 > 30 μM, ∼10-fold decrease in comparison with 1).  Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid.  Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rqm9J1xyJbVg90H21EOLACvtfcHk0lgZ0uCz8F2WIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF&md5=d92739f38cc85e69ca280dc62b198934</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01300%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520Terminal%2520Bipheny-based%2520Diapophytoene%2520Desaturases%2520%2528CrtN%2529%2520Inhibitors%2520as%2520Anti-MRSA%252FVISR%252FLRSA%2520Agents%2520with%2520Reduced%2520hERG%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D224%26epage%3D250%26doi%3D10.1021%2Facs.jmedchem.7b01300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonck, M. G. C.</span>; <span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Roux, B.</span>; <span class="NLM_string-name">Pilatte, I. N. C.</span>; <span class="NLM_string-name">Ten Holte, P.</span>; <span class="NLM_string-name">Arts, J.</span>; <span class="NLM_string-name">Van Emelen, K.</span>; <span class="NLM_string-name">Holte, P. T.</span>; <span class="NLM_string-name">Verdonck, M. G.</span>; <span class="NLM_string-name">Celine, V. M. G.</span>; <span class="NLM_string-name">Constance, P. I. N.</span>; <span class="NLM_string-name">Holte, A. J. A. P. T.</span>; <span class="NLM_string-name">Ten Holte, P. A. J.</span>; <span class="NLM_string-name">Van, E. K.</span>; <span class="NLM_string-name">Ten, H. P.</span>; <span class="NLM_string-name">Janssen, P. N. V.</span>; <span class="NLM_string-name">Veronck, M. G. C.</span>; <span class="NLM_string-name">Emelen, K. V.</span>; <span class="NLM_string-name">Celine, M. G.</span>; <span class="NLM_string-name">Van Emelein, K.</span></span> <span> </span><span class="NLM_article-title">Substituted Indolyl Alkyl Amino Derivatives as Novel Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">SG156687A1</span>, February 02, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+C.+Verdonck&author=P.+R.+Angibaud&author=B.+Roux&author=I.+N.+C.+Pilatte&author=P.+Ten+Holte&author=J.+Arts&author=K.+Van+Emelen&author=P.+T.+Holte&author=M.+G.+Verdonck&author=V.+M.+G.+Celine&author=P.+I.+N.+Constance&author=A.+J.+A.+P.+T.+Holte&author=P.+A.+J.+Ten+Holte&author=E.+K.+Van&author=H.+P.+Ten&author=P.+N.+V.+Janssen&author=M.+G.+C.+Veronck&author=K.+V.+Emelen&author=M.+G.+Celine&author=K.+Van+Emelein&title=Substituted+Indolyl+Alkyl+Amino+Derivatives+as+Novel+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonck%26aufirst%3DM.%2BG.%2BC.%26atitle%3DSubstituted%2520Indolyl%2520Alkyl%2520Amino%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, J. W. J.</span>; <span class="NLM_string-name">Houpis, I. N.</span>; <span class="NLM_string-name">Lang, Y. L.</span>; <span class="NLM_string-name">Leys, C.</span>; <span class="NLM_string-name">Stokbroekx, S. C. M.</span>; <span class="NLM_string-name">Weerts, J. E. E.</span>; <span class="NLM_string-name">Dickens, J. W.</span>; <span class="NLM_string-name">Ioanneseu Nikolraoseu, H.</span></span>.; <span class="NLM_contrib-group"><span class="NLM_string-name">Julrieoseu Deobeulyu
Jei, D.</span>; <span class="NLM_string-name">Karina, R.</span>; <span class="NLM_string-name">Sigeurideu Kaal
Maria, S.</span>; <span class="NLM_string-name">Yohan
Eowin Edeumondeu, W.</span>; <span class="NLM_string-name">Yolrandeu Ridia, R.</span>; <span class="NLM_string-name">Houpis, L. N.</span>; <span class="NLM_string-name">Dickens, W. J. J.</span>; <span class="NLM_string-name">Ertis, J. E. I.</span>; <span class="NLM_string-name">Hubez, I. N.</span>; <span class="NLM_string-name">Liz, K.</span>; <span class="NLM_string-name">Stkbrox, C. M.</span>; <span class="NLM_string-name">Dickens Julius, W. J.</span>; <span class="NLM_string-name">Houpis Ioannes, N.</span>; <span class="NLM_string-name">Lang Yolande, L.</span>; <span class="NLM_string-name">Stokbroekx Sigrid, C. M.</span>; <span class="NLM_string-name">Weerts Johan, E. E.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors</span>. World Patent <span class="NLM_patent">123121</span>, November 23, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+W.+J.+Dickens&author=I.+N.+Houpis&author=Y.+L.+Lang&author=C.+Leys&author=S.+C.+M.+Stokbroekx&author=J.+E.+E.+Weerts&author=J.+W.+Dickens&author=H.+Ioanneseu+Nikolraoseuauthor=D.+Julrieoseu+Deobeulyu%0AJei&author=R.+Karina&author=S.+Sigeurideu+Kaal%0AMaria&author=W.+Yohan%0AEowin+Edeumondeu&author=R.+Yolrandeu+Ridia&author=L.+N.+Houpis&author=W.+J.+J.+Dickens&author=J.+E.+I.+Ertis&author=I.+N.+Hubez&author=K.+Liz&author=C.+M.+Stkbrox&author=W.+J.+Dickens+Julius&author=N.+Houpis+Ioannes&author=L.+Lang+Yolande&author=C.+M.+Stokbroekx+Sigrid&author=E.+E.+Weerts+Johan&title=Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DJ.%2BW.%2BJ.%26aulast%3DJulrieoseu%2BDeobeulyu%2BJei%26aufirst%3DD.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, B.</span>; <span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Laux, B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclylalkyl Derivatives as Novel Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US7834011B2</span>, July 26, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Roux&author=P.+R.+Angibaud&author=B.+Laux&title=Heterocyclylalkyl+Derivatives+as+Novel+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DB.%26atitle%3DHeterocyclylalkyl%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Pilatte, I. N. C.</span>; <span class="NLM_string-name">Angibaud, P.</span>; <span class="NLM_string-name">Pilatte, I.</span></span> <span> </span><span class="NLM_article-title">Substituted Indolyl-alkyl-amino-derivatives as Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US7834011B2</span>, July 26, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+R.+Angibaud&author=I.+N.+C.+Pilatte&author=P.+Angibaud&author=I.+Pilatte&title=Substituted+Indolyl-alkyl-amino-derivatives+as+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAngibaud%26aufirst%3DP.%2BR.%26atitle%3DSubstituted%2520Indolyl-alkyl-amino-derivatives%2520as%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arts, J.</span>; <span class="NLM_string-name">Hellemans, P. W. J.</span>; <span class="NLM_string-name">Janicot, M. M. F.</span>; <span class="NLM_string-name">Page, M. J.</span>; <span class="NLM_string-name">Hellemans Peter, W. J.</span>; <span class="NLM_string-name">Janicot Michel, M. F.</span>; <span class="NLM_string-name">Page Martin, J.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors with Combined Activity on Class-i and Class-iib Histone Deacetylases in Combination with Proteasome Inhibitors</span>. World Patent <span class="NLM_patent">JP5185274B2</span>, March 20, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Arts&author=P.+W.+J.+Hellemans&author=M.+M.+F.+Janicot&author=M.+J.+Page&author=W.+J.+Hellemans+Peter&author=M.+F.+Janicot+Michel&author=J.+Page+Martin&title=Histone+Deacetylase+Inhibitors+with+Combined+Activity+on+Class-i+and+Class-iib+Histone+Deacetylases+in+Combination+with+Proteasome+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArts%26aufirst%3DJ.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%2520with%2520Combined%2520Activity%2520on%2520Class-i%2520and%2520Class-iib%2520Histone%2520Deacetylases%2520in%2520Combination%2520with%2520Proteasome%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">The Use of Spirocyclic Scaffolds in Drug Discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3682</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.bmcl.2014.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25052427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3673-3682&author=Y.+Zhengauthor=C.+M.+Ticeauthor=S.+B.+Singh&title=The+Use+of+Spirocyclic+Scaffolds+in+Drug+Discovery&doi=10.1016%2Fj.bmcl.2014.06.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The use of spirocyclic scaffolds in drug discovery</span></div><div class="casAuthors">Zheng, Yajun; Tice, Colin M.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3673-3682</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery.  In this brief review, we highlight selected examples from the primary medicinal chem. literature during the last three years to demonstrate the versatility of spiro scaffolds.  With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzTjJrsRkyLVg90H21EOLACvtfcHk0liqIupbEQa9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM&md5=9a2a644cf2b97edf7876b43b6457f6d5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DThe%2520Use%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Drug%2520Discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3673%26epage%3D3682%26doi%3D10.1016%2Fj.bmcl.2014.06.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span> <span> </span><span class="NLM_article-title">The Utilization of Spirocyclic Scaffolds in Novel Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1195367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1080%2F17460441.2016.1195367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27233084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FktVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=831-834&author=Y.+J.+Zhengauthor=C.+M.+Tice&title=The+Utilization+of+Spirocyclic+Scaffolds+in+Novel+Drug+Discovery&doi=10.1080%2F17460441.2016.1195367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The utilization of spirocyclic scaffolds in novel drug discovery</span></div><div class="casAuthors">Zheng Ya-Jun; Tice Colin M</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">831-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYAtKgZnFeprYtC3U5jeOifW6udTcc2ebvozr7OIn4CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FktVGkug%253D%253D&md5=a736a7ecb934f323069bef58eaed9bbe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1195367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1195367%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BJ.%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Utilization%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Novel%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2016%26volume%3D11%26spage%3D831%26epage%3D834%26doi%3D10.1080%2F17460441.2016.1195367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voss, F.</span>; <span class="NLM_string-name">Schunk, S.</span>; <span class="NLM_string-name">Steinhagen, H.</span></span> Chapter 16 <span> </span><span class="NLM_article-title">Spirocycles as Privileged Structural Motifs in Medicinal Chemistry</span><i>.</i> In  <i>Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, B.</span></span>; Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry: London</span>, <span class="NLM_year">2016</span>; pp.  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">458</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=439-458&author=F.+Voss&author=S.+Schunk&author=H.+Steinhagenauthor=B.+Stefan&title=Privileged+Scaffolds+in+Medicinal+Chemistry%3A+Design%2C+Synthesis%2C+Evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DF.%26atitle%3DSpirocycles%2520as%2520Privileged%2520Structural%2520Motifs%2520in%2520Medicinal%2520Chemistry%26btitle%3DPrivileged%2520Scaffolds%2520in%2520Medicinal%2520Chemistry%253A%2520Design%252C%2520Synthesis%252C%2520Evaluation%26aulast%3DStefan%26aufirst%3DB.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%253A%2520London%26date%3D2016%26spage%3D439%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span>; <span class="NLM_string-name">Li, R.</span>; <span class="NLM_string-name">Tang, T.</span>; <span class="NLM_string-name">Ling, D.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Xu, D.</span>; <span class="NLM_string-name">Sun, M.</span>; <span class="NLM_string-name">Zheng, L.</span>; <span class="NLM_string-name">Zhu, F.</span>; <span class="NLM_string-name">Min, H.</span>; <span class="NLM_string-name">Boonhok, R.</span>; <span class="NLM_string-name">Ding, Y.</span>; <span class="NLM_string-name">Wen, Y.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Liu, T.</span>; <span class="NLM_string-name">Han, J.</span>; <span class="NLM_string-name">Miao, J.</span>; <span class="NLM_string-name">Fang, Q.</span>; <span class="NLM_string-name">Cao, Y.</span>; <span class="NLM_string-name">Tang, Y.</span>; <span class="NLM_string-name">Cui, J.</span>; <span class="NLM_string-name">Xu, W.</span>; <span class="NLM_string-name">Cui, L.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Jiang, L.</span></span> <span> </span><span class="NLM_article-title">A Novel Multistage Antiplasmodial Inhibitor Targeting <i>Plasmodium Falciparum</i> Histone Deacetylase 1</span>.  <i>Cell Discov.</i> <span class="NLM_year">2020</span>,  <span class="NLM_volume">6</span>, <span class="NLM_publisher-name">93</span>, <span class="refDoi"> DOI: 10.1038/s41421-020-00215-4</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fs41421-020-00215-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Z.+Huang&author=R.+Li&author=T.+Tang&author=D.+Ling&author=M.+Wang&author=D.+Xu&author=M.+Sun&author=L.+Zheng&author=F.+Zhu&author=H.+Min&author=R.+Boonhok&author=Y.+Ding&author=Y.+Wen&author=Y.+Chen&author=X.+Li&author=Y.+Chen&author=T.+Liu&author=J.+Han&author=J.+Miao&author=Q.+Fang&author=Y.+Cao&author=Y.+Tang&author=J.+Cui&author=W.+Xu&author=L.+Cui&author=J.+Zhu&author=J.+Li&author=L.+Jiang&title=Cell+Discov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41421-020-00215-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1038%252Fs41421-020-00215-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DA%2520Novel%2520Multistage%2520Antiplasmodial%2520Inhibitor%2520Targeting%2520Plasmodium%2520Falciparum%2520Histone%2520Deacetylase%25201%26btitle%3DCell%2520Discov.%26date%3D2020%26volume%3D6%26pub%3D93%26doi%3D10.1038%2Fs41421-020-00215-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, J. W. J.</span>; <span class="NLM_string-name">Houpis, I. N.</span>; <span class="NLM_string-name">Lang, Y. L.</span>; <span class="NLM_string-name">Leys, C.</span>; <span class="NLM_string-name">Stokbroekx, S. C. M.</span>; <span class="NLM_string-name">Weerts, J. E. E.</span></span> <span> </span><span class="NLM_article-title">Mono-hydrochloric Salts of an Inhibitor of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US8759519B2</span>, November 20, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+W.+J.+Dickens&author=I.+N.+Houpis&author=Y.+L.+Lang&author=C.+Leys&author=S.+C.+M.+Stokbroekx&author=J.+E.+E.+Weerts&title=Mono-hydrochloric+Salts+of+an+Inhibitor+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DJ.%2BW.%2BJ.%26atitle%3DMono-hydrochloric%2520Salts%2520of%2520an%2520Inhibitor%2520of%2520Histone%2520Deacetylase%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricklefs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waisberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairatana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krudsood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udomsangpetch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokunthea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socheat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturdevant, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcella, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awadalla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> Genome-wide Scans for Positive Selection, Recombination Hot Spots and Resistance to Antimalarial Drugs</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1038/ng.528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fng.528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20101240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=268-271&author=J.+Muauthor=R.+A.+Myersauthor=H.+Jiangauthor=S.+Liuauthor=S.+Ricklefsauthor=M.+Waisbergauthor=K.+Chotivanichauthor=P.+Wilairatanaauthor=S.+Krudsoodauthor=N.+J.+Whiteauthor=R.+Udomsangpetchauthor=L.+Cuiauthor=M.+Hoauthor=F.+Ouauthor=H.+Liauthor=J.+Songauthor=G.+Liauthor=X.+Wangauthor=S.+Seilaauthor=S.+Sokuntheaauthor=D.+Socheatauthor=D.+E.+Sturdevantauthor=S.+F.+Porcellaauthor=R.+M.+Fairhurstauthor=T.+E.+Wellemsauthor=P.+Awadallaauthor=X.+Z.+Su&title=Plasmodium+falciparum+Genome-wide+Scans+for+Positive+Selection%2C+Recombination+Hot+Spots+and+Resistance+to+Antimalarial+Drugs&doi=10.1038%2Fng.528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs</span></div><div class="casAuthors">Mu, Jianbing; Myers, Rachel A.; Jiang, Hongying; Liu, Shengfa; Ricklefs, Stacy; Waisberg, Michael; Chotivanich, Kesinee; Wilairatana, Polrat; Krudsood, Srivicha; White, Nicholas J.; Udomsangpetch, Rachanee; Cui, Liwang; Ho, May; Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao; Wang, Xinhua; Seila, Suon; Sokunthea, Sreng; Socheat, Duong; Sturdevant, Daniel E.; Porcella, Stephen F.; Fairhurst, Rick M.; Wellems, Thomas E.; Awadalla, Philip; Su, Xin-zhuan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-271</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antimalarial drugs impose strong selective pressure on Plasmodium falciparum parasites and leave signatures of selection in the parasite genome; screening for genes under selection may suggest potential drug or immune targets.  Genome-wide assocn. studies (GWAS) of parasite traits have been hampered by the lack of high-throughput genotyping methods, inadequate knowledge of parasite population history and time-consuming adaptations of parasites to in vitro culture.  Here, the authors report the first Plasmodium GWAS, which included 189 culture-adapted P. falciparum parasites genotyped using a custom-built Affymetrix mol. inversion probe 3K malaria panel array with a coverage of ∼1 SNP per 7 kb.  Population structure, variation in recombination rate and loci under recent pos. selection were detected.  Parasite half-max. inhibitory concns. for seven antimalarial drugs were obtained and used in GWAS to identify genes assocd. with drug responses.  This study provides valuable tools and insight into the P. falciparum genome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGxCGf-xYgLVg90H21EOLACvtfcHk0lgHEsbYXA18Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWrurc%253D&md5=413cb89495a114390244d160b0e9cb74</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fng.528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.528%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DR.%2BA.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRicklefs%26aufirst%3DS.%26aulast%3DWaisberg%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DWilairatana%26aufirst%3DP.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DUdomsangpetch%26aufirst%3DR.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DOu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSeila%26aufirst%3DS.%26aulast%3DSokunthea%26aufirst%3DS.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DSturdevant%26aufirst%3DD.%2BE.%26aulast%3DPorcella%26aufirst%3DS.%2BF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26aulast%3DAwadalla%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26atitle%3DPlasmodium%2520falciparum%2520Genome-wide%2520Scans%2520for%2520Positive%2520Selection%252C%2520Recombination%2520Hot%2520Spots%2520and%2520Resistance%2520to%2520Antimalarial%2520Drugs%26jtitle%3DNat.%2520Genet.%26date%3D2010%26volume%3D42%26spage%3D268%26epage%3D271%26doi%3D10.1038%2Fng.528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saintpierre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beghain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloeung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span> <span> </span><span class="NLM_article-title">A Surrogate Marker of Piperaquine-resistant <i>Plasmodium Falciparum</i> Malaria: a Phenotype-genotype Association Study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(16)30415-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2FS1473-3099%2816%2930415-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27818097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVShsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=174-183&author=B.+Witkowskiauthor=V.+Duruauthor=N.+Khimauthor=L.+S.+Rossauthor=B.+Saintpierreauthor=J.+Beghainauthor=S.+Chyauthor=S.+Kimauthor=S.+Keauthor=N.+Kloeungauthor=R.+Eamauthor=C.+Kheanauthor=M.+Kenauthor=K.+Lochauthor=A.+Bouillonauthor=A.+Domergueauthor=L.+Maauthor=C.+Bouchierauthor=R.+Leangauthor=R.+Huyauthor=G.+Nuelauthor=J.+C.+Baraleauthor=E.+Legrandauthor=P.+Ringwaldauthor=D.+A.+Fidockauthor=O.+Mercereau-Puijalonauthor=F.+Arieyauthor=D.+Menard&title=A+Surrogate+Marker+of+Piperaquine-resistant+Plasmodium+Falciparum+Malaria%3A+a+Phenotype-genotype+Association+Study&doi=10.1016%2FS1473-3099%2816%2930415-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study</span></div><div class="casAuthors">Witkowski, Benoit; Duru, Valentine; Khim, Nimol; Ross, Leila S.; Saintpierre, Benjamin; Beghain, Johann; Chy, Sophy; Kim, Saorin; Ke, Sopheakvatey; Kloeung, Nimol; Eam, Rotha; Khean, Chanra; Ken, Malen; Loch, Kaknika; Bouillon, Anthony; Domergue, Anais; Ma, Laurence; Bouchier, Christiane; Leang, Rithea; Huy, Rekol; Nuel, Gregory; Barale, Jean-Christophe; Legrand, Eric; Ringwald, Pascal; Fidock, David A.; Mercereau-Puijalon, Odile; Ariey, Frederic; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Western Cambodia is the epicentre of Plasmodium falciparum multidrug resistance and is facing high rates of dihydroartemisinin-piperaquine treatment failures.  Genetic tools to detect the multidrug-resistant parasites are needed.  Artemisinin resistance can be tracked using the K13 mol. marker, but no marker exists for piperaquine resistance.  We aimed to identify genetic markers of piperaquine resistance and study their assocn. with dihydroartemisinin-piperaquine treatment failures.  We obtained blood samples from Cambodian patients infected with P falciparum and treated with dihydroartemisinin-piperaquine.  Patients were followed up for 42 days during the years 2009-15.  We established in-vitro and ex-vivo susceptibility profiles for a subset using piperaquine survival assays.  We detd. whole-genome sequences by Illumina paired-reads sequencing, copy no. variations by qPCR, RNA concns. by qRT-PCR, and protein concns. by immunoblotting.  Fisher's exact and non-parametric Wilcoxon rank-sum tests were used to identify significant differences in single-nucleotide polymorphisms or copy no. variants, resp., for differential distribution between piperaquine-resistant and piperaquine-sensitive parasite lines.  Whole-genome exon sequence anal. of 31 culture-adapted parasite lines assocd. amplification of the plasmepsin 2-plasmepsin 3 gene cluster with in-vitro piperaquine resistance.  Ex-vivo piperaquine survival assay profiles of 134 isolates correlated with plasmepsin 2 gene copy no.  In 725 patients treated with dihydroartemisinin-piperaquine, multicopy plasmepsin 2 in the sample collected before treatment was assocd. with an adjusted hazard ratio (aHR) for treatment failure of 20·4 (95% CI 9·1-45·5, p<0·0001).  Multicopy plasmepsin 2 predicted dihydroartemisinin-piperaquine failures with 0·94 (95% CI 0·88-0·98) sensitivity and 0·77 (0·74-0·81) specificity.  Anal. of samples collected across the country from 2002 to 2015 showed that the geog. and temporal increase of the proportion of multicopy plasmepsin 2 parasites was highly correlated with increasing dihydroartemisinin-piperaquine treatment failure rates (r=0·89 [95% CI 0·77-0·95], p<0·0001, Spearman's coeff. of rank correlation).  Dihydroartemisinin-piperaquine efficacy at day 42 fell below 90% when the proportion of multicopy plasmepsin 2 parasites exceeded 22%.  Piperaquine resistance in Cambodia is strongly assocd. with amplification of plasmepsin 2-3, encoding Hb-digesting proteases, regardless of the location.  Multicopy plasmepsin 2 constitutes a surrogate mol. marker to track piperaquine resistance.  A mol. toolkit combining plasmepsin 2 with K13 and mdr1 monitoring should provide timely information for antimalarial treatment and containment policies.  Institut Pasteur in Cambodia, Institut Pasteur Paris, National Institutes of Health, WHO, Agence Nationale de la Recherche, Investissement d'Avenir program, Laboratoire d'Excellence Integrative "Biol. of Emerging Infectious Diseases".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvoDyiPpSGNbVg90H21EOLACvtfcHk0lgHEsbYXA18Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVShsLbM&md5=f4071b4b74c54848259c3c5c2b40e673</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930415-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930415-7%26sid%3Dliteratum%253Aachs%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DSaintpierre%26aufirst%3DB.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DChy%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DKloeung%26aufirst%3DN.%26aulast%3DEam%26aufirst%3DR.%26aulast%3DKhean%26aufirst%3DC.%26aulast%3DKen%26aufirst%3DM.%26aulast%3DLoch%26aufirst%3DK.%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DDomergue%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DHuy%26aufirst%3DR.%26aulast%3DNuel%26aufirst%3DG.%26aulast%3DBarale%26aufirst%3DJ.%2BC.%26aulast%3DLegrand%26aufirst%3DE.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DA%2520Surrogate%2520Marker%2520of%2520Piperaquine-resistant%2520Plasmodium%2520Falciparum%2520Malaria%253A%2520a%2520Phenotype-genotype%2520Association%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3D174%26epage%3D183%26doi%3D10.1016%2FS1473-3099%2816%2930415-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marapana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span> <span> </span><span class="NLM_article-title">Malaria: Biology and Disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.07.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.cell.2016.07.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27768886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=610-624&author=A.+F.+Cowmanauthor=J.+Healerauthor=D.+Marapanaauthor=K.+Marsh&title=Malaria%3A+Biology+and+Disease&doi=10.1016%2Fj.cell.2016.07.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria: Biology and Disease</span></div><div class="casAuthors">Cowman, Alan F.; Healer, Julie; Marapana, Danushka; Marsh, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-624</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Malaria has been a major global health problem of humans through history and is a leading cause of death and disease across many tropical and subtropical countries.  Over the last fifteen years renewed efforts at control have reduced the prevalence of malaria by over half, raising the prospect that elimination and perhaps eradication may be a long-term possibility.  Achievement of this goal requires the development of new tools including novel antimalarial drugs and more efficacious vaccines as well as an increased understanding of the disease and biol. of the parasite.  This has catalyzed a major effort resulting in development and regulatory approval of the first vaccine against malaria (RTS,S/AS01) as well as identification of novel drug targets and antimalarial compds., some of which are in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-6Sl33soPLVg90H21EOLACvtfcHk0liRv9icatpqbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrnF&md5=9260ee8a73d8da971fd0691300839b08</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.07.055%26sid%3Dliteratum%253Aachs%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DHealer%26aufirst%3DJ.%26aulast%3DMarapana%26aufirst%3DD.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DMalaria%253A%2520Biology%2520and%2520Disease%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D610%26epage%3D624%26doi%3D10.1016%2Fj.cell.2016.07.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mair, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuschewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span> <span> </span><span class="NLM_article-title">High Efficiency Transfection of <i>Plasmodium Berghei</i> Facilitates Novel Selection Procedures</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.molbiopara.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=16242190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=60-70&author=C.+J.+Janseauthor=B.+Franke-Fayardauthor=G.+R.+Mairauthor=J.+Ramesarauthor=C.+Thielauthor=S.+Engelmannauthor=K.+Matuschewskiauthor=G.+J.+van+Gemertauthor=R.+W.+Sauerweinauthor=A.+P.+Waters&title=High+Efficiency+Transfection+of+Plasmodium+Berghei+Facilitates+Novel+Selection+Procedures&doi=10.1016%2Fj.molbiopara.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">High efficiency transfection of Plasmodium berghei facilitates novel selection procedures</span></div><div class="casAuthors">Janse, Chris J.; Franke-Fayard, Blandine; Mair, Gunnar R.; Ramesar, Jai; Thiel, Corinna; Engelmann, Sabine; Matuschewski, Kai; van Gemert, Geert Jan; Sauerwein, Robert W.; Waters, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-70</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The use of transfection in the study of the biol. of malaria parasites has been limited due to poor transfection efficiencies (frequency of 10-6 to 10-9) and a paucity of selectable markers.  Here, a new method of transfection, using non-viral Nucleofector technol., is described for the rodent parasite Plasmodium berghei.  The transfection efficiency obtained (episomal and targeted integration into the genome) is in the range of 10-2 to 10-3.  Such high transfection efficiency strongly reduces the time, no. of lab. animals and amt. of materials required to generate transfected parasites.  Moreover, it allows different exptl. strategies for reverse genetics to be developed and we demonstrate direct selection of stably and non-reversibly transformed, fluorescent protein (FP)-expressing parasites using FACS.  Since there is no need to use a drug-selectable marker, this method increases the (low) no. of selectable markers available for transformation of P. berghei and can in principle be extended to utilize addnl. FP.  Furthermore the FACS-selected, FP-expressing parasites may serve as easily visualized ref. lines that may still be genetically manipulated with the existing drug-selectable markers.  The combination of enhanced transfection efficiency and a versatile rodent model provides a basis for the further development of novel tools for high throughput genome manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCeNdKkjHOrVg90H21EOLACvtfcHk0liRv9icatpqbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE&md5=6f0aec711668825f48cf2b54067f1be6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%26aulast%3DMair%26aufirst%3DG.%2BR.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DC.%26aulast%3DEngelmann%26aufirst%3DS.%26aulast%3DMatuschewski%26aufirst%3DK.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26atitle%3DHigh%2520Efficiency%2520Transfection%2520of%2520Plasmodium%2520Berghei%2520Facilitates%2520Novel%2520Selection%2520Procedures%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2006%26volume%3D145%26spage%3D60%26epage%3D70%26doi%3D10.1016%2Fj.molbiopara.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manary, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Targeting <i>Plasmodium</i> PI(4)K to Eliminate Malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature12782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnature12782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24284631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=248-253&author=C.+W.+McNamaraauthor=M.+C.+S.+Leeauthor=C.+S.+Limauthor=S.+H.+Limauthor=J.+Rolandauthor=A.+Nagleauthor=O.+Simonauthor=B.+K.+S.+Yeungauthor=A.+K.+Chatterjeeauthor=S.+L.+McCormackauthor=M.+J.+Manaryauthor=A.-M.+Zeemanauthor=K.+J.+Decheringauthor=T.+R.+S.+Kumarauthor=P.+P.+Henrichauthor=K.+Gagaringauthor=M.+Ibanezauthor=N.+Katoauthor=K.+L.+Kuhenauthor=C.+Fischliauthor=M.+Rottmannauthor=D.+M.+Plouffeauthor=B.+Bursulayaauthor=S.+Meisterauthor=L.+Ramehauthor=J.+Trappeauthor=D.+Haasenauthor=M.+Timmermanauthor=R.+W.+Sauerweinauthor=R.+Suwanaruskauthor=B.+Russellauthor=L.+Reniaauthor=F.+Nostenauthor=D.+C.+Tullyauthor=C.+H.+M.+Kockenauthor=R.+J.+Glynneauthor=C.+Bodenreiderauthor=D.+A.+Fidockauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Targeting+Plasmodium+PI%284%29K+to+Eliminate+Malaria&doi=10.1038%2Fnature12782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Plasmodium PI(4)K to eliminate malaria</span></div><div class="casAuthors">McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7479</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages.  Here the authors identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compd. class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host.  Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi.  The authors show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate.  Collectively, the authors' data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOmMeWluIubVg90H21EOLACvtfcHk0lga2yafnIqe8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP&md5=9ed8f3e41d257bb4535b4c813abd54cf</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnature12782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12782%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DO.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DMcCormack%26aufirst%3DS.%2BL.%26aulast%3DManary%26aufirst%3DM.%2BJ.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DRameh%26aufirst%3DL.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DTimmerman%26aufirst%3DM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520Plasmodium%2520PI%25284%2529K%2520to%2520Eliminate%2520Malaria%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature12782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boullé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriprawat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDew-White, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-resistant <i>Plasmodium Falciparum</i> K13 Mutant Alleles, Thailand–Myanmar Border</span>. <i>Emerg. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1505</span>, <span class="refDoi"> DOI: 10.3201/eid2208.160004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.3201%2Feid2208.160004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27433806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC2s3itlSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1503-1505&author=M.+Boull%C3%A9author=B.+Witkowskiauthor=V.+Duruauthor=K.+Sriprawatauthor=S.+K.+Nairauthor=M.+McDew-Whiteauthor=T.+J.+C.+Andersonauthor=A.+P.+Phyoauthor=D.+Menardauthor=F.+Nosten&title=Artemisinin-resistant+Plasmodium+Falciparum+K13+Mutant+Alleles%2C+Thailand%E2%80%93Myanmar+Border&doi=10.3201%2Feid2208.160004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border</span></div><div class="casAuthors">Boulle Mikael; Witkowski Benoit; Duru Valentine; Sriprawat Kanlaya; Nair Shalini K; McDew-White Marina; Anderson Tim J C; Phyo Aung Pyae; Menard Didier; Nosten Francois</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1503-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS333hXxw2omCCEBeYuoi7AfW6udTcc2ebxyoxuxHXoi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3itlSrtw%253D%253D&md5=ed366660db2212e0f87353b146a258a2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3201%2Feid2208.160004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid2208.160004%26sid%3Dliteratum%253Aachs%26aulast%3DBoull%25C3%25A9%26aufirst%3DM.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DSriprawat%26aufirst%3DK.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DMcDew-White%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26atitle%3DArtemisinin-resistant%2520Plasmodium%2520Falciparum%2520K13%2520Mutant%2520Alleles%252C%2520Thailand%25E2%2580%2593Myanmar%2520Border%26jtitle%3DEmerg.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D22%26spage%3D1503%26epage%3D1505%26doi%3D10.3201%2Feid2208.160004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariën, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliën, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilatte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilissen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vreys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talloen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goris, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Jardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janicot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Emelen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P.</span></span> <span> </span><span class="NLM_article-title">JNJ-26481585, a Novel “Second-generation” Oral Histone Deacetylase Inhibitor, Shows Broad-spectrum Preclinical Antitumoral Activity</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6841</span>– <span class="NLM_lpage">6851</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-0547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1158%2F1078-0432.CCR-09-0547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=19861438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=6841-6851&author=J.+Artsauthor=P.+Kingauthor=A.+Mari%C3%ABnauthor=W.+Florenauthor=A.+Beli%C3%ABnauthor=L.+Janssenauthor=I.+Pilatteauthor=B.+Rouxauthor=L.+Decraneauthor=R.+Gilissenauthor=I.+Hicksonauthor=V.+Vreysauthor=E.+Coxauthor=K.+Bolauthor=W.+Talloenauthor=I.+Gorisauthor=L.+Andriesauthor=M.+Du+Jardinauthor=M.+Janicotauthor=M.+Pageauthor=K.+van+Emelenauthor=P.+Angibaud&title=JNJ-26481585%2C+a+Novel+%E2%80%9CSecond-generation%E2%80%9D+Oral+Histone+Deacetylase+Inhibitor%2C+Shows+Broad-spectrum+Preclinical+Antitumoral+Activity&doi=10.1158%2F1078-0432.CCR-09-0547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity</span></div><div class="casAuthors">Arts, Janine; King, Peter; Marien, Ann; Floren, Wim; Belien, Ann; Janssen, Lut; Pilatte, Isabelle; Roux, Bruno; Decrane, Laurence; Gilissen, Ron; Hickson, Ian; Vreys, Veronique; Cox, Eugene; Bol, Kees; Talloen, Willem; Goris, Ilse; Andries, Luc; Du Jardin, Marc; Janicot, Michel; Page, Martin; van Emelen, Kristof; Angibaud, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6841-6851</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Histone deacetylase (HDAC) inhibitors have shown promising clin. activity in the treatment of hematol. malignancies, but their activity in solid tumor indications has been limited.  Most HDAC inhibitors in clin. development only transiently induce histone acetylation in tumor tissue.  Here, we sought to identify a "second-generation" class I HDAC inhibitor with prolonged pharmacodynamic response in vivo, to assess whether this results in superior antitumoral efficacy.  Exptl. Design: To identify novel HDAC inhibitors with superior pharmacodynamic properties, we developed a preclin. in vivo tumor model, in which tumor cells have been engineered to express fluorescent protein dependent on HDAC1 inhibition, thereby allowing noninvasive real-time evaluation of the tumor response to HDAC inhibitors.  Results: In vivo pharmacodynamic anal. of 140 potent pyrimidyl-hydroxamic acid analogs resulted in the identification of JNJ-26481585.  Once daily oral administration of JNJ-26481585 induced continuous histone H3 acetylation.  The prolonged pharmacodynamic response translated into complete tumor growth inhibition in Ras mutant HCT116 colon carcinoma xenografts, whereas 5-fluorouracil was less active.  JNJ-26481585 also fully inhibited the growth of C170HM2 colorectal liver metastases, whereas again 5-fluorouracil/Leucovorin showed modest activity.  Further characterization revealed that JNJ-26481585 is a pan-HDAC inhibitor with marked potency toward HDAC1 (IC50, 0.16 nmol/L).  Conclusions: The potent antitumor activity as a single agent in preclin. models combined with its favorable pharmacodynamic profile makes JNJ-26481585 a promising "second-generation" HDAC inhibitor.  The compd. is currently in clin. studies, to evaluate its potential applicability in a broad spectrum of both solid and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKc9hyMiADZrVg90H21EOLACvtfcHk0lga2yafnIqe8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ktLzE&md5=8f199c25c92c967a76f273d879d6c577</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0547%26sid%3Dliteratum%253Aachs%26aulast%3DArts%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DMari%25C3%25ABn%26aufirst%3DA.%26aulast%3DFloren%26aufirst%3DW.%26aulast%3DBeli%25C3%25ABn%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DL.%26aulast%3DPilatte%26aufirst%3DI.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DDecrane%26aufirst%3DL.%26aulast%3DGilissen%26aufirst%3DR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DVreys%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DE.%26aulast%3DBol%26aufirst%3DK.%26aulast%3DTalloen%26aufirst%3DW.%26aulast%3DGoris%26aufirst%3DI.%26aulast%3DAndries%26aufirst%3DL.%26aulast%3DDu%2BJardin%26aufirst%3DM.%26aulast%3DJanicot%26aufirst%3DM.%26aulast%3DPage%26aufirst%3DM.%26aulast%3Dvan%2BEmelen%26aufirst%3DK.%26aulast%3DAngibaud%26aufirst%3DP.%26atitle%3DJNJ-26481585%252C%2520a%2520Novel%2520%25E2%2580%259CSecond-generation%25E2%2580%259D%2520Oral%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520Shows%2520Broad-spectrum%2520Preclinical%2520Antitumoral%2520Activity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D6841%26epage%3D6851%26doi%3D10.1158%2F1078-0432.CCR-09-0547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prommana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uthaipibull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongsombat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamchonwongpaisan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuthavong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuepfer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. J.</span></span> <span> </span><span class="NLM_article-title">Inducible Knockdown of <i>Plasmodium</i> Gene Expression Using the <i>glmS</i> Ribozyme</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73783</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pone.0073783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24023691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=P.+Prommanaauthor=C.+Uthaipibullauthor=C.+Wongsombatauthor=S.+Kamchonwongpaisanauthor=Y.+Yuthavongauthor=E.+Knuepferauthor=A.+A.+Holderauthor=P.+J.+Shaw&title=Inducible+Knockdown+of+Plasmodium+Gene+Expression+Using+the+glmS+Ribozyme&doi=10.1371%2Fjournal.pone.0073783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Inducible knockdown of Plasmodium gene expression using the glmS ribozyme</span></div><div class="casAuthors">Prommana, Parichat; Uthaipibull, Chairat; Wongsombat, Chayaphat; Kamchonwongpaisan, Sumalee; Yuthavong, Yongyuth; Knuepfer, Ellen; Holder, Anthony A.; Shaw, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e73783</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Conventional reverse genetic approaches for study of Plasmodium malaria parasite gene function are limited, or not applicable.  Hence, new inducible systems are needed.  Here we describe a method to control P. falciparum gene expression in which target genes bearing a glmS ribozyme in the 3' untranslated region are efficiently knocked down in transgenic P. falciparum parasites in response to glucosamine inducer.  Using reporter genes, we show that the glmS ribozyme cleaves reporter mRNA in vivo leading to redn. in mRNA expression following glucosamine treatment.  Glucosamine-induced ribozyme activation led to efficient redn. of reporter protein, which could be rapidly reversed by removing the inducer.  The glmS ribozyme was validated as a reverse-genetic tool by integration into the essential gene and antifolate drug target dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).  Glucosamine treatment of transgenic parasites led to rapid and efficient knockdown of PfDHFR-TS mRNA and protein.  PfDHFR-TS knockdown led to a growth/arrest mutant phenotype and hypersensitivity to pyrimethamine.  The glmS ribozyme may thus be a tool for study of essential genes in P. falciparum and other parasite species amenable to transfection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9O7ED3rN_XbVg90H21EOLACvtfcHk0ljf3rjG37A6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLnK&md5=8139aa444ad0931c0487ab01edf4ebc1</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073783%26sid%3Dliteratum%253Aachs%26aulast%3DPrommana%26aufirst%3DP.%26aulast%3DUthaipibull%26aufirst%3DC.%26aulast%3DWongsombat%26aufirst%3DC.%26aulast%3DKamchonwongpaisan%26aufirst%3DS.%26aulast%3DYuthavong%26aufirst%3DY.%26aulast%3DKnuepfer%26aufirst%3DE.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DInducible%2520Knockdown%2520of%2520Plasmodium%2520Gene%2520Expression%2520Using%2520the%2520glmS%2520Ribozyme%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghorbal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rubio, J. J.</span></span> <span> </span><span class="NLM_article-title">Genome Editing in the Human Malaria Parasite <i>Plasmodium Falciparum</i> Using the CRISPR-Cas9 System</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1038/nbt.2925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnbt.2925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24880488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=819-821&author=M.+Ghorbalauthor=M.+Gormanauthor=C.+R.+Macphersonauthor=R.+M.+Martinsauthor=A.+Scherfauthor=J.+J.+Lopez-Rubio&title=Genome+Editing+in+the+Human+Malaria+Parasite+Plasmodium+Falciparum+Using+the+CRISPR-Cas9+System&doi=10.1038%2Fnbt.2925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system</span></div><div class="casAuthors">Ghorbal, Mehdi; Gorman, Molly; MacPherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">819-821</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome manipulation in the malaria parasite Plasmodium falciparum remains largely intractable and improved genomic tools are needed to further understand pathogenesis and drug resistance.  We demonstrated the CRISPR-Cas9 system for use in P. falciparum by disrupting chromosomal loci and generating marker-free, single-nucleotide substitutions with high efficiency.  Addnl., an artemisinin-resistant strain was generated by introducing a previously implicated polymorphism, thus illustrating the value of efficient genome editing in malaria research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlTMgyo5Q0zrVg90H21EOLACvtfcHk0ljf3rjG37A6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCgtLg%253D&md5=71e895d9c64baa6be829e9e9fb774705</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2925%26sid%3Dliteratum%253Aachs%26aulast%3DGhorbal%26aufirst%3DM.%26aulast%3DGorman%26aufirst%3DM.%26aulast%3DMacpherson%26aufirst%3DC.%2BR.%26aulast%3DMartins%26aufirst%3DR.%2BM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DLopez-Rubio%26aufirst%3DJ.%2BJ.%26atitle%3DGenome%2520Editing%2520in%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%2520Using%2520the%2520CRISPR-Cas9%2520System%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26spage%3D819%26epage%3D821%26doi%3D10.1038%2Fnbt.2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ontoria, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrigno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biancofiore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malancona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresciani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsale, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veneziano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective Series of Inhibitors of <i>Plasmodium falciparum</i> HDACs</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00468</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00468" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=454-459&author=J.+M.+Ontoriaauthor=G.+Paonessaauthor=S.+Ponziauthor=F.+Ferrignoauthor=E.+Niziauthor=I.+Biancofioreauthor=S.+Malanconaauthor=R.+Grazianiauthor=D.+Robertsauthor=P.+Willisauthor=A.+Brescianiauthor=N.+Gennariauthor=O.+Cecchettiauthor=E.+Monteagudoauthor=M.+V.+Orsaleauthor=M.+Venezianoauthor=A.+Di+Marcoauthor=A.+Cellucciauthor=R.+Lauferauthor=S.+Altamuraauthor=V.+Summaauthor=S.+Harper&title=Discovery+of+a+Selective+Series+of+Inhibitors+of+Plasmodium+falciparum+HDACs&doi=10.1021%2Facsmedchemlett.5b00468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs</span></div><div class="casAuthors">Ontoria, Jesus M.; Paonessa, Giacomo; Ponzi, Simona; Ferrigno, Federica; Nizi, Emanuela; Biancofiore, Ilaria; Malancona, Savina; Graziani, Rita; Roberts, David; Willis, Paul; Bresciani, Alberto; Gennari, Nadia; Cecchetti, Ottavia; Monteagudo, Edith; Orsale, Maria V.; Veneziano, Maria; Di Marco, Annalise; Cellucci, Antonella; Laufer, Ralph; Altamura, Sergio; Summa, Vincenzo; Harper, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a new series of P. falciparum growth inhibitors is described.  Starting from a series of known human class I HDAC inhibitors a SAR exploration based on growth inhibitory activity in parasite and human cells-based assays led to the identification of compds. with submicromolar inhibition of P. falciparum growth (EC50 < 500 nM) and good selectivity over the activity of human HDAC in cells (up to >50-fold).  Inhibition of parasital HDACs as the mechanism of action of this new class of selective growth inhibitors is supported by hyperacetylation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2IhJExDD3WbVg90H21EOLACvtfcHk0ljf3rjG37A6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqurw%253D&md5=e0155db1e624465bf36caf13b3a14271</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00468%26sid%3Dliteratum%253Aachs%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DFerrigno%26aufirst%3DF.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DBiancofiore%26aufirst%3DI.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DGraziani%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DWillis%26aufirst%3DP.%26aulast%3DBresciani%26aufirst%3DA.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DCecchetti%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DOrsale%26aufirst%3DM.%2BV.%26aulast%3DVeneziano%26aufirst%3DM.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DCellucci%26aufirst%3DA.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520Series%2520of%2520Inhibitors%2520of%2520Plasmodium%2520falciparum%2520HDACs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D454%26epage%3D459%26doi%3D10.1021%2Facsmedchemlett.5b00468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayavara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavstsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theander, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aravind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. H.</span></span> <span> </span><span class="NLM_article-title"><i>Pf</i>SETvs Methylation of Histone H3K36 Represses Virulence Genes in <i>Plasmodium falciparum</i></span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>499</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1038/nature12361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnature12361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23823717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2013&pages=223-227&author=L.+Jiangauthor=J.+Muauthor=Q.+Zhangauthor=T.+Niauthor=P.+Srinivasanauthor=K.+Rayavaraauthor=W.+Yangauthor=L.+Turnerauthor=T.+Lavstsenauthor=T.+G.+Theanderauthor=W.+Pengauthor=G.+Weiauthor=Q.+Jingauthor=Y.+Wakabayashiauthor=A.+Bansalauthor=Y.+Luoauthor=J.+M.+C.+Ribeiroauthor=A.+Scherfauthor=L.+Aravindauthor=J.+Zhuauthor=K.+Zhaoauthor=L.+H.+Miller&title=PfSETvs+Methylation+of+Histone+H3K36+Represses+Virulence+Genes+in+Plasmodium+falciparum&doi=10.1038%2Fnature12361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum</span></div><div class="casAuthors">Jiang, Lubin; Mu, Jianbing; Zhang, Qingfeng; Ni, Ting; Srinivasan, Prakash; Rayavara, Kempaiah; Yang, Wenjing; Turner, Louise; Lavstsen, Thomas; Theander, Thor G.; Peng, Weiqun; Wei, Guiying; Jing, Qingqing; Wakabayashi, Yoshiyuki; Bansal, Abhisheka; Luo, Yan; Ribeiro, Jose M. C.; Scherf, Artur; Aravind, L.; Zhu, Jun; Zhao, Keji; Miller, Louis H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">499</span>
        (<span class="NLM_cas:issue">7457</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is expressed on the surface of P. falciparum-infected red blood cells, is a crit. virulence factor for malaria.  Each parasite has 60 antigenically distinct var genes that each code for a different PfEMP1 protein.  During infection, the clonal parasite population expresses only one gene at a time before switching to the expression of a new variant antigen as an immune-evasion mechanism to avoid the host antibody response.  The mechanism by which 59 of the 60 var genes are silenced remains largely unknown.  Here, the authors show that knocking out the P. falciparum variant-silencing SET gene (here termed PfSETvs), which encodes an ortholog of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, results in the transcription of virtually all var genes in the single parasite nuclei and their expression as proteins on the surface of individual infected red blood cells.  PfSETvs-dependent H3K36me3 is present along the entire gene body, including the transcription start site, to silence var genes.  With low occupancy of PfSETvs at both the transcription start site of var genes and the intronic promoter, expression of var genes coincides with transcription of their corresponding antisense long noncoding RNA.  These results uncover a previously unknown role of PfSETvs-dependent H3K36me3 in silencing var genes in P. falciparum that might provide a general mechanism by which orthologues of PfSETvs repress gene expression in other eukaryotes.  PfSETvs knockout parasites expressing all PfEMP1 proteins may also be applied to the development of a malaria vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2fB2f-8mUPbVg90H21EOLACvtfcHk0lguQheJSZEmMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsr%252FM&md5=7c507e7aecd5b158738965204ebcb4fb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature12361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12361%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DT.%26aulast%3DSrinivasan%26aufirst%3DP.%26aulast%3DRayavara%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DTurner%26aufirst%3DL.%26aulast%3DLavstsen%26aufirst%3DT.%26aulast%3DTheander%26aufirst%3DT.%2BG.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DWakabayashi%26aufirst%3DY.%26aulast%3DBansal%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DAravind%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DL.%2BH.%26atitle%3DPfSETvs%2520Methylation%2520of%2520Histone%2520H3K36%2520Represses%2520Virulence%2520Genes%2520in%2520Plasmodium%2520falciparum%26jtitle%3DNature%26date%3D2013%26volume%3D499%26spage%3D223%26epage%3D227%26doi%3D10.1038%2Fnature12361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and Inexpensive Fluorescence-based Technique for High-throughput Antimalarial Drug Screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+Inexpensive+Fluorescence-based+Technique+for+High-throughput+Antimalarial+Drug+Screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lguQheJSZEmMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520Inexpensive%2520Fluorescence-based%2520Technique%2520for%2520High-throughput%2520Antimalarial%2520Drug%2520Screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinzei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuda, M.</span></span> <span> </span><span class="NLM_article-title">A Calcium-dependent Protein Kinase Regulates <i>Plasmodium</i> Ookinete Access to the Midgut Epithelial Cell</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.05014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1111%2Fj.1365-2958.2005.05014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=16430692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD28XislWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=1175-1184&author=T.+Ishinoauthor=Y.+Oritoauthor=Y.+Chinzeiauthor=M.+Yuda&title=A+Calcium-dependent+Protein+Kinase+Regulates+Plasmodium+Ookinete+Access+to+the+Midgut+Epithelial+Cell&doi=10.1111%2Fj.1365-2958.2005.05014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A calcium-dependent protein kinase regulates Plasmodium ookinete access to the midgut epithelial cell</span></div><div class="casAuthors">Ishino, Tomoko; Orito, Yuki; Chinzel, Yasuo; Yuda, Masao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Plasmodium parasites are fertilized in the mosquito midgut and develop into motile zygotes, called ookinetes, which invade the midgut epithelium.  Here we show that a calcium-dependent protein kinase, CDPK3, of the rodent malarial parasite (Plasmodium berghei) is produced in the ookinete stage and has a crit. role in parasite transmission to the mosquito vector.  Targeted disruption of the CDPK3 gene decreased ookinete ability to infect the mosquito midgut by nearly two orders of magnitude.  Electron microscopic analyses demonstrated that the disruptant ookinetes could not access midgut epithelial cells by traversing the layer covering the cell surface.  An in vitro migration assay showed that these ookinetes lack the ability to migrate through an artificial gel, suggesting that this defect caused their failure to access the epithelium.  In vitro migration assays also suggested that this motility is induced in the wild type by mobilization of intracellular stored calcium.  These results indicate that a signaling pathway involving calcium and CDPK3 regulates ookinete penetration of the layer covering the midgut epithelium.  Because humans do not possess CDPK family proteins, CDPK3 is a good target for blocking malarial transmission to the mosquito vector.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlHpqhGhm7nbVg90H21EOLACvtfcHk0lgGn6NdGmTKSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislWhsro%253D&md5=0298f9942e050150a025c8914d138d6c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.05014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.05014.x%26sid%3Dliteratum%253Aachs%26aulast%3DIshino%26aufirst%3DT.%26aulast%3DOrito%26aufirst%3DY.%26aulast%3DChinzei%26aufirst%3DY.%26aulast%3DYuda%26aufirst%3DM.%26atitle%3DA%2520Calcium-dependent%2520Protein%2520Kinase%2520Regulates%2520Plasmodium%2520Ookinete%2520Access%2520to%2520the%2520Midgut%2520Epithelial%2520Cell%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D59%26spage%3D1175%26epage%3D1184%26doi%3D10.1111%2Fj.1365-2958.2005.05014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brancucci, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederwieser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wampfler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freymond, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T. S.</span></span> <span> </span><span class="NLM_article-title">Heterochromatin Protein 1 Secures Survival and Transmission of Malaria Parasites</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.chom.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25121746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=165-176&author=N.+M.+B.+Brancucciauthor=N.+L.+Bertschiauthor=L.+Zhuauthor=I.+Niederwieserauthor=W.+H.+Chinauthor=R.+Wampflerauthor=C.+Freymondauthor=M.+Rottmannauthor=I.+Felgerauthor=Z.+Bozdechauthor=T.+S.+Voss&title=Heterochromatin+Protein+1+Secures+Survival+and+Transmission+of+Malaria+Parasites&doi=10.1016%2Fj.chom.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Heterochromatin Protein 1 Secures Survival and Transmission of Malaria Parasites</span></div><div class="casAuthors">Brancucci, Nicolas M. B.; Bertschi, Nicole L.; Zhu, Lei; Niederwieser, Igor; Chin, Wai Hoe; Wampfler, Rahel; Freymond, Celine; Rottmann, Matthias; Felger, Ingrid; Bozdech, Zbynek; Voss, Till S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clonally variant expression of surface antigens allows the malaria parasite Plasmodium falciparum to evade immune recognition during blood stage infection and secure malaria transmission.  We demonstrate that heterochromatin protein 1 (HP1), an evolutionary conserved regulator of heritable gene silencing, controls expression of numerous P. falciparum virulence genes as well as differentiation into the sexual forms that transmit to mosquitoes.  Conditional depletion of P. falciparum HP1 (PfHP1) prevents mitotic proliferation of blood stage parasites and disrupts mutually exclusive expression and antigenic variation of the major virulence factor PfEMP1.  Addnl., PfHP1-dependent regulation of PfAP2-G, a transcription factor required for gametocyte conversion, controls the switch from asexual proliferation to sexual differentiation, providing insight into the epigenetic mechanisms underlying gametocyte commitment.  These findings show that PfHP1 is centrally involved in clonally variant gene expression and sexual differentiation in P. falciparum and have major implications for developing antidisease and transmission-blocking interventions against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7HbcmA9FpHbVg90H21EOLACvtfcHk0lgGn6NdGmTKSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KqsrfJ&md5=102db8673da3841a859d3eae9a828c3d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrancucci%26aufirst%3DN.%2BM.%2BB.%26aulast%3DBertschi%26aufirst%3DN.%2BL.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DNiederwieser%26aufirst%3DI.%26aulast%3DChin%26aufirst%3DW.%2BH.%26aulast%3DWampfler%26aufirst%3DR.%26aulast%3DFreymond%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DFelger%26aufirst%3DI.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DVoss%26aufirst%3DT.%2BS.%26atitle%3DHeterochromatin%2520Protein%25201%2520Secures%2520Survival%2520and%2520Transmission%2520of%2520Malaria%2520Parasites%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2014%26volume%3D16%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.chom.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoy, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billadeau, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">A Series of Potent and Selective, Triazolylphenyl-based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and <i>Plasmodium Falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3448</span>, <span class="refDoi"> DOI: 10.1021/jm701606b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701606b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3437-3448&author=Y.+Chenauthor=M.+Lopez-Sanchezauthor=D.+N.+Savoyauthor=D.+D.+Billadeauauthor=G.+S.+Dowauthor=A.+P.+Kozikowski&title=A+Series+of+Potent+and+Selective%2C+Triazolylphenyl-based+Histone+Deacetylases+Inhibitors+with+Activity+against+Pancreatic+Cancer+Cells+and+Plasmodium+Falciparum&doi=10.1021%2Fjm701606b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum</span></div><div class="casAuthors">Chen, Yufeng; Lopez-Sanchez, Miriam; Savoy, Doris N.; Billadeau, Daniel D.; Dow, Geoffrey S.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3437-3448</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the rules governing the inhibition of the various HDAC isoforms is likely to be key to identifying improved therapeutics that act as epigenetic modulators of gene transcription.  Herein we present results on the modification of the CAP region of a set of triazolylphenyl-based HDACIs, and show that the nature of substitution on the Ph ring plays a role in their selectivity for HDAC1 vs. HDAC6, with low to moderate selectivity (2-51-fold) being achieved.  In light of the valuable selectivity and potency that were identified for the triazolylphenyl ligand 6b in the inhibition of HDAC6 (IC50 = 1.9 nM), this compd. represents a valuable research tool and a candidate for further chem. modifications.  Lastly, these new HDACIs were studied for both their anticancer and antimalarial activity, which serve to validate the superior activity of the HDACI 10c.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtC-MXCaqyVLVg90H21EOLACvtfcHk0lgGn6NdGmTKSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtF2rs7c%253D&md5=5a9e96ed8e268a04d387ca1f60b57837</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm701606b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701606b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLopez-Sanchez%26aufirst%3DM.%26aulast%3DSavoy%26aufirst%3DD.%2BN.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DA%2520Series%2520of%2520Potent%2520and%2520Selective%252C%2520Triazolylphenyl-based%2520Histone%2520Deacetylases%2520Inhibitors%2520with%2520Activity%2520against%2520Pancreatic%2520Cancer%2520Cells%2520and%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3437%26epage%3D3448%26doi%3D10.1021%2Fjm701606b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohann  Le Govic</span>, <span class="hlFld-ContribAuthor ">Sandrine  Houzé</span>, <span class="hlFld-ContribAuthor ">Nicolas  Papon</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing Anticancer Drugs To Tackle Malaria. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (14)
                                     , 2192-2194. <a href="https://doi.org/10.1002/cmdc.202100176" title="DOI URL">https://doi.org/10.1002/cmdc.202100176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100176%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRepurposing%252BAnticancer%252BDrugs%252BTo%252BTackle%252BMalaria%26aulast%3DLe%2BGovic%26aufirst%3DYohann%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D14%26spage%3D2192%26epage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of US FDA-approved anticancer HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design of Novel Spirocyclic Hydroxamic Acid Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2–32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl 2-chloropyrimidine-5-carboxylate, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (b) HCl/1,4-dioxane (4 M), CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (c) PhCH<sub>2</sub>OC(O)Cl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (d) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, H<sub>2</sub>O, 65 °C; (e) THPONH<sub>2</sub>, EDCI, HOBt, Et<sub>3</sub>N, Me<sub>2</sub>NCHO, 25 °C; (f) Et<sub>3</sub>SiH, Pd/C, CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub> (1:1 v/v), 25 °C; (g) R-CHO, NaBH<sub>3</sub>(CN), CH<sub>3</sub>OH, 25 °C; (h) HCl/1,4-dioxane (4 M), CH<sub>2</sub>Cl<sub>2</sub>, 25 °C.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>In vivo</i> erythrocytic antimalarial activity of compounds <b>1</b>, <b>2</b>, <b>11</b>, and <b>16</b>–<b>19</b>. Blank indicates the non-drug-treated group. Each group contained five mice. Piperaquine phosphate (PPQ) was selected as a positive control. Mice were infected by 10<sup>5</sup><i>P. yoelli</i> in red blood cells (RBCs) with saline via intraperitoneal injection at day 0, and compound in vehicle or vehicle alone (blank) was delivered intraperitoneally once a day on days 1–5. Tail vein blood smears were collected on the indicated days, and the percentage of parasitemia was determined via microscopic examination of 5000 red bold cells and expressed as the mean ± SD. Percentage of parasitemia (A) and survival ratio (B) of compounds <b>1</b>, <b>11</b>, and <b>17</b> at doses of 10 and 30 mg/kg. Percentage of parasitemia (C) and the survival ratio (D) of compounds <b>1</b>, <b>2</b>, <b>11</b>, <b>16</b>, <b>18</b>, and <b>19</b> at a dose of 60 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vivo</i> liver-stage antimalarial activity of compounds <b>1</b> and <b>11</b>. Blank indicates the non-drug-treated group. Each group contained five mice. KDU-691 was selected as a positive control. Mice were intravenously administered vehicle alone (blank) or a single dose of the test compound in the vehicle at the indicated dose after inoculation with of 5000 sporozoites at day 0. Bioluminescence was detected on days 1–4 after inoculation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> erythrocytic stage-specific inhibition of compounds <b>1</b> and <b>11</b>. (A) Schematic diagram of the experimental design. Highly synchronized ring-stage 3D7 parasites were incubated with <b>1</b> or <b>11</b> at a concentration of 10 × IC<sub>50</sub> (3D7) for three consecutive periods of 12 h corresponding to the parasite erythrocytic life cycle. Then, the parasites were transferred into compound-free culture medium and was diluted to 1/40. Dimethyl sulfoxide (DMSO) was used as a negative control. At 50 ± 2 hpi, morphological analysis of the parasites was conducted by microscopy. At 50 ± 2 and 146 ± 2 hpi, parasitemia was counted by flow cytometry. hpi, hours post infection. (B) Morphological analysis of the parasites at 50 ± 2 hpi observed by Giemsa-staining smear. (C) Parasitemia from reinvasion analysis at 50 ± 2 hpi counted by flow cytometry. (D) Parasitemia from growth analysis at 146 ± 2 hpi. For (C) and (D), parasitemia is shown as the mean ± SEM of 100,000 RBCs from three independent biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vitro</i> RSA of DHA, <b>1</b>, and <b>11</b> against artemisinin-resistant Parasites. Highly synchronized ring-stage 6218 and 6320 parasites carrying the kelch 13 C508Y mutation were incubated with 700 nM concentrations of compound <b>1</b>, compound <b>11</b>, DHA, or DMSO (same volume, negative control) for 6 h and then washed three times with the fresh medium and further cultivated in the compound-free medium for 66 h. Blood smears were collected, and parasitemia was counted in at least 10,000 RBCs by microscopy. The percentage of parasite survival was defined as parasitemia (compound) / parasitemia (DMSO) × 100%</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hyperacetylation analysis of <i>P. falciparum</i> histone H3 by compounds <b>1</b> and <b>11</b>. DMSO was selected as the blank control, vorinostat (SAHA) as the positive control, and H3 as the loading control. Asynchronous 3D7 parasites were treated with DMSO or a 20 × IC<sub>50</sub> concentration of SAHA, <b>1</b>, or <b>11</b> for 4 h, and then parasite nuclear protein samples were harvested for the histone H3 acetylation level (H3-Ac) detection via the western blot assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/medium/jm0c02104_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effect of compounds <b>1</b> and <b>11</b> against <i>Pf</i>HDAC1/2. (A, D) RT-qPCR verification of the gene expression of <i>PfHDCA1</i> (A) or <i>PfHDAC2</i> (D) in 3D7<sup>HDAC1-TY1</sup>/3D7<sup>HDAC1-<i>glmS</i></sup> (A) or 3D7<sup>HDAC2-TY1</sup>/3D7<sup>HDAC2-<i>glmS</i></sup> (D) parasites in the ring (R), trophozoite (T), and schizont (S) stages after cultivation with 2.5 mM glucosamine (GlcN). The expression values were normalized by the housekeeping gene <i>seryl-tRNA synthetase</i>. (B, E) Inhibition rate curves of compound <b>1</b> against transgenic 3D7 parasites from (A) and (D), respectively. (C, F) Inhibition rate curves of compound <b>11</b> against transgenic 3D7 parasites from (A) and (D), respectively. (C, F) Inhibition rate curves and IC<sub>50</sub> values of compound <b>11</b> against transgenic 3D7 parasites from (A) and (D), respectively. (G) IC<sub>50</sub> values of compounds <b>1</b> and <b>11</b> against four transgenic 3D7 parasites treated with GlcN or recombinant <i>Pf</i>HDAC1 protein. Data in (A)–(G) are the mean ± SEM obtained from three biological repeats except the inhibition against <i>Pf</i>HDAC1 are the mean ± SD obtained from two independent biological repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c02104/20210218/images/large/jm0c02104_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02104&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Malaria%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherbuin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Drug Discovery – the Path towards Eradication</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1017/S0031182013000826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1017%2FS0031182013000826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23863111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=128-139&author=J.+N.+Burrowsauthor=E.+Burlotauthor=B.+Campoauthor=S.+Cherbuinauthor=S.+Jeanneretauthor=D.+Leroyauthor=T.+Spangenbergauthor=D.+Watersonauthor=T.+N.+Wellsauthor=P.+Willis&title=Antimalarial+Drug+Discovery+%E2%80%93+the+Path+towards+Eradication&doi=10.1017%2FS0031182013000826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - the path towards eradication</span></div><div class="casAuthors">Burrows Jeremy N; Burlot Emilie; Campo Brice; Cherbuin Stephanie; Jeanneret Sarah; Leroy Didier; Spangenberg Thomas; Waterson David; Wells Timothy Nc; Willis Paul</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a disease that still affects a significant proportion of the global human population.  Whilst advances have been made in lowering the numbers of cases and deaths, it is clear that a strategy based solely on disease control year on year, without reducing transmission and ultimately eradicating the parasite, is unsustainable.  This article highlights the current mainstay treatments alongside a selection of emerging new clinical molecules from the portfolio of Medicines for Malaria Venture (MMV) and our partners.  In each case, the key highlights from each research phase are described to demonstrate how these new potential medicines were discovered.  Given the increased focus of the community on eradicating the disease, the strategy for next generation combination medicines that will provide such potential is explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3YKOgrIcfkIvKgEt20y1XfW6udTcc2eZpjJOeVKjyS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhslGhuw%253D%253D&md5=24b1b3b746eb152a54f68c090cad3421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS0031182013000826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182013000826%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBurlot%26aufirst%3DE.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DCherbuin%26aufirst%3DS.%26aulast%3DJeanneret%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3DWillis%26aufirst%3DP.%26atitle%3DAntimalarial%2520Drug%2520Discovery%2520%25E2%2580%2593%2520the%2520Path%2520towards%2520Eradication%26jtitle%3DParasitology%26date%3D2014%26volume%3D141%26spage%3D128%26epage%3D139%26doi%3D10.1017%2FS0031182013000826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Guidelines for the Treatment of Malaria,
Third Edition</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=World+Health+Organization&title=Guidelines+for+the+Treatment+of+Malaria%2C%0AThird+Edition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DGuidelines%2520for%2520the%2520Treatment%2520of%2520Malaria%252C%250AThird%2520Edition%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Drug Resistance: Linking <i>Plasmodium Falciparum</i> Parasite Biology to the Clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1038/nm.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnm.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=28777791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=917-928&author=B.+Blascoauthor=D.+Leroyauthor=D.+A.+Fidock&title=Antimalarial+Drug+Resistance%3A+Linking+Plasmodium+Falciparum+Parasite+Biology+to+the+Clinic&doi=10.1038%2Fnm.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic</span></div><div class="casAuthors">Blasco, Benjamin; Leroy, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-928</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria.  However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivs. and ACT partner drugs, resulting in increasing rates of treatment failures.  Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combating resistance, optimizing treatment and advancing the global campaign to eliminate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbN71qlYUi97Vg90H21EOLACvtfcHk0ljvIH1yKfuNuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yit7%252FO&md5=832e6fdea00ba5ddc25308c682758eb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4381%26sid%3Dliteratum%253Aachs%26aulast%3DBlasco%26aufirst%3DB.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DAntimalarial%2520Drug%2520Resistance%253A%2520Linking%2520Plasmodium%2520Falciparum%2520Parasite%2520Biology%2520to%2520the%2520Clinic%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D917%26epage%3D928%26doi%3D10.1038%2Fnm.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Status Report on Artemisinin Resistance
and ACT Efficacy</i>; <span class="NLM_publisher-name">World Health Organization</span>, December, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Status+Report+on+Artemisinin+Resistance%0Aand+ACT+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DStatus%2520Report%2520on%2520Artemisinin%2520Resistance%250Aand%2520ACT%2520Efficacy%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span> <span> </span><span class="NLM_article-title">A Temporizing Solution to ″Artemisinin Resistance″</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1056/NEJMp1901233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1056%2FNEJMp1901233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=31018065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FoslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=2087-2089&author=J.+Wangauthor=C.+Xuauthor=F.+L.+Liaoauthor=T.+Jiangauthor=S.+Krishnaauthor=Y.+Tu&title=A+Temporizing+Solution+to+%E2%80%B3Artemisinin+Resistance%E2%80%B3&doi=10.1056%2FNEJMp1901233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Temporizing Solution to "Artemisinin Resistance"</span></div><div class="casAuthors">Wang Jigang; Xu Chengchao; Liao Fu Long; Jiang Tingliang; Krishna Sanjeev; Tu Youyou</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2087-2089</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9xWJtaaze2v3jf77P2BG3fW6udTcc2eZpjJOeVKjyS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FoslamtA%253D%253D&md5=214cbb6f2ef0a4b51a728e974c8d5975</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1901233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1901233%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DF.%2BL.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DY.%26atitle%3DA%2520Temporizing%2520Solution%2520to%2520%25E2%2580%25B3Artemisinin%2520Resistance%25E2%2580%25B3%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D2087%26epage%3D2089%26doi%3D10.1056%2FNEJMp1901233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimondo, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rots, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeronimo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdasco, M.</span></span> <span> </span><span class="NLM_article-title">The Timeline of Epigenetic Drug Discovery: from Reality to Dreams</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1186/s13148-019-0776-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1186%2Fs13148-019-0776-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=31791394" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=174-190&author=A.+Ganesanauthor=P.+B.+Arimondoauthor=M.+G.+Rotsauthor=C.+Jeronimoauthor=M.+Berdasco&title=The+Timeline+of+Epigenetic+Drug+Discovery%3A+from+Reality+to+Dreams&doi=10.1186%2Fs13148-019-0776-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2Fs13148-019-0776-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-019-0776-0%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DArimondo%26aufirst%3DP.%2BB.%26aulast%3DRots%26aufirst%3DM.%2BG.%26aulast%3DJeronimo%26aufirst%3DC.%26aulast%3DBerdasco%26aufirst%3DM.%26atitle%3DThe%2520Timeline%2520of%2520Epigenetic%2520Drug%2520Discovery%253A%2520from%2520Reality%2520to%2520Dreams%26jtitle%3DClin.%2520Epigenet.%26date%3D2019%26volume%3D11%26spage%3D174%26epage%3D190%26doi%3D10.1186%2Fs13148-019-0776-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hailu, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4780</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4780-4804&author=G.+S.+Hailuauthor=D.+Robaaauthor=M.+Forgioneauthor=W.+Sipplauthor=D.+Rotiliauthor=A.+Mai&title=Lysine+Deacetylase+Inhibitors+in+Parasites%3A+Past%2C+Present%2C+and+Future+Perspectives&doi=10.1021%2Facs.jmedchem.6b01595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives</span></div><div class="casAuthors">Hailu, Gebremedhin S.; Robaa, Dina; Forgione, Mariantonietta; Sippl, Wolfgang; Rotili, Dante; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4780-4804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current therapies for human parasite infections rely on a few drugs, most of which have severe side effects, and their helpfulness is being seriously compromised by the drug resistance problem.  Globally, this is pushing discovery research of antiparasitic drugs toward new agents endowed with new mechanisms of action.  By using a "drug repurposing" strategy, histone deacetylase inhibitors (HDACi), which are presently clin. approved for cancer use, are now under investigation for various parasite infections.  Because parasitic Zn2+- and NAD+-dependent HDACs play crucial roles in the modulation of parasite gene expression and many of them are pro-survival for several parasites under various conditions, they are now emerging as novel potential antiparasitic targets.  This Perspective summarizes the state of knowledge of HDACi (both class I/II HDACi and sirtuin inhibitors) targeted to the main human parasitic diseases (schistosomiasis, malaria, trypanosomiasis, leishmaniasis, and toxoplasmosis) and provides visions into the main issues that challenge their development as antiparasitic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHB7ia90mr4LVg90H21EOLACvtfcHk0ljxs8DKxSuiaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaksr4%253D&md5=7969f188d68e38d6254e98feb771613d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01595%26sid%3Dliteratum%253Aachs%26aulast%3DHailu%26aufirst%3DG.%2BS.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DLysine%2520Deacetylase%2520Inhibitors%2520in%2520Parasites%253A%2520Past%252C%2520Present%252C%2520and%2520Future%2520Perspectives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4780%26epage%3D4804%26doi%3D10.1021%2Facs.jmedchem.6b01595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancio-Silva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Meza, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Rivas, R.</span></span> <span> </span><span class="NLM_article-title">Differential Association of Orc1 and Sir2 Proteins to Telomeric Domains in <i>Plasmodium Falciparum</i></span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">2046</span>– <span class="NLM_lpage">2053</span>, <span class="refDoi"> DOI: 10.1242/jcs.026427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1242%2Fjcs.026427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=18525026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=2046-2053&author=L.+Mancio-Silvaauthor=A.+P.+Rojas-Mezaauthor=M.+Vargasauthor=A.+Scherfauthor=R.+Hernandez-Rivas&title=Differential+Association+of+Orc1+and+Sir2+Proteins+to+Telomeric+Domains+in+Plasmodium+Falciparum&doi=10.1242%2Fjcs.026427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differential association of Orc1 and Sir2 proteins to telomeric domains in Plasmodium falciparum</span></div><div class="casAuthors">Mancio-Silva, Liliana; Rojas-Meza, Ana Paola; Vargas, Miguel; Scherf, Artur; Hernandez-Rivas, Rosaura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2046-2053</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Telomeres have the capacity to recruit proteins that facilitate the spreading of heterochromatin into subtelomeric DNA regions.  In the human protozoan pathogen Plasmodium falciparum, the telomere-assocd. protein Sir2 has been shown to control the silencing of members of virulence genes at some, but not all, chromosome-end loci, indicating that addnl. proteins are involved in telomere position effect.  Here, we identified, in P. falciparum, a novel telomere-assocd. protein that displays homol. with the origin-of-recognition-complex 1 protein Orc1.  Antibodies raised against this P. falciparum protein localized to telomeric clusters in the nuclear periphery and the nucleolus.  It was found that, prior to DNA replication, P. falciparum Orc1 and Sir2 undergo drastic subcellular reorganization, such as dissocn. from the telomere cluster and spreading into the nucleus and parasite cytoplasm.  Relocation of Orc1 and Sir2 was also linked to the partial dissocn. of telomere clusters.  Super gel-shift and chromatin-immunopptn. expts. showed the phys. assocn. of Orc1 with telomere repeats but revealed a differential assocn. with adjacent non-coding repeat DNA elements.  The data suggest that Plasmodium telomeres might fold back and that Orc1 cooperates with Sir2 in telomeric silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNibQxom2UrVg90H21EOLACvtfcHk0ljxs8DKxSuiaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFakt70%253D&md5=203e4cdef40fe30a145ef262a023c95e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1242%2Fjcs.026427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.026427%26sid%3Dliteratum%253Aachs%26aulast%3DMancio-Silva%26aufirst%3DL.%26aulast%3DRojas-Meza%26aufirst%3DA.%2BP.%26aulast%3DVargas%26aufirst%3DM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DHernandez-Rivas%26aufirst%3DR.%26atitle%3DDifferential%2520Association%2520of%2520Orc1%2520and%2520Sir2%2520Proteins%2520to%2520Telomeric%2520Domains%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2008%26volume%3D121%26spage%3D2046%26epage%3D2053%26doi%3D10.1242%2Fjcs.026427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carret, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span> <span> </span><span class="NLM_article-title">Sir2 Paralogues Cooperate to Regulate Virulence Genes and Antigenic Variation in <i>Plasmodium Falciparum</i></span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pbio.1000084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=771-779&author=C.+J.+Tonkinauthor=C.+K.+Carretauthor=M.+T.+Duraisinghauthor=T.+S.+Vossauthor=S.+A.+Ralphauthor=M.+Hommelauthor=M.+F.+Duffyauthor=L.+M.+da+Silvaauthor=A.+Scherfauthor=A.+Ivensauthor=T.+P.+Speedauthor=J.+G.+Beesonauthor=A.+F.+Cowman&title=Sir2+Paralogues+Cooperate+to+Regulate+Virulence+Genes+and+Antigenic+Variation+in+Plasmodium+Falciparum&doi=10.1371%2Fjournal.pbio.1000084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000084%26sid%3Dliteratum%253Aachs%26aulast%3DTonkin%26aufirst%3DC.%2BJ.%26aulast%3DCarret%26aufirst%3DC.%2BK.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26aulast%3DVoss%26aufirst%3DT.%2BS.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DHommel%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DM.%2BF.%26aulast%3Dda%2BSilva%26aufirst%3DL.%2BM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DIvens%26aufirst%3DA.%26aulast%3DSpeed%26aufirst%3DT.%2BP.%26aulast%3DBeeson%26aufirst%3DJ.%2BG.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26atitle%3DSir2%2520Paralogues%2520Cooperate%2520to%2520Regulate%2520Virulence%2520Genes%2520and%2520Antigenic%2520Variation%2520in%2520Plasmodium%2520Falciparum%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D771%26epage%3D779%26doi%3D10.1371%2Fjournal.pbio.1000084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaal, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastuwidyaningtyas, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luah, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylases Play a Major Role in the Transcriptional Regulation of the <i>Plasmodium Falciparum</i> Life Cycle</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000737</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.ppat.1000737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20107518" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&author=B.+K.+Chaalauthor=A.+P.+Guptaauthor=B.+D.+Wastuwidyaningtyasauthor=Y.+H.+Luahauthor=Z.+Bozdech&title=Histone+Deacetylases+Play+a+Major+Role+in+the+Transcriptional+Regulation+of+the+Plasmodium+Falciparum+Life+Cycle&doi=10.1371%2Fjournal.ppat.1000737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000737%26sid%3Dliteratum%253Aachs%26aulast%3DChaal%26aufirst%3DB.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BP.%26aulast%3DWastuwidyaningtyas%26aufirst%3DB.%2BD.%26aulast%3DLuah%26aufirst%3DY.%2BH.%26aulast%3DBozdech%26aufirst%3DZ.%26atitle%3DHistone%2520Deacetylases%2520Play%2520a%2520Major%2520Role%2520in%2520the%2520Transcriptional%2520Regulation%2520of%2520the%2520Plasmodium%2520Falciparum%2520Life%2520Cycle%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26doi%3D10.1371%2Fjournal.ppat.1000737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobert, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span> <span> </span><span class="NLM_article-title">Comparative Gene Expression Profiling of <i>P falciparum Malaria Parasites Exposed to Three Different Histone Deacetylase Inhibitors</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e31847</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0031847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pone.0031847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22384084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFylsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+T.+Andrewsauthor=A.+P.+Guptaauthor=T.+N.+Tranauthor=D.+P.+Fairlieauthor=G.+N.+Gobertauthor=Z.+Bozdech&title=Comparative+Gene+Expression+Profiling+of+P+falciparum+Malaria+Parasites+Exposed+to+Three+Different+Histone+Deacetylase+Inhibitors&doi=10.1371%2Fjournal.pone.0031847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors</span></div><div class="casAuthors">Andrews, Katherine T.; Gupta, Archna P.; Tran, Thanh N.; Fairlie, David P.; Gobert, Geoffrey N.; Bozdech, Zbynek</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e31847</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors are being intensively pursued as potential new drugs for a range of diseases, including malaria.  HDAC inhibitors are also important tools for the study of epigenetic mechanisms, transcriptional control, and other important cellular processes.  In this study the effects of three structurally related antimalarial HDAC inhibitors on P. falciparum malaria parasite gene expression were compared.  The three hydroxamate-based compds., trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA; Vorinostat) and a 2-aminosuberic acid deriv. (2-ASA-9), all caused profound transcriptional effects, with ∼ 2-21% of genes having >2-fold altered expression following 2 h exposure to the compds.  Only two genes, alpha tubulin II and a hydrolase, were up-regulated by all three compds. after 2 h exposure in all biol. replicates examd.  The transcriptional changes obsd. after 2 h exposure to HDAC inhibitors were found to be largely transitory, with only 1-5 % of genes being regulated after removing the compds. and culturing for a further 2 h.  Despite some structural similarity, the three inhibitors caused quite diverse transcriptional effects, possibly reflecting subtle differences in mode of action or cellular distribution.  This dataset represents an important contribution to our understanding of how HDAC inhibitors act on malaria parasites and identifies alpha tubulin II as a potential transcriptional marker of HDAC inhibition in malaria parasites that may be able to be exploited for future development of HDAC inhibitors as new antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6BwfqS4RO_rVg90H21EOLACvtfcHk0lh51q4WPbHREg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFylsLs%253D&md5=3b1d97984e1f643427ff6278e3804545</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031847%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DGupta%26aufirst%3DA.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DGobert%26aufirst%3DG.%2BN.%26aulast%3DBozdech%26aufirst%3DZ.%26atitle%3DComparative%2520Gene%2520Expression%2520Profiling%2520of%2520P%2520falciparum%2520Malaria%2520Parasites%2520Exposed%2520to%2520Three%2520Different%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0031847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. K.</span></span> <span> </span><span class="NLM_article-title">HDAC Inhibitors in Parasitic Diseases</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/icb.2011.97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Ficb.2011.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22124373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=66-77&author=K.+T.+Andrewsauthor=A.+Haqueauthor=M.+K.+Jones&title=HDAC+Inhibitors+in+Parasitic+Diseases&doi=10.1038%2Ficb.2011.97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitors in parasitic diseases</span></div><div class="casAuthors">Andrews, Katherine T.; Haque, Ashraful; Jones, Malcolm K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-77</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Parasitic diseases cause significant global morbidity and mortality, particularly in underdeveloped regions of the world.  Malaria alone causes ∼800 000 deaths each year, with children and pregnant women being at highest risk.  There is no licensed vaccine available for any human parasitic disease and drug resistance is compromising the efficacy of many available anti-parasitic drugs.  This is driving drug discovery research on new agents with novel modes of action.  Histone deacetylase (HDAC) inhibitors are being investigated as drugs for a range of diseases, including cancers and infectious diseases such as HIV/AIDS, and several parasitic diseases.  This review focuses on the current state of knowledge of HDAC inhibitors targeted to the major human parasitic diseases malaria, schistosomiasis, trypanosomiasis, toxoplasmosis and leishmaniasis.  Insights are provided into the unique challenges that will need to be considered if HDAC inhibitors are to be progressed towards clin. development as potential new anti-parasitic drugs.  Immunol. and Cell Biol. (2012) 90, 66-77; doi:10.1038/icb.2011.97; published online 29 Nov. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkvVI4Oq1MYbVg90H21EOLACvtfcHk0lhhAbshtkRGpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslyltA%253D%253D&md5=dfddf07627e40d37df311c5b4ef8a29d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Ficb.2011.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.2011.97%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DHaque%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DM.%2BK.%26atitle%3DHDAC%2520Inhibitors%2520in%2520Parasitic%2520Diseases%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D90%26spage%3D66%26epage%3D77%26doi%3D10.1038%2Ficb.2011.97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs</span>. <i>Curr. Pharm. Design</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3479</span>, <span class="refDoi"> DOI: 10.2174/138161212801327257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.2174%2F138161212801327257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22607140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KltrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=3467-3479&author=K.+T.+Andrewsauthor=T.+N.+Tranauthor=D.+P.+Fairlie&title=Towards+Histone+Deacetylase+Inhibitors+as+New+Antimalarial+Drugs&doi=10.2174%2F138161212801327257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Towards histone deacetylase inhibitors as new antimalarial drugs</span></div><div class="casAuthors">Andrews, Katherine T.; Tran, Thanh N.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3467-3479</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are important enzymes that effect post-translational modifications of proteins by altering the acetylation state of lysine residues.  HDACs control epigenetic changes that trigger cell transformation and proliferation of transformed cells assocd. with many diseases.  These enzymes are validated drug targets for some types of cancer and are promising therapeutic targets for a range of other diseases, including malaria.  Annually, there are ∼500 million clin. cases of malaria and ∼0.8-1.2 million deaths.  There is no licensed vaccine for preventing malaria, and parasites that cause malaria are becoming resistant to current drugs, necessitating the search for new therapies.  HDAC inhibitors are emerging as a promising new class of antimalarial drugs with potent and selective action against Plasmodium parasites in vitro.  Recent studies on the effects of HDAC inhibitors on the growth and development of P. falciparum have provided important new information on transcriptional regulation in malaria parasites and have validated the potential of this class of inhibitors for malaria therapy.  To realize effective HDAC inhibitors for clin. trials, next generation inhibitors must not inhibit other human HDACs or proteins required for normal human physiol., be highly selective in killing parasites in vivo without killing normal host cells, and have improved bioavailability and pharmacokinetic profiles.  This review summarizes current knowledge about malaria parasite HDACs and HDAC inhibitors with antimalarial properties, and provides insights for their development into new drugs for treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-TC7XQUTlLVg90H21EOLACvtfcHk0lhhAbshtkRGpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KltrfK&md5=8499726373358c2b61e28639c53cedba</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161212801327257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212801327257%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DTowards%2520Histone%2520Deacetylase%2520Inhibitors%2520as%2520New%2520Antimalarial%2520Drugs%26jtitle%3DCurr.%2520Pharm.%2520Design%26date%3D2012%26volume%3D18%26spage%3D3467%26epage%3D3479%26doi%3D10.2174%2F138161212801327257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancio-Silva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rubio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span> <span> </span><span class="NLM_article-title">Si2a Regulates rDNA Transcription and Multiplication Rate in the Human Malaria Parasite <i>Plasmodium Falciparum</i></span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1530</span>, <span class="refDoi"> DOI: 10.1038/ncomms2539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fncomms2539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23443558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC3svhslersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1530&author=L.+Mancio-Silvaauthor=J.+J.+Lopez-Rubioauthor=A.+Claesauthor=A.+Scherf&title=Si2a+Regulates+rDNA+Transcription+and+Multiplication+Rate+in+the+Human+Malaria+Parasite+Plasmodium+Falciparum&doi=10.1038%2Fncomms2539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sir2a regulates rDNA transcription and multiplication rate in the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Mancio-Silva Liliana; Lopez-Rubio Jose Juan; Claes Aurelie; Scherf Artur</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1530</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Plasmodium falciparum histone deacetylase Sir2a localizes at telomeric regions where it contributes to epigenetic silencing of clonally variant virulence genes.  Apart from telomeres, PfSir2a also accumulates in the nucleolus, which harbours the developmentally regulated ribosomal RNA genes.  Here we investigate the nucleolar function of PfSir2a and demonstrate that PfSir2a fine-tunes ribosomal RNA gene transcription.  Using a parasite line in which PfSir2a has been disrupted, we observe that histones near the transcription start sites of all ribosomal RNA genes are hyperacetylated and that transcription of ribosomal RNA genes is upregulated.  Complementation of the PfSir2a-disrupted parasites restores the ribosomal RNA levels, whereas PfSir2a overexpression in wild-type parasites decreases ribosomal RNA synthesis.  Furthermore, we observe that PfSir2a modulation of ribosomal RNA synthesis is linked to an altered number of daughter merozoites and the parasite multiplication rate.  These findings provide new insights into an epigenetic mechanism that controls malaria parasite proliferation and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNNvXEU0QC0IUSrryheKE6fW6udTcc2eauPYSblANCMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svhslersA%253D%253D&md5=01ae424a0abe3467de29481a50f97266</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncomms2539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2539%26sid%3Dliteratum%253Aachs%26aulast%3DMancio-Silva%26aufirst%3DL.%26aulast%3DLopez-Rubio%26aufirst%3DJ.%2BJ.%26aulast%3DClaes%26aufirst%3DA.%26aulast%3DScherf%26aufirst%3DA.%26atitle%3DSi2a%2520Regulates%2520rDNA%2520Transcription%2520and%2520Multiplication%2520Rate%2520in%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1530%26doi%3D10.1038%2Fncomms2539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childs, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenhofen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldowitz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafsack, B. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckee, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span> <span> </span><span class="NLM_article-title">A <i>Plasmodium Falciparum</i> Histone Deacetylase Regulates Antigenic Variation and Gametocyte Conversion</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2014.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.chom.2014.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25121747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OjtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=177-186&author=B.+I.+Colemanauthor=K.+M.+Skillmanauthor=R.+H.+Y.+Jiangauthor=L.+M.+Childsauthor=L.+M.+Altenhofenauthor=M.+Ganterauthor=Y.+Leungauthor=I.+Goldowitzauthor=B.+F.+C.+Kafsackauthor=M.+Martiauthor=M.+Llin%C3%A1sauthor=C.+O.+Buckeeauthor=M.+T.+Duraisingh&title=A+Plasmodium+Falciparum+Histone+Deacetylase+Regulates+Antigenic+Variation+and+Gametocyte+Conversion&doi=10.1016%2Fj.chom.2014.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Plasmodium falciparum Histone Deacetylase Regulates Antigenic Variation and Gametocyte Conversion</span></div><div class="casAuthors">Coleman, Bradley I.; Skillman, Kristen M.; Jiang, Rays H. Y.; Childs, Lauren M.; Altenhofen, Lindsey M.; Ganter, Markus; Leung, Yvette; Goldowitz, Ilana; Kafsack, Bjorn F. C.; Marti, Matthias; Llinas, Manuel; Buckee, Caroline O.; Duraisingh, Manoj T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The asexual forms of the malaria parasite Plasmodium falciparum are adapted for chronic persistence in human red blood cells, continuously evading host immunity using epigenetically regulated antigenic variation of virulence-assocd. genes.  Parasite survival on a population level also requires differentiation into sexual forms, an obligatory step for further human transmission.  We reveal that the essential nuclear gene, P. falciparum histone deacetylase 2 (PfHda2), is a global silencer of virulence gene expression and controls the frequency of switching from the asexual cycle to sexual development.  PfHda2 depletion leads to dysregulated expression of both virulence-assocd. var genes and PfAP2-g, a transcription factor controlling sexual conversion, and is accompanied by increases in gametocytogenesis.  Math. modeling further indicates that PfHda2 has likely evolved to optimize the parasite's infectious period by achieving low frequencies of virulence gene expression switching and sexual conversion.  This common regulation of cellular transcriptional programs mechanistically links parasite transmissibility and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7_de7f4ySrVg90H21EOLACvtfcHk0lhwNa_JOICXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OjtLvO&md5=fc0b76408ac427d0b3489ede96b9ac31</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2014.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2014.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DB.%2BI.%26aulast%3DSkillman%26aufirst%3DK.%2BM.%26aulast%3DJiang%26aufirst%3DR.%2BH.%2BY.%26aulast%3DChilds%26aufirst%3DL.%2BM.%26aulast%3DAltenhofen%26aufirst%3DL.%2BM.%26aulast%3DGanter%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DY.%26aulast%3DGoldowitz%26aufirst%3DI.%26aulast%3DKafsack%26aufirst%3DB.%2BF.%2BC.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DBuckee%26aufirst%3DC.%2BO.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26atitle%3DA%2520Plasmodium%2520Falciparum%2520Histone%2520Deacetylase%2520Regulates%2520Antigenic%2520Variation%2520and%2520Gametocyte%2520Conversion%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2014%26volume%3D16%26spage%3D177%26epage%3D186%26doi%3D10.1016%2Fj.chom.2014.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darkin-Rattray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurnett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulski, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumley, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allocco, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombrowski, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polishook, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmatz, D. M.</span></span> <span> </span><span class="NLM_article-title">Apicidin: a Novel Antiprotozoal Agent that Inhibits Parasite Histone Deacetylase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">13143</span>– <span class="NLM_lpage">13147</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.23.13143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1073%2Fpnas.93.23.13143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=8917558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADyaK28XmvV2qtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=13143-13147&author=S.+J.+Darkin-Rattrayauthor=A.+M.+Gurnettauthor=R.+W.+Myersauthor=P.+M.+Dulskiauthor=T.+M.+Crumleyauthor=J.+J.+Alloccoauthor=C.+Cannovaauthor=P.+T.+Meinkeauthor=S.+L.+Collettiauthor=M.+A.+Bednarekauthor=S.+B.+Singhauthor=M.+A.+Goetzauthor=A.+W.+Dombrowskiauthor=J.+D.+Polishookauthor=D.+M.+Schmatz&title=Apicidin%3A+a+Novel+Antiprotozoal+Agent+that+Inhibits+Parasite+Histone+Deacetylase&doi=10.1073%2Fpnas.93.23.13143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase</span></div><div class="casAuthors">Darkin-Rattray, Sandra J.; Gurnett, Anne M.; Myers, Robert W.; Dulski, Paula M.; Crumley, Tami M.; Allocco, John J.; Cannova, Christine; Meinke, Peter T.; Colletti, Steven L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13143-13147</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel fungal metabolite, apicidin [cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)], that exhibits potent, broad spectrum antiprotozoal activity in vitro against Apicomplexan parasites has been identified.  It is also orally and parenterally active in vivo against Plasmodium berghei malaria in mice.  Many Apicomplexan parasites cause serious, life-threatening human and animal diseases, such as malaria, cryptosporidiosis, toxoplasmosis, and coccidiosis, and new therapeutic agents are urgently needed.  Apicidin's antiparasitic activity appears to be due to low nanomolar inhibition of Apicomplexan histone deacetylase (HDA), which induces hyperacetylation of histones in treated parasites.  The acetylation-deacetylation of histones is thought to play a central role in transcriptional control in eukaryotic cells.  Other known HDA inhibitors were also evaluated and found to possess antiparasitic activity, suggesting that HDA is an attractive target for the development of novel antiparasitic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqub6fPyIvFQrVg90H21EOLACvtfcHk0lhwNa_JOICXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvV2qtrk%253D&md5=3738f88674b6e5856d55bab7a0701e22</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.23.13143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.23.13143%26sid%3Dliteratum%253Aachs%26aulast%3DDarkin-Rattray%26aufirst%3DS.%2BJ.%26aulast%3DGurnett%26aufirst%3DA.%2BM.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DDulski%26aufirst%3DP.%2BM.%26aulast%3DCrumley%26aufirst%3DT.%2BM.%26aulast%3DAllocco%26aufirst%3DJ.%2BJ.%26aulast%3DCannova%26aufirst%3DC.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DBednarek%26aufirst%3DM.%2BA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DGoetz%26aufirst%3DM.%2BA.%26aulast%3DDombrowski%26aufirst%3DA.%2BW.%26aulast%3DPolishook%26aufirst%3DJ.%2BD.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26atitle%3DApicidin%253A%2520a%2520Novel%2520Antiprotozoal%2520Agent%2520that%2520Inhibits%2520Parasite%2520Histone%2520Deacetylase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D13143%26epage%3D13147%26doi%3D10.1073%2Fpnas.93.23.13143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walduck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, P. G.</span></span> <span> </span><span class="NLM_article-title">Anti-malarial Effect of Histone Deacetylation Inhibitors and Mammalian Tumour Cytodifferentiating Agents</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1016/S0020-7519(00)00043-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2FS0020-7519%2800%2900043-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10856511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslyrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=761-768&author=K.+T.+Andrewsauthor=A.+Walduckauthor=M.+J.+Kelsoauthor=D.+P.+Fairlieauthor=A.+Saulauthor=P.+G.+Parsons&title=Anti-malarial+Effect+of+Histone+Deacetylation+Inhibitors+and+Mammalian+Tumour+Cytodifferentiating+Agents&doi=10.1016%2FS0020-7519%2800%2900043-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents</span></div><div class="casAuthors">Andrews, Kathy T.; Walduck, Anna; Kelso, Mike J.; Fairlie, David P.; Saul, Allan; Parsons, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The histones of Plasmodium falciparum represent a potential new target for anti-malarial compds.  A naturally occurring compd., apicidin, has recently been shown to inhibit the in vitro growth of P. falciparum.  Apicidin was shown to hyperacetylate histones, suggesting that its mode of action is through histone deacetylase inhibition.  We have tested the ability of known histone deacetylase inhibitors, mammalian tumor suppressor compds., and cytodifferentiating agents to inhibit the in vitro growth of a drug sensitive and resistant strain of P. falciparum.  Seven of the tested compds. had μM IC50 values, and trichostatin A, a histone deacetylation inhibitor and cytodifferentiating agent, was active at low nM concns.  One compd., suberic acid bisdimethylamide, which selectively arrests tumor cells as opposed to normal mammalian cells, had an in vivo cytostatic effect against the acute murine malaria Plasmodium berghei, and one round of treatment with the compd. failed to select for resistant mutations.  These results suggest a promising role for histone deacetylase inhibitors and cytodifferentiating agents as antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRESA5UQICWLVg90H21EOLACvtfcHk0ljfJl3F0HQ6Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslyrtr4%253D&md5=74f82add94f7167d8953ddcdd87ab619</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2800%2900043-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252800%252900043-6%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DWalduck%26aufirst%3DA.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DP.%2BG.%26atitle%3DAnti-malarial%2520Effect%2520of%2520Histone%2520Deacetylation%2520Inhibitors%2520and%2520Mammalian%2520Tumour%2520Cytodifferentiating%2520Agents%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2000%26volume%3D30%26spage%3D761%26epage%3D768%26doi%3D10.1016%2FS0020-7519%2800%2900043-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Activity of Phenylthiazolyl-bearing Hydroxamate-based Histone Deacetylase Inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3477</span>, <span class="refDoi"> DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+Activity+of+Phenylthiazolyl-bearing+Hydroxamate-based+Histone+Deacetylase+Inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 μM.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0lgdNGtDMKbwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520Activity%2520of%2520Phenylthiazolyl-bearing%2520Hydroxamate-based%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sumanadasa, S. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3849</span>– <span class="NLM_lpage">3856</span>, <span class="refDoi"> DOI: 10.1128/AAC.00030-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.00030-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=22508312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2isbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3849-3856&author=S.+D.+M.+Sumanadasaauthor=C.+D.+Goodmanauthor=A.+J.+Luckeauthor=T.+Skinner-Adamsauthor=I.+Sahamaauthor=A.+Haqueauthor=T.+A.+Doauthor=G.+I.+McFaddenauthor=D.+P.+Fairlieauthor=K.+T.+Andrews&title=Antimalarial+Activity+of+the+Anticancer+Histone+Deacetylase+Inhibitor+SB939&doi=10.1128%2FAAC.00030-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of the anticancer histone deacetylase inhibitor SB939</span></div><div class="casAuthors">Sumanadasa, Subathdrage D. M.; Goodman, Christopher D.; Lucke, Andrew J.; Skinner-Adams, Tina; Sahama, Ishani; Haque, Ashraful; Do, Tram Anh; McFadden, Geoffrey I.; Fairlie, David P.; Andrews, Katherine T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3849-3856</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymes posttranslationally modify lysines on histone and nonhistone proteins and play crucial roles in epigenetic regulation and other important cellular processes.  HDAC inhibitors (e.g., suberoylanilide hydroxamic acid [SAHA; also known as vorinostat]) are used clin. to treat some cancers and are under investigation for use against many other diseases.  Development of new HDAC inhibitors for noncancer indications has the potential to be accelerated by piggybacking onto cancer studies, as several HDAC inhibitors have undergone or are undergoing clin. trials.  One such compd., SB939, is a new orally active hydroxamate-based HDAC inhibitor with an improved pharmacokinetic profile compared to that of SAHA.  In this study, the in vitro and in vivo antiplasmodial activities of SB939 were investigated.  SB939 was found to be a potent inhibitor of the growth of Plasmodium falciparum asexual-stage parasites in vitro (50% inhibitory concn. [IC50], 100 to 200 nM), causing hyperacetylation of parasite histone and nonhistone proteins.  In combination with the aspartic protease inhibitor lopinavir, SB939 displayed additive activity.  SB939 also potently inhibited the in vitro growth of exoerythrocytic-stage Plasmodium parasites in liver cells (IC50, ∼150 nM), suggesting that inhibitor targeting to multiple malaria parasite life cycle stages may be possible.  In an exptl. in vivo murine model of cerebral malaria, orally administered SB939 significantly inhibited P. berghei ANKA parasite growth, preventing development of cerebral malaria-like symptoms.  These results identify SB939 as a potent new antimalarial HDAC inhibitor and underscore the potential of investigating next-generation anticancer HDAC inhibitors as prospective new drug leads for treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9VOh-rgoatLVg90H21EOLACvtfcHk0lgdNGtDMKbwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2isbk%253D&md5=39b3013e97dec44eb326bd8d86101519</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.00030-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00030-12%26sid%3Dliteratum%253Aachs%26aulast%3DSumanadasa%26aufirst%3DS.%2BD.%2BM.%26aulast%3DGoodman%26aufirst%3DC.%2BD.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%26aulast%3DSahama%26aufirst%3DI.%26aulast%3DHaque%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DT.%2BA.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26atitle%3DAntimalarial%2520Activity%2520of%2520the%2520Anticancer%2520Histone%2520Deacetylase%2520Inhibitor%2520SB939%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3849%26epage%3D3856%26doi%3D10.1128%2FAAC.00030-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignola, D.</span></span> <span> </span><span class="NLM_article-title">Hydroxamic Acid Based Histone Deacetylase Inhibitors with Confirmed Activity against the Malaria Parasite</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.bmcl.2014.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25563890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=459-461&author=G.+Gianniniauthor=G.+Battistuzziauthor=D.+Vignola&title=Hydroxamic+Acid+Based+Histone+Deacetylase+Inhibitors+with+Confirmed+Activity+against+the+Malaria+Parasite&doi=10.1016%2Fj.bmcl.2014.12.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite</span></div><div class="casAuthors">Giannini, Giuseppe; Battistuzzi, Gianfranco; Vignola, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-461</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies have highlighted a key role in regulating gene transcription, in both eukaryotes and prokaryotes, by enzymes that control the acetylation and deacetylation of histones.  In particular, inhibitors of histone deacetylases (HDAC-Is) have been shown effective in controlling the development of many parasites, such as the plasmodium of malaria.  Here we report the results of a study aimed at evaluating antiparasitic effect of two classes of HDAC-Is bearing different zinc binding group (hydroxamic acid vs thiol).  The study showed that only the hydroxamic acid based HDAC inhibitors were active, with Plasmodium falciparum being the most sensitive parasite, having from low double-digit to single-digit nanomolar range in vitro activities.  Among three derivs. evaluated also in vivo, ST8086AA1 (8) effectively inhibited 88% of the development of Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvc4vbdguDrVg90H21EOLACvtfcHk0lgdNGtDMKbwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWgsw%253D%253D&md5=368003ce13e438d7d20eeefe2c232aec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DVignola%26aufirst%3DD.%26atitle%3DHydroxamic%2520Acid%2520Based%2520Histone%2520Deacetylase%2520Inhibitors%2520with%2520Confirmed%2520Activity%2520against%2520the%2520Malaria%2520Parasite%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D459%26epage%3D461%26doi%3D10.1016%2Fj.bmcl.2014.12.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, M. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancelot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Späth, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span> <span> </span><span class="NLM_article-title">Effect of Clinically Approved HDAC Inhibitors on <i>Plasmodium</i>, <i>Leishmania</i> and <i>Schistosoma</i> Parasite Growth</span>. <i>Int. J. Parasitol. Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2016.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.ijpddr.2016.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=28107750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nslOgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=42-50&author=M.+J.+Chuaauthor=M.+S.+J.+Arnoldauthor=W.+Xuauthor=J.+Lancelotauthor=S.+Lamotteauthor=G.+F.+Sp%C3%A4thauthor=E.+Prinaauthor=R.+J.+Pierceauthor=D.+P.+Fairlieauthor=T.+S.+Skinner-Adamsauthor=K.+T.+Andrews&title=Effect+of+Clinically+Approved+HDAC+Inhibitors+on+Plasmodium%2C+Leishmania+and+Schistosoma+Parasite+Growth&doi=10.1016%2Fj.ijpddr.2016.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth</span></div><div class="casAuthors">Chua Ming Jang; Arnold Megan S J; Skinner-Adams Tina S; Xu Weijun; Fairlie David P; Lancelot Julien; Pierce Raymond J; Lamotte Suzanne; Spath Gerald F; Prina Eric; Andrews Katherine T</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria, schistosomiasis and leishmaniases are among the most prevalent tropical parasitic diseases and each requires new innovative treatments.  Targeting essential parasite pathways, such as those that regulate gene expression and cell cycle progression, is a key strategy for discovering new drug leads.  In this study, four clinically approved anti-cancer drugs (Vorinostat, Belinostat, Panobinostat and Romidepsin) that target histone/lysine deacetylase enzymes were examined for in vitro activity against Plasmodium knowlesi, Schistosoma mansoni, Leishmania amazonensis and L. donovani parasites and two for in vivo activity in a mouse malaria model.  All four compounds were potent inhibitors of P. knowlesi malaria parasites (IC50 9-370 nM), with belinostat, panobinostat and vorinostat having 8-45 fold selectivity for the parasite over human neonatal foreskin fibroblast (NFF) or human embryonic kidney (HEK 293) cells, while romidepsin was not selective.  Each of the HDAC inhibitor drugs caused hyperacetylation of P. knowlesi histone H4.  None of the drugs was active against Leishmania amastigote or promastigote parasites (IC50 > 20 μM) or S. mansoni schistosomula (IC50 > 10 μM), however romidepsin inhibited S. mansoni adult worm parings and egg production (IC50 ∼10 μM).  Modest in vivo activity was observed in P. berghei infected mice dosed orally with vorinostat or panobinostat (25 mg/kg twice daily for four days), with a significant reduction in parasitemia observed on days 4-7 and 4-10 after infection (P < 0.05), respectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4PFWYnE_iRT69zv1FsJFMfW6udTcc2eYC50garyONObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nslOgsw%253D%253D&md5=699b8901c27dd849096a3b728c0de891</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DM.%2BJ.%26aulast%3DArnold%26aufirst%3DM.%2BS.%2BJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DS.%26aulast%3DSp%25C3%25A4th%26aufirst%3DG.%2BF.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26atitle%3DEffect%2520of%2520Clinically%2520Approved%2520HDAC%2520Inhibitors%2520on%2520Plasmodium%252C%2520Leishmania%2520and%2520Schistosoma%2520Parasite%2520Growth%26jtitle%3DInt.%2520J.%2520Parasitol.%2520Drugs%2520Drug%2520Resist.%26date%3D2017%26volume%3D7%26spage%3D42%26epage%3D50%26doi%3D10.1016%2Fj.ijpddr.2016.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urgaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisingh, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from <i>Plasmodium Falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2185</span>– <span class="NLM_lpage">2187</span>, <span class="refDoi"> DOI: 10.1021/jm801654y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801654y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Gmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2185-2187&author=V.+Patelauthor=R.+Mazitschekauthor=B.+Colemanauthor=C.+Nguyenauthor=S.+Urgaonkarauthor=J.+Corteseauthor=R.+H.+Barkerauthor=E.+Greenbergauthor=W.+Tangauthor=J.+E.+Bradnerauthor=S.+L.+Schreiberauthor=M.+T.+Duraisinghauthor=D.+F.+Wirthauthor=J.+Clardy&title=Identification+and+Characterization+of+Small+Molecule+Inhibitors+of+a+Class+I+Histone+Deacetylase+from+Plasmodium+Falciparum&doi=10.1021%2Fjm801654y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparum</span></div><div class="casAuthors">Patel, Vishal; Mazitschek, Ralph; Coleman, Bradley; Nguyen, Cokey; Urgaonkar, Sameer; Cortese, Joseph; Barker, Robert H., Jr.; Greenberg, Edward; Tang, Weiping; Bradner, James E.; Schreiber, Stuart L.; Duraisingh, Manoj T.; Wirth, Dyann F.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2185-2187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of approx. 2000 small mols. biased toward inhibition of histone deacetylases was assayed for antimalarial activity in a high-throughput P. falciparum viability assay.  Active compds. were cross-analyzed for induction of histone hyperacetylation in a human myeloma cell line to identify HDAC inhibitors with selectivity for P. falciparum over the human host.  To verify on-target selectivity, pfHDAC-1 was expressed and purified and a biochem. assay for pfHDAC-1 activity was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2aI4Y1nc2M7Vg90H21EOLACvtfcHk0lhZlAF26MoorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Gmurk%253D&md5=0cee47c16047222dc6283f98ee2961fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm801654y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801654y%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DColeman%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DUrgaonkar%26aufirst%3DS.%26aulast%3DCortese%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DR.%2BH.%26aulast%3DGreenberg%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DDuraisingh%26aufirst%3DM.%2BT.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520a%2520Class%2520I%2520Histone%2520Deacetylase%2520from%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2185%26epage%3D2187%26doi%3D10.1021%2Fjm801654y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwakwari, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">A Structure–activity Relationship Study of the Antimalarial and Antileishmanial Activities of Nonpeptide Macrocyclic Histone Deacetylase Inhibitors</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1002%2Fcmdc.201000087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20533500" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1232-1235&author=W.+Guerrantauthor=S.+C.+Mwakwariauthor=P.+C.+Chenauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=A.+K.+Oyelere&title=A+Structure%E2%80%93activity+Relationship+Study+of+the+Antimalarial+and+Antileishmanial+Activities+of+Nonpeptide+Macrocyclic+Histone+Deacetylase+Inhibitors&doi=10.1002%2Fcmdc.201000087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000087%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DA%2520Structure%25E2%2580%2593activity%2520Relationship%2520Study%2520of%2520the%2520Antimalarial%2520and%2520Antileishmanial%2520Activities%2520of%2520Nonpeptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2010%26volume%3D5%26spage%3D1232%26epage%3D1235%26doi%3D10.1002%2Fcmdc.201000087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mwakwari, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurard-Levin, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrksich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">Non-peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6100</span>– <span class="NLM_lpage">6111</span>, <span class="refDoi"> DOI: 10.1021/jm100507q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsV2mtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-peptide+Macrocyclic+Histone+Deacetylase+Inhibitors+Derived+from+Tricyclic+Ketolide+Skeleton&doi=10.1021%2Fjm100507q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton</span></div><div class="casAuthors">Mwakwari, Sandra C.; Guerrant, William; Patil, Vishal; Khan, Shabana I.; Tekwani, Babu L.; Gurard-Levin, Zachary A.; Mrksich, Milan; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6100-6111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of histone deacetylase (HDAC) function is a validated therapeutic strategy for cancer treatment.  Of the several structurally distinct small mol. histone deacetylase inhibitors (HDACi) reported, macrocyclic depsipeptides possess the most complex cap groups and have demonstrated excellent HDAC inhibition potency and isoform selectivity.  Unfortunately, the development of macrocyclic depsipeptides has been hampered in part because of development problems characteristic of large peptides and the complex reaction schemes required for their synthesis.  Herein we report that tricyclic ketolide TE-802 is an excellent mimetic for the peptide backbone of macrocyclic HDACi.  Compds. derived from this template are particularly selective against HDACs 1 and 2 with nanomolar inhibitory activity.  Interrogation of the assocn. between a subset of these compds. and key HDAC isoforms, using AutoDock, enables a mol. description of the interaction between the HDAC enzyme's outer rim and the inhibitors' macrocyclic cap group that are responsible for compd. affinity and presumably isoform selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt9QPKI33jvbVg90H21EOLACvtfcHk0lhZlAF26MoorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsV2mtLk%253D&md5=6407dc82e9fb2dab6313d32956600659</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-peptide%2520Macrocyclic%2520Histone%2520Deacetylase%2520Inhibitors%2520Derived%2520from%2520Tricyclic%2520Ketolide%2520Skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6100%26epage%3D6111%26doi%3D10.1021%2Fjm100507q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumanadasa, S. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenzel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmetter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordmüller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of HDAC Inhibitors with Potent Activity against Multiple Malaria Parasite Life Cycle Stages</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.ejmech.2014.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24904967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=204-213&author=F.+K.+Hansenauthor=S.+D.+M.+Sumanadasaauthor=K.+Stenzelauthor=S.+Duffyauthor=S.+Meisterauthor=L.+Marekauthor=R.+Schmetterauthor=K.+Kunaauthor=A.+Hamacherauthor=B.+Mordm%C3%BCllerauthor=M.+U.+Kassackauthor=E.+A.+Winzelerauthor=V.+M.+Averyauthor=K.+T.+Andrewsauthor=T.+Kurz&title=Discovery+of+HDAC+Inhibitors+with+Potent+Activity+against+Multiple+Malaria+Parasite+Life+Cycle+Stages&doi=10.1016%2Fj.ejmech.2014.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages</span></div><div class="casAuthors">Hansen, Finn K.; Sumanadasa, Subathdrage D. M.; Stenzel, Katharina; Duffy, Sandra; Meister, Stephan; Marek, Linda; Schmetter, Rebekka; Kuna, Krystina; Hamacher, Alexandra; Mordmueller, Benjamin; Kassack, Matthias U.; Winzeler, Elizabeth A.; Avery, Vicky M.; Andrews, Katherine T.; Kurz, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-213</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this work the authors investigated the antiplasmodial activity of a series of HDAC inhibitors contg. an alkoxyamide connecting-unit linker region.  HDAC inhibitor LMK235, previously shown to be a novel and specific inhibitor of human HDAC4 and 5, was used as a starting point to rapidly construct a mini-library of HDAC inhibitors using a straightforward solid-phase supported synthesis.  Several of these novel HDAC inhibitors were found to have potent in vitro activity against asexual stage Plasmodium falciparum malaria parasites.  Representative compds. were shown to hyperacetylate P. falciparum histones and to inhibit deacetylase activity of recombinant PfHDAC1 and P. falciparum nuclear exts.  All compds. were also screened in vitro for activity against Plasmodium berghei exo-erythrocytic stages and selected compds. were further tested against late stage (IV and V) P. falciparum gametocytes.  Of note, some compds. showed nanomolar activity against all three life cycle stages tested (asexual, exo-erythrocytic and gametocyte stages) and several compds. displayed significantly increased parasite selectivity compared to the ref. HDAC inhibitor suberoylanilide hydroxamic acid (SAHA).  These data suggest that it may be possible to develop HDAC inhibitors that target multiple malaria parasite life cycle stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyJ3jTxcuXi7Vg90H21EOLACvtfcHk0lhLKBXp6UQMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu77P&md5=b0582421de08370dda4cb4bf6c370256</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DF.%2BK.%26aulast%3DSumanadasa%26aufirst%3DS.%2BD.%2BM.%26aulast%3DStenzel%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DL.%26aulast%3DSchmetter%26aufirst%3DR.%26aulast%3DKuna%26aufirst%3DK.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DMordm%25C3%25BCller%26aufirst%3DB.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DKurz%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520HDAC%2520Inhibitors%2520with%2520Potent%2520Activity%2520against%2520Multiple%2520Malaria%2520Parasite%2520Life%2520Cycle%2520Stages%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D204%26epage%3D213%26doi%3D10.1016%2Fj.ejmech.2014.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Haung, Z.</span></span> <span> </span><span class="NLM_article-title">Novel High-efficiency Antimalarial Drug, Quisinostat</span>. World Patent <span class="NLM_patent">WO2017143964A1</span>, August 31, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Jiang&author=Z.+Haung&title=Novel+High-efficiency+Antimalarial+Drug%2C+Quisinostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DNovel%2520High-efficiency%2520Antimalarial%2520Drug%252C%2520Quisinostat%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katsuno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmatz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slingsby, B. T.</span></span> <span> </span><span class="NLM_article-title">Hit and Lead Criteria in Drug Discovery for Infectious Diseases of the Developing World</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">758</span>, <span class="refDoi"> DOI: 10.1038/nrd4683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnrd4683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=26435527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SitL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=751-758&author=K.+Katsunoauthor=J.+N.+Burrowsauthor=K.+Duncanauthor=R.+H.+van+Huijsduijnenauthor=T.+Kanekoauthor=K.+Kitaauthor=C.+E.+Mowbrayauthor=D.+Schmatzauthor=P.+Warnerauthor=B.+T.+Slingsby&title=Hit+and+Lead+Criteria+in+Drug+Discovery+for+Infectious+Diseases+of+the+Developing+World&doi=10.1038%2Fnrd4683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hit and lead criteria in drug discovery for infectious diseases of the developing world</span></div><div class="casAuthors">Katsuno, Kei; Burrows, Jeremy N.; Duncan, Ken; van Huijsduijnen, Rob Hooft; Kaneko, Takushi; Kita, Kiyoshi; Mowbray, Charles E.; Schmatz, Dennis; Warner, Peter; Slingsby, B. T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">751-758</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reducing the burden of infectious diseases that affect people in the developing world requires sustained collaborative drug discovery efforts.  The quality of the chem. starting points for such projects is a key factor in improving the likelihood of clin. success, and so it is important to set clear go/no-go criteria for the progression of hit and lead compds.  With this in mind, the Japanese Global Health Innovative Technol. (GHIT) Fund convened with experts from the Medicines for Malaria Venture, the Drugs for Neglected Diseases initiative and the TB Alliance, together with representatives from the Bill & Melinda Gates Foundation, to set disease-specific criteria for hits and leads for malaria, tuberculosis, visceral leishmaniasis and Chagas disease.  Here, we present the agreed criteria and discuss the underlying rationale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFQHFz6z3D_rVg90H21EOLACvtfcHk0lhLKBXp6UQMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SitL7O&md5=6cd6d7c8ca3a85d64f24915da8e1120c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrd4683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4683%26sid%3Dliteratum%253Aachs%26aulast%3DKatsuno%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuncan%26aufirst%3DK.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DSchmatz%26aufirst%3DD.%26aulast%3DWarner%26aufirst%3DP.%26aulast%3DSlingsby%26aufirst%3DB.%2BT.%26atitle%3DHit%2520and%2520Lead%2520Criteria%2520in%2520Drug%2520Discovery%2520for%2520Infectious%2520Diseases%2520of%2520the%2520Developing%2520World%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2015%26volume%3D14%26spage%3D751%26epage%3D758%26doi%3D10.1038%2Fnrd4683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span> <span> </span><span class="NLM_article-title">Small-molecule Targeting of a Diapophytoene Desaturase Inhibits <i>S, aureus Virulence</i></span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.+G.+Yangauthor=Y.+Xuauthor=H.+Jiangauthor=F.+Lianauthor=N.+Zhangauthor=J.+Liauthor=L.+Lan&title=Small-molecule+Targeting+of+a+Diapophytoene+Desaturase+Inhibits+S%2C+aureus+Virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0ljVXCjVB5sVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLian%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DSmall-molecule%2520Targeting%2520of%2520a%2520Diapophytoene%2520Desaturase%2520Inhibits%2520S%252C%2520aureus%2520Virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Benzofuran-derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-resistant <i>Staphylococcus Aureus</i> (MRSA) Infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3215</span>– <span class="NLM_lpage">3230</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3215-3230&author=Y.+Wangauthor=F.+Chenauthor=H.+Diauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=C.+Shengauthor=L.+Lanauthor=J.+Li&title=Discovery+of+Potent+Benzofuran-derived+Diapophytoene+Desaturase+%28CrtN%29+Inhibitors+with+Enhanced+Oral+Bioavailability+for+the+Treatment+of+Methicillin-resistant+Staphylococcus+Aureus+%28MRSA%29+Infections&doi=10.1021%2Facs.jmedchem.5b01984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections</span></div><div class="casAuthors">Wang, Youxin; Chen, Feifei; Di, Hongxia; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Sheng, Chunquan; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3215-3230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blocking the staphyloxanthin biosynthesis process has emerged as a new promising antivirulence strategy.  Previously, we first revealed that CrtN is a druggable target against infections caused by pigmented Staphylococcus aureus (S. aureus) and that naftifine was an effective CrtN inhibitor.  Here, we identify a new type of benzofuran-derived CrtN inhibitor with submicromolar IC50 values that is based on the naftifine scaffold.  The most potent analog, 5m, inhibits the pigment prodn. of S. aureus Newman and three MRSA strains, with IC50 values of 0.38-5.45 nM, without any impact on the survival of four strains (up to 200 μM).  Notably, compd. 5m (1 μM) could significantly sensitize four strains to immune clearance and could effectively attenuate the virulence of three strains in vivo.  Moreover, 5m was detd. to be a weak antifungal reagent (MIC > 16 μg/mL).  Combined with good oral bioavailability (F = 42.2%) and excellent safety profiles, these data demonstrate that 5m may be a good candidate for the treatment of MRSA infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahz7Kq8Z-k7Vg90H21EOLACvtfcHk0ljVXCjVB5sVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D&md5=109908ff78289f118ced8c8883622f02</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01984%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Potent%2520Benzofuran-derived%2520Diapophytoene%2520Desaturase%2520%2528CrtN%2529%2520Inhibitors%2520with%2520Enhanced%2520Oral%2520Bioavailability%2520for%2520the%2520Treatment%2520of%2520Methicillin-resistant%2520Staphylococcus%2520Aureus%2520%2528MRSA%2529%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3215%26epage%3D3230%26doi%3D10.1021%2Facs.jmedchem.5b01984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-resistant <i>S. Aureus</i> (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4831</span>– <span class="NLM_lpage">4848</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XntFCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4831-4848&author=Y.+Wangauthor=H.+Diauthor=F.+Chenauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Discovery+of+Benzocycloalkane+Derivatives+Efficiently+Blocking+Bacterial+Virulence+for+the+Treatment+of+Methicillin-resistant+S.+Aureus+%28MRSA%29+Infections+by+Targeting+Diapophytoene+Desaturase+%28CrtN%29&doi=10.1021%2Facs.jmedchem.6b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN)</span></div><div class="casAuthors">Wang, Youxin; Di, Hongxia; Chen, Feifei; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4831-4848</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antivirulence strategies are now attracting interest for the inherent mechanism of action advantages.  In the previous work, diapophytoene desaturase (CrtN) was identified to be an attractive and drugable target for fighting pigmented S. aureus infections.  In this research, the authors developed a series of effective benzocycloalkane-derived CrtN inhibitors with submicromolar IC50.  Analog I blocked the pigment biosynthesis of three MRSA strains with a nanomolar IC50 value.  Corresponding to its mode of action, I did not function as a bactericidal agent. I could sensitize S. aureus to immune clearance.  In vivo, I was proven to be efficacious in an S. aureus Newman sepsis model and abscess formation model.  For two typical MRSAs, USA400 MW2 and Mu50, I significantly decreased the staphylococcal loads in the liver and kidneys.  Moreover, I showed minimal antifungal activity compared to that of NTF.  In summary, I has the potential to be developed as a therapeutic drug, esp. against intractable MRSA issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_zFIf63DmLVg90H21EOLACvtfcHk0lhTUVkj65bgOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntFCjs78%253D&md5=f6065a8db5d957c4ea44d059ad58736f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Benzocycloalkane%2520Derivatives%2520Efficiently%2520Blocking%2520Bacterial%2520Virulence%2520for%2520the%2520Treatment%2520of%2520Methicillin-resistant%2520S.%2520Aureus%2520%2528MRSA%2529%2520Infections%2520by%2520Targeting%2520Diapophytoene%2520Desaturase%2520%2528CrtN%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4831%26epage%3D4848%26doi%3D10.1021%2Facs.jmedchem.6b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-resistant, Linezolid-resistant, and Vancomycin-intermediate <i>Staphylococcus Aureus</i> Infections In Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8145</span>– <span class="NLM_lpage">8159</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+Inhibitors+of+Staphyloxanthin+Virulence+Factor+in+Comparison+with+Linezolid+and+Vancomycin+versus+Methicillin-resistant%2C+Linezolid-resistant%2C+and+Vancomycin-intermediate+Staphylococcus+Aureus+Infections+In+Vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo</span></div><div class="casAuthors">Ni, Shuaishuai; Wei, Hanwen; Li, Baoli; Chen, Feifei; Liu, Yifu; Chen, Wenhua; Xu, Yixiang; Qiu, Xiaoxia; Li, Xiaokang; Lu, Yanli; Liu, Wenwen; Hu, Linhao; Lin, Dazheng; Wang, Manjiong; Zheng, Xinyu; Mao, Fei; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8145-8159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors' previous work (Wang, et al. J. Med. Chem. 2016, 59, 4831-4848) revealed that effective benzocycloalkane-derived staphyloxanthin inhibitors against methicillin-resistant Staphylococcus aureus (S. aureus) infections were accompanied by poor water soly. and high hERG inhibition and dosages (pre-administration).  In this study, ninety-two chroman and coumaran derivs. as novel inhibitors have been addressed for overcoming deficiencies above.  Derivs. 69 ((E)-N-(coumaran-5-methyl)-N-methyl-3-(4-biphenyl)prop-2-en-1-amine hydrochloride) and 105 ((E,E)-N-(chroman-7-methyl)-N-methyl-5-(4-biphenyl)pent-2,4-dien-1-amine hydrochloride) displayed the excellent pigment inhibitory activities and low hERG inhibition, along with the improvement of soly. by salt type selection.  The broad and significantly potent antibacterial spectra of 69 and 105 were displayed firstly with normal administration in the livers and hearts in mice against pigmented S. aureus Newman, Mu50 (vancomycin-intermediate S. aureus) and NRS271 (linezolid-resistant S. aureus), compared with linezolid and vancomycin.  In summary, both 69 and 105 have the potential to be developed as good antibacterial candidates targeting virulence factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcybrWG0xXSLVg90H21EOLACvtfcHk0li9Jls-e83UpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKgs7vN&md5=c29f6cf0efd0584034f623d62222a943</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520Inhibitors%2520of%2520Staphyloxanthin%2520Virulence%2520Factor%2520in%2520Comparison%2520with%2520Linezolid%2520and%2520Vancomycin%2520versus%2520Methicillin-resistant%252C%2520Linezolid-resistant%252C%2520and%2520Vancomycin-intermediate%2520Staphylococcus%2520Aureus%2520Infections%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel Terminal Bipheny-based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced <i>h</i>ERG Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01300</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01300" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=224-250&author=B.+Liauthor=S.+Niauthor=F.+Maoauthor=F.+Chenauthor=Y.+Liuauthor=H.+Weiauthor=W.+Chenauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+Terminal+Bipheny-based+Diapophytoene+Desaturases+%28CrtN%29+Inhibitors+as+Anti-MRSA%2FVISR%2FLRSA+Agents+with+Reduced+hERG+Activity&doi=10.1021%2Facs.jmedchem.7b01300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity</span></div><div class="casAuthors">Li, Baoli; Ni, Shuaishuai; Mao, Fei; Chen, Feifei; Liu, Yifu; Wei, Hanwen; Chen, Wenhua; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections.  More than 100 new compds. were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1 (I).  Analogs 23a ((E)-3-([1,1'-biphenyl]-4-yl)-N-(benzofuran-3-ylmethyl)-N-methylprop-2-en-1-amine hydrochloride) and 23b ((E)-N-((1H-indol-7-yl)methyl)-3-([1,1'-biphenyl]-4-yl)-N-methylprop-2-en-1-amine hydrochloride) demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02-10.5 nM), along with lower hERG inhibition (IC50 > 30 μM, ∼10-fold decrease in comparison with 1).  Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid.  Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rqm9J1xyJbVg90H21EOLACvtfcHk0li9Jls-e83UpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF&md5=d92739f38cc85e69ca280dc62b198934</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01300%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520Terminal%2520Bipheny-based%2520Diapophytoene%2520Desaturases%2520%2528CrtN%2529%2520Inhibitors%2520as%2520Anti-MRSA%252FVISR%252FLRSA%2520Agents%2520with%2520Reduced%2520hERG%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D224%26epage%3D250%26doi%3D10.1021%2Facs.jmedchem.7b01300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonck, M. G. C.</span>; <span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Roux, B.</span>; <span class="NLM_string-name">Pilatte, I. N. C.</span>; <span class="NLM_string-name">Ten Holte, P.</span>; <span class="NLM_string-name">Arts, J.</span>; <span class="NLM_string-name">Van Emelen, K.</span>; <span class="NLM_string-name">Holte, P. T.</span>; <span class="NLM_string-name">Verdonck, M. G.</span>; <span class="NLM_string-name">Celine, V. M. G.</span>; <span class="NLM_string-name">Constance, P. I. N.</span>; <span class="NLM_string-name">Holte, A. J. A. P. T.</span>; <span class="NLM_string-name">Ten Holte, P. A. J.</span>; <span class="NLM_string-name">Van, E. K.</span>; <span class="NLM_string-name">Ten, H. P.</span>; <span class="NLM_string-name">Janssen, P. N. V.</span>; <span class="NLM_string-name">Veronck, M. G. C.</span>; <span class="NLM_string-name">Emelen, K. V.</span>; <span class="NLM_string-name">Celine, M. G.</span>; <span class="NLM_string-name">Van Emelein, K.</span></span> <span> </span><span class="NLM_article-title">Substituted Indolyl Alkyl Amino Derivatives as Novel Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">SG156687A1</span>, February 02, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+C.+Verdonck&author=P.+R.+Angibaud&author=B.+Roux&author=I.+N.+C.+Pilatte&author=P.+Ten+Holte&author=J.+Arts&author=K.+Van+Emelen&author=P.+T.+Holte&author=M.+G.+Verdonck&author=V.+M.+G.+Celine&author=P.+I.+N.+Constance&author=A.+J.+A.+P.+T.+Holte&author=P.+A.+J.+Ten+Holte&author=E.+K.+Van&author=H.+P.+Ten&author=P.+N.+V.+Janssen&author=M.+G.+C.+Veronck&author=K.+V.+Emelen&author=M.+G.+Celine&author=K.+Van+Emelein&title=Substituted+Indolyl+Alkyl+Amino+Derivatives+as+Novel+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonck%26aufirst%3DM.%2BG.%2BC.%26atitle%3DSubstituted%2520Indolyl%2520Alkyl%2520Amino%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, J. W. J.</span>; <span class="NLM_string-name">Houpis, I. N.</span>; <span class="NLM_string-name">Lang, Y. L.</span>; <span class="NLM_string-name">Leys, C.</span>; <span class="NLM_string-name">Stokbroekx, S. C. M.</span>; <span class="NLM_string-name">Weerts, J. E. E.</span>; <span class="NLM_string-name">Dickens, J. W.</span>; <span class="NLM_string-name">Ioanneseu Nikolraoseu, H.</span></span>.; <span class="NLM_contrib-group"><span class="NLM_string-name">Julrieoseu Deobeulyu
Jei, D.</span>; <span class="NLM_string-name">Karina, R.</span>; <span class="NLM_string-name">Sigeurideu Kaal
Maria, S.</span>; <span class="NLM_string-name">Yohan
Eowin Edeumondeu, W.</span>; <span class="NLM_string-name">Yolrandeu Ridia, R.</span>; <span class="NLM_string-name">Houpis, L. N.</span>; <span class="NLM_string-name">Dickens, W. J. J.</span>; <span class="NLM_string-name">Ertis, J. E. I.</span>; <span class="NLM_string-name">Hubez, I. N.</span>; <span class="NLM_string-name">Liz, K.</span>; <span class="NLM_string-name">Stkbrox, C. M.</span>; <span class="NLM_string-name">Dickens Julius, W. J.</span>; <span class="NLM_string-name">Houpis Ioannes, N.</span>; <span class="NLM_string-name">Lang Yolande, L.</span>; <span class="NLM_string-name">Stokbroekx Sigrid, C. M.</span>; <span class="NLM_string-name">Weerts Johan, E. E.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors</span>. World Patent <span class="NLM_patent">123121</span>, November 23, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+W.+J.+Dickens&author=I.+N.+Houpis&author=Y.+L.+Lang&author=C.+Leys&author=S.+C.+M.+Stokbroekx&author=J.+E.+E.+Weerts&author=J.+W.+Dickens&author=H.+Ioanneseu+Nikolraoseuauthor=D.+Julrieoseu+Deobeulyu%0AJei&author=R.+Karina&author=S.+Sigeurideu+Kaal%0AMaria&author=W.+Yohan%0AEowin+Edeumondeu&author=R.+Yolrandeu+Ridia&author=L.+N.+Houpis&author=W.+J.+J.+Dickens&author=J.+E.+I.+Ertis&author=I.+N.+Hubez&author=K.+Liz&author=C.+M.+Stkbrox&author=W.+J.+Dickens+Julius&author=N.+Houpis+Ioannes&author=L.+Lang+Yolande&author=C.+M.+Stokbroekx+Sigrid&author=E.+E.+Weerts+Johan&title=Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DJ.%2BW.%2BJ.%26aulast%3DJulrieoseu%2BDeobeulyu%2BJei%26aufirst%3DD.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, B.</span>; <span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Laux, B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclylalkyl Derivatives as Novel Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US7834011B2</span>, July 26, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Roux&author=P.+R.+Angibaud&author=B.+Laux&title=Heterocyclylalkyl+Derivatives+as+Novel+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DB.%26atitle%3DHeterocyclylalkyl%2520Derivatives%2520as%2520Novel%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P. R.</span>; <span class="NLM_string-name">Pilatte, I. N. C.</span>; <span class="NLM_string-name">Angibaud, P.</span>; <span class="NLM_string-name">Pilatte, I.</span></span> <span> </span><span class="NLM_article-title">Substituted Indolyl-alkyl-amino-derivatives as Inhibitors of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US7834011B2</span>, July 26, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+R.+Angibaud&author=I.+N.+C.+Pilatte&author=P.+Angibaud&author=I.+Pilatte&title=Substituted+Indolyl-alkyl-amino-derivatives+as+Inhibitors+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAngibaud%26aufirst%3DP.%2BR.%26atitle%3DSubstituted%2520Indolyl-alkyl-amino-derivatives%2520as%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arts, J.</span>; <span class="NLM_string-name">Hellemans, P. W. J.</span>; <span class="NLM_string-name">Janicot, M. M. F.</span>; <span class="NLM_string-name">Page, M. J.</span>; <span class="NLM_string-name">Hellemans Peter, W. J.</span>; <span class="NLM_string-name">Janicot Michel, M. F.</span>; <span class="NLM_string-name">Page Martin, J.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors with Combined Activity on Class-i and Class-iib Histone Deacetylases in Combination with Proteasome Inhibitors</span>. World Patent <span class="NLM_patent">JP5185274B2</span>, March 20, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Arts&author=P.+W.+J.+Hellemans&author=M.+M.+F.+Janicot&author=M.+J.+Page&author=W.+J.+Hellemans+Peter&author=M.+F.+Janicot+Michel&author=J.+Page+Martin&title=Histone+Deacetylase+Inhibitors+with+Combined+Activity+on+Class-i+and+Class-iib+Histone+Deacetylases+in+Combination+with+Proteasome+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArts%26aufirst%3DJ.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%2520with%2520Combined%2520Activity%2520on%2520Class-i%2520and%2520Class-iib%2520Histone%2520Deacetylases%2520in%2520Combination%2520with%2520Proteasome%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">The Use of Spirocyclic Scaffolds in Drug Discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3682</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.bmcl.2014.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25052427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3673-3682&author=Y.+Zhengauthor=C.+M.+Ticeauthor=S.+B.+Singh&title=The+Use+of+Spirocyclic+Scaffolds+in+Drug+Discovery&doi=10.1016%2Fj.bmcl.2014.06.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The use of spirocyclic scaffolds in drug discovery</span></div><div class="casAuthors">Zheng, Yajun; Tice, Colin M.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3673-3682</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery.  In this brief review, we highlight selected examples from the primary medicinal chem. literature during the last three years to demonstrate the versatility of spiro scaffolds.  With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzTjJrsRkyLVg90H21EOLACvtfcHk0lhMssUkYDpO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM&md5=9a2a644cf2b97edf7876b43b6457f6d5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DThe%2520Use%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Drug%2520Discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3673%26epage%3D3682%26doi%3D10.1016%2Fj.bmcl.2014.06.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span> <span> </span><span class="NLM_article-title">The Utilization of Spirocyclic Scaffolds in Novel Drug Discovery</span>. <i>Expert Opin. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1195367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1080%2F17460441.2016.1195367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27233084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FktVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=831-834&author=Y.+J.+Zhengauthor=C.+M.+Tice&title=The+Utilization+of+Spirocyclic+Scaffolds+in+Novel+Drug+Discovery&doi=10.1080%2F17460441.2016.1195367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The utilization of spirocyclic scaffolds in novel drug discovery</span></div><div class="casAuthors">Zheng Ya-Jun; Tice Colin M</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">831-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYAtKgZnFeprYtC3U5jeOifW6udTcc2ea0WMxoTdNdh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FktVGkug%253D%253D&md5=a736a7ecb934f323069bef58eaed9bbe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1195367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1195367%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BJ.%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Utilization%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Novel%2520Drug%2520Discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discov.%26date%3D2016%26volume%3D11%26spage%3D831%26epage%3D834%26doi%3D10.1080%2F17460441.2016.1195367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voss, F.</span>; <span class="NLM_string-name">Schunk, S.</span>; <span class="NLM_string-name">Steinhagen, H.</span></span> Chapter 16 <span> </span><span class="NLM_article-title">Spirocycles as Privileged Structural Motifs in Medicinal Chemistry</span><i>.</i> In  <i>Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, B.</span></span>; Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry: London</span>, <span class="NLM_year">2016</span>; pp.  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">458</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=439-458&author=F.+Voss&author=S.+Schunk&author=H.+Steinhagenauthor=B.+Stefan&title=Privileged+Scaffolds+in+Medicinal+Chemistry%3A+Design%2C+Synthesis%2C+Evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVoss%26aufirst%3DF.%26atitle%3DSpirocycles%2520as%2520Privileged%2520Structural%2520Motifs%2520in%2520Medicinal%2520Chemistry%26btitle%3DPrivileged%2520Scaffolds%2520in%2520Medicinal%2520Chemistry%253A%2520Design%252C%2520Synthesis%252C%2520Evaluation%26aulast%3DStefan%26aufirst%3DB.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%253A%2520London%26date%3D2016%26spage%3D439%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span>; <span class="NLM_string-name">Li, R.</span>; <span class="NLM_string-name">Tang, T.</span>; <span class="NLM_string-name">Ling, D.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Xu, D.</span>; <span class="NLM_string-name">Sun, M.</span>; <span class="NLM_string-name">Zheng, L.</span>; <span class="NLM_string-name">Zhu, F.</span>; <span class="NLM_string-name">Min, H.</span>; <span class="NLM_string-name">Boonhok, R.</span>; <span class="NLM_string-name">Ding, Y.</span>; <span class="NLM_string-name">Wen, Y.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Liu, T.</span>; <span class="NLM_string-name">Han, J.</span>; <span class="NLM_string-name">Miao, J.</span>; <span class="NLM_string-name">Fang, Q.</span>; <span class="NLM_string-name">Cao, Y.</span>; <span class="NLM_string-name">Tang, Y.</span>; <span class="NLM_string-name">Cui, J.</span>; <span class="NLM_string-name">Xu, W.</span>; <span class="NLM_string-name">Cui, L.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Jiang, L.</span></span> <span> </span><span class="NLM_article-title">A Novel Multistage Antiplasmodial Inhibitor Targeting <i>Plasmodium Falciparum</i> Histone Deacetylase 1</span>.  <i>Cell Discov.</i> <span class="NLM_year">2020</span>,  <span class="NLM_volume">6</span>, <span class="NLM_publisher-name">93</span>, <span class="refDoi"> DOI: 10.1038/s41421-020-00215-4</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fs41421-020-00215-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Z.+Huang&author=R.+Li&author=T.+Tang&author=D.+Ling&author=M.+Wang&author=D.+Xu&author=M.+Sun&author=L.+Zheng&author=F.+Zhu&author=H.+Min&author=R.+Boonhok&author=Y.+Ding&author=Y.+Wen&author=Y.+Chen&author=X.+Li&author=Y.+Chen&author=T.+Liu&author=J.+Han&author=J.+Miao&author=Q.+Fang&author=Y.+Cao&author=Y.+Tang&author=J.+Cui&author=W.+Xu&author=L.+Cui&author=J.+Zhu&author=J.+Li&author=L.+Jiang&title=Cell+Discov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41421-020-00215-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1038%252Fs41421-020-00215-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DA%2520Novel%2520Multistage%2520Antiplasmodial%2520Inhibitor%2520Targeting%2520Plasmodium%2520Falciparum%2520Histone%2520Deacetylase%25201%26btitle%3DCell%2520Discov.%26date%3D2020%26volume%3D6%26pub%3D93%26doi%3D10.1038%2Fs41421-020-00215-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickens, J. W. J.</span>; <span class="NLM_string-name">Houpis, I. N.</span>; <span class="NLM_string-name">Lang, Y. L.</span>; <span class="NLM_string-name">Leys, C.</span>; <span class="NLM_string-name">Stokbroekx, S. C. M.</span>; <span class="NLM_string-name">Weerts, J. E. E.</span></span> <span> </span><span class="NLM_article-title">Mono-hydrochloric Salts of an Inhibitor of Histone Deacetylase</span>. World Patent <span class="NLM_patent">US8759519B2</span>, November 20, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+W.+J.+Dickens&author=I.+N.+Houpis&author=Y.+L.+Lang&author=C.+Leys&author=S.+C.+M.+Stokbroekx&author=J.+E.+E.+Weerts&title=Mono-hydrochloric+Salts+of+an+Inhibitor+of+Histone+Deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DJ.%2BW.%2BJ.%26atitle%3DMono-hydrochloric%2520Salts%2520of%2520an%2520Inhibitor%2520of%2520Histone%2520Deacetylase%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricklefs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waisberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairatana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krudsood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udomsangpetch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokunthea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socheat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturdevant, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcella, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awadalla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> Genome-wide Scans for Positive Selection, Recombination Hot Spots and Resistance to Antimalarial Drugs</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1038/ng.528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fng.528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=20101240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=268-271&author=J.+Muauthor=R.+A.+Myersauthor=H.+Jiangauthor=S.+Liuauthor=S.+Ricklefsauthor=M.+Waisbergauthor=K.+Chotivanichauthor=P.+Wilairatanaauthor=S.+Krudsoodauthor=N.+J.+Whiteauthor=R.+Udomsangpetchauthor=L.+Cuiauthor=M.+Hoauthor=F.+Ouauthor=H.+Liauthor=J.+Songauthor=G.+Liauthor=X.+Wangauthor=S.+Seilaauthor=S.+Sokuntheaauthor=D.+Socheatauthor=D.+E.+Sturdevantauthor=S.+F.+Porcellaauthor=R.+M.+Fairhurstauthor=T.+E.+Wellemsauthor=P.+Awadallaauthor=X.+Z.+Su&title=Plasmodium+falciparum+Genome-wide+Scans+for+Positive+Selection%2C+Recombination+Hot+Spots+and+Resistance+to+Antimalarial+Drugs&doi=10.1038%2Fng.528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs</span></div><div class="casAuthors">Mu, Jianbing; Myers, Rachel A.; Jiang, Hongying; Liu, Shengfa; Ricklefs, Stacy; Waisberg, Michael; Chotivanich, Kesinee; Wilairatana, Polrat; Krudsood, Srivicha; White, Nicholas J.; Udomsangpetch, Rachanee; Cui, Liwang; Ho, May; Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao; Wang, Xinhua; Seila, Suon; Sokunthea, Sreng; Socheat, Duong; Sturdevant, Daniel E.; Porcella, Stephen F.; Fairhurst, Rick M.; Wellems, Thomas E.; Awadalla, Philip; Su, Xin-zhuan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-271</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Antimalarial drugs impose strong selective pressure on Plasmodium falciparum parasites and leave signatures of selection in the parasite genome; screening for genes under selection may suggest potential drug or immune targets.  Genome-wide assocn. studies (GWAS) of parasite traits have been hampered by the lack of high-throughput genotyping methods, inadequate knowledge of parasite population history and time-consuming adaptations of parasites to in vitro culture.  Here, the authors report the first Plasmodium GWAS, which included 189 culture-adapted P. falciparum parasites genotyped using a custom-built Affymetrix mol. inversion probe 3K malaria panel array with a coverage of ∼1 SNP per 7 kb.  Population structure, variation in recombination rate and loci under recent pos. selection were detected.  Parasite half-max. inhibitory concns. for seven antimalarial drugs were obtained and used in GWAS to identify genes assocd. with drug responses.  This study provides valuable tools and insight into the P. falciparum genome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGxCGf-xYgLVg90H21EOLACvtfcHk0lgXAOVfxJPoPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWrurc%253D&md5=413cb89495a114390244d160b0e9cb74</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fng.528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.528%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DR.%2BA.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRicklefs%26aufirst%3DS.%26aulast%3DWaisberg%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DWilairatana%26aufirst%3DP.%26aulast%3DKrudsood%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DUdomsangpetch%26aufirst%3DR.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DOu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSeila%26aufirst%3DS.%26aulast%3DSokunthea%26aufirst%3DS.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DSturdevant%26aufirst%3DD.%2BE.%26aulast%3DPorcella%26aufirst%3DS.%2BF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26aulast%3DAwadalla%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26atitle%3DPlasmodium%2520falciparum%2520Genome-wide%2520Scans%2520for%2520Positive%2520Selection%252C%2520Recombination%2520Hot%2520Spots%2520and%2520Resistance%2520to%2520Antimalarial%2520Drugs%26jtitle%3DNat.%2520Genet.%26date%3D2010%26volume%3D42%26spage%3D268%26epage%3D271%26doi%3D10.1038%2Fng.528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saintpierre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beghain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloeung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span> <span> </span><span class="NLM_article-title">A Surrogate Marker of Piperaquine-resistant <i>Plasmodium Falciparum</i> Malaria: a Phenotype-genotype Association Study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(16)30415-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2FS1473-3099%2816%2930415-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27818097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVShsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=174-183&author=B.+Witkowskiauthor=V.+Duruauthor=N.+Khimauthor=L.+S.+Rossauthor=B.+Saintpierreauthor=J.+Beghainauthor=S.+Chyauthor=S.+Kimauthor=S.+Keauthor=N.+Kloeungauthor=R.+Eamauthor=C.+Kheanauthor=M.+Kenauthor=K.+Lochauthor=A.+Bouillonauthor=A.+Domergueauthor=L.+Maauthor=C.+Bouchierauthor=R.+Leangauthor=R.+Huyauthor=G.+Nuelauthor=J.+C.+Baraleauthor=E.+Legrandauthor=P.+Ringwaldauthor=D.+A.+Fidockauthor=O.+Mercereau-Puijalonauthor=F.+Arieyauthor=D.+Menard&title=A+Surrogate+Marker+of+Piperaquine-resistant+Plasmodium+Falciparum+Malaria%3A+a+Phenotype-genotype+Association+Study&doi=10.1016%2FS1473-3099%2816%2930415-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study</span></div><div class="casAuthors">Witkowski, Benoit; Duru, Valentine; Khim, Nimol; Ross, Leila S.; Saintpierre, Benjamin; Beghain, Johann; Chy, Sophy; Kim, Saorin; Ke, Sopheakvatey; Kloeung, Nimol; Eam, Rotha; Khean, Chanra; Ken, Malen; Loch, Kaknika; Bouillon, Anthony; Domergue, Anais; Ma, Laurence; Bouchier, Christiane; Leang, Rithea; Huy, Rekol; Nuel, Gregory; Barale, Jean-Christophe; Legrand, Eric; Ringwald, Pascal; Fidock, David A.; Mercereau-Puijalon, Odile; Ariey, Frederic; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Western Cambodia is the epicentre of Plasmodium falciparum multidrug resistance and is facing high rates of dihydroartemisinin-piperaquine treatment failures.  Genetic tools to detect the multidrug-resistant parasites are needed.  Artemisinin resistance can be tracked using the K13 mol. marker, but no marker exists for piperaquine resistance.  We aimed to identify genetic markers of piperaquine resistance and study their assocn. with dihydroartemisinin-piperaquine treatment failures.  We obtained blood samples from Cambodian patients infected with P falciparum and treated with dihydroartemisinin-piperaquine.  Patients were followed up for 42 days during the years 2009-15.  We established in-vitro and ex-vivo susceptibility profiles for a subset using piperaquine survival assays.  We detd. whole-genome sequences by Illumina paired-reads sequencing, copy no. variations by qPCR, RNA concns. by qRT-PCR, and protein concns. by immunoblotting.  Fisher's exact and non-parametric Wilcoxon rank-sum tests were used to identify significant differences in single-nucleotide polymorphisms or copy no. variants, resp., for differential distribution between piperaquine-resistant and piperaquine-sensitive parasite lines.  Whole-genome exon sequence anal. of 31 culture-adapted parasite lines assocd. amplification of the plasmepsin 2-plasmepsin 3 gene cluster with in-vitro piperaquine resistance.  Ex-vivo piperaquine survival assay profiles of 134 isolates correlated with plasmepsin 2 gene copy no.  In 725 patients treated with dihydroartemisinin-piperaquine, multicopy plasmepsin 2 in the sample collected before treatment was assocd. with an adjusted hazard ratio (aHR) for treatment failure of 20·4 (95% CI 9·1-45·5, p<0·0001).  Multicopy plasmepsin 2 predicted dihydroartemisinin-piperaquine failures with 0·94 (95% CI 0·88-0·98) sensitivity and 0·77 (0·74-0·81) specificity.  Anal. of samples collected across the country from 2002 to 2015 showed that the geog. and temporal increase of the proportion of multicopy plasmepsin 2 parasites was highly correlated with increasing dihydroartemisinin-piperaquine treatment failure rates (r=0·89 [95% CI 0·77-0·95], p<0·0001, Spearman's coeff. of rank correlation).  Dihydroartemisinin-piperaquine efficacy at day 42 fell below 90% when the proportion of multicopy plasmepsin 2 parasites exceeded 22%.  Piperaquine resistance in Cambodia is strongly assocd. with amplification of plasmepsin 2-3, encoding Hb-digesting proteases, regardless of the location.  Multicopy plasmepsin 2 constitutes a surrogate mol. marker to track piperaquine resistance.  A mol. toolkit combining plasmepsin 2 with K13 and mdr1 monitoring should provide timely information for antimalarial treatment and containment policies.  Institut Pasteur in Cambodia, Institut Pasteur Paris, National Institutes of Health, WHO, Agence Nationale de la Recherche, Investissement d'Avenir program, Laboratoire d'Excellence Integrative "Biol. of Emerging Infectious Diseases".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvoDyiPpSGNbVg90H21EOLACvtfcHk0lgXAOVfxJPoPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVShsLbM&md5=f4071b4b74c54848259c3c5c2b40e673</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930415-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930415-7%26sid%3Dliteratum%253Aachs%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DRoss%26aufirst%3DL.%2BS.%26aulast%3DSaintpierre%26aufirst%3DB.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DChy%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DKloeung%26aufirst%3DN.%26aulast%3DEam%26aufirst%3DR.%26aulast%3DKhean%26aufirst%3DC.%26aulast%3DKen%26aufirst%3DM.%26aulast%3DLoch%26aufirst%3DK.%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DDomergue%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DHuy%26aufirst%3DR.%26aulast%3DNuel%26aufirst%3DG.%26aulast%3DBarale%26aufirst%3DJ.%2BC.%26aulast%3DLegrand%26aufirst%3DE.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DA%2520Surrogate%2520Marker%2520of%2520Piperaquine-resistant%2520Plasmodium%2520Falciparum%2520Malaria%253A%2520a%2520Phenotype-genotype%2520Association%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3D174%26epage%3D183%26doi%3D10.1016%2FS1473-3099%2816%2930415-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marapana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span> <span> </span><span class="NLM_article-title">Malaria: Biology and Disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.07.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.cell.2016.07.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27768886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=610-624&author=A.+F.+Cowmanauthor=J.+Healerauthor=D.+Marapanaauthor=K.+Marsh&title=Malaria%3A+Biology+and+Disease&doi=10.1016%2Fj.cell.2016.07.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria: Biology and Disease</span></div><div class="casAuthors">Cowman, Alan F.; Healer, Julie; Marapana, Danushka; Marsh, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-624</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Malaria has been a major global health problem of humans through history and is a leading cause of death and disease across many tropical and subtropical countries.  Over the last fifteen years renewed efforts at control have reduced the prevalence of malaria by over half, raising the prospect that elimination and perhaps eradication may be a long-term possibility.  Achievement of this goal requires the development of new tools including novel antimalarial drugs and more efficacious vaccines as well as an increased understanding of the disease and biol. of the parasite.  This has catalyzed a major effort resulting in development and regulatory approval of the first vaccine against malaria (RTS,S/AS01) as well as identification of novel drug targets and antimalarial compds., some of which are in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH-6Sl33soPLVg90H21EOLACvtfcHk0lggGc5sF9Eclg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrnF&md5=9260ee8a73d8da971fd0691300839b08</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.07.055%26sid%3Dliteratum%253Aachs%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DHealer%26aufirst%3DJ.%26aulast%3DMarapana%26aufirst%3DD.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DMalaria%253A%2520Biology%2520and%2520Disease%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D610%26epage%3D624%26doi%3D10.1016%2Fj.cell.2016.07.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mair, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuschewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span> <span> </span><span class="NLM_article-title">High Efficiency Transfection of <i>Plasmodium Berghei</i> Facilitates Novel Selection Procedures</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.molbiopara.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=16242190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=60-70&author=C.+J.+Janseauthor=B.+Franke-Fayardauthor=G.+R.+Mairauthor=J.+Ramesarauthor=C.+Thielauthor=S.+Engelmannauthor=K.+Matuschewskiauthor=G.+J.+van+Gemertauthor=R.+W.+Sauerweinauthor=A.+P.+Waters&title=High+Efficiency+Transfection+of+Plasmodium+Berghei+Facilitates+Novel+Selection+Procedures&doi=10.1016%2Fj.molbiopara.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">High efficiency transfection of Plasmodium berghei facilitates novel selection procedures</span></div><div class="casAuthors">Janse, Chris J.; Franke-Fayard, Blandine; Mair, Gunnar R.; Ramesar, Jai; Thiel, Corinna; Engelmann, Sabine; Matuschewski, Kai; van Gemert, Geert Jan; Sauerwein, Robert W.; Waters, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-70</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The use of transfection in the study of the biol. of malaria parasites has been limited due to poor transfection efficiencies (frequency of 10-6 to 10-9) and a paucity of selectable markers.  Here, a new method of transfection, using non-viral Nucleofector technol., is described for the rodent parasite Plasmodium berghei.  The transfection efficiency obtained (episomal and targeted integration into the genome) is in the range of 10-2 to 10-3.  Such high transfection efficiency strongly reduces the time, no. of lab. animals and amt. of materials required to generate transfected parasites.  Moreover, it allows different exptl. strategies for reverse genetics to be developed and we demonstrate direct selection of stably and non-reversibly transformed, fluorescent protein (FP)-expressing parasites using FACS.  Since there is no need to use a drug-selectable marker, this method increases the (low) no. of selectable markers available for transformation of P. berghei and can in principle be extended to utilize addnl. FP.  Furthermore the FACS-selected, FP-expressing parasites may serve as easily visualized ref. lines that may still be genetically manipulated with the existing drug-selectable markers.  The combination of enhanced transfection efficiency and a versatile rodent model provides a basis for the further development of novel tools for high throughput genome manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCeNdKkjHOrVg90H21EOLACvtfcHk0lggGc5sF9Eclg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE&md5=6f0aec711668825f48cf2b54067f1be6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%26aulast%3DMair%26aufirst%3DG.%2BR.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DC.%26aulast%3DEngelmann%26aufirst%3DS.%26aulast%3DMatuschewski%26aufirst%3DK.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26atitle%3DHigh%2520Efficiency%2520Transfection%2520of%2520Plasmodium%2520Berghei%2520Facilitates%2520Novel%2520Selection%2520Procedures%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2006%26volume%3D145%26spage%3D60%26epage%3D70%26doi%3D10.1016%2Fj.molbiopara.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manary, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, T. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Targeting <i>Plasmodium</i> PI(4)K to Eliminate Malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature12782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnature12782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24284631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=248-253&author=C.+W.+McNamaraauthor=M.+C.+S.+Leeauthor=C.+S.+Limauthor=S.+H.+Limauthor=J.+Rolandauthor=A.+Nagleauthor=O.+Simonauthor=B.+K.+S.+Yeungauthor=A.+K.+Chatterjeeauthor=S.+L.+McCormackauthor=M.+J.+Manaryauthor=A.-M.+Zeemanauthor=K.+J.+Decheringauthor=T.+R.+S.+Kumarauthor=P.+P.+Henrichauthor=K.+Gagaringauthor=M.+Ibanezauthor=N.+Katoauthor=K.+L.+Kuhenauthor=C.+Fischliauthor=M.+Rottmannauthor=D.+M.+Plouffeauthor=B.+Bursulayaauthor=S.+Meisterauthor=L.+Ramehauthor=J.+Trappeauthor=D.+Haasenauthor=M.+Timmermanauthor=R.+W.+Sauerweinauthor=R.+Suwanaruskauthor=B.+Russellauthor=L.+Reniaauthor=F.+Nostenauthor=D.+C.+Tullyauthor=C.+H.+M.+Kockenauthor=R.+J.+Glynneauthor=C.+Bodenreiderauthor=D.+A.+Fidockauthor=T.+T.+Diaganaauthor=E.+A.+Winzeler&title=Targeting+Plasmodium+PI%284%29K+to+Eliminate+Malaria&doi=10.1038%2Fnature12782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Plasmodium PI(4)K to eliminate malaria</span></div><div class="casAuthors">McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7479</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages.  Here the authors identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compd. class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host.  Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi.  The authors show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate.  Collectively, the authors' data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOmMeWluIubVg90H21EOLACvtfcHk0lg2f31Qw0MPwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaqsLzP&md5=9ed8f3e41d257bb4535b4c813abd54cf</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnature12782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12782%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DRoland%26aufirst%3DJ.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DO.%26aulast%3DYeung%26aufirst%3DB.%2BK.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DMcCormack%26aufirst%3DS.%2BL.%26aulast%3DManary%26aufirst%3DM.%2BJ.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DKumar%26aufirst%3DT.%2BR.%2BS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DRameh%26aufirst%3DL.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DTimmerman%26aufirst%3DM.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520Plasmodium%2520PI%25284%2529K%2520to%2520Eliminate%2520Malaria%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature12782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boullé, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriprawat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDew-White, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-resistant <i>Plasmodium Falciparum</i> K13 Mutant Alleles, Thailand–Myanmar Border</span>. <i>Emerg. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1505</span>, <span class="refDoi"> DOI: 10.3201/eid2208.160004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.3201%2Feid2208.160004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=27433806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A280%3ADC%252BC2s3itlSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1503-1505&author=M.+Boull%C3%A9author=B.+Witkowskiauthor=V.+Duruauthor=K.+Sriprawatauthor=S.+K.+Nairauthor=M.+McDew-Whiteauthor=T.+J.+C.+Andersonauthor=A.+P.+Phyoauthor=D.+Menardauthor=F.+Nosten&title=Artemisinin-resistant+Plasmodium+Falciparum+K13+Mutant+Alleles%2C+Thailand%E2%80%93Myanmar+Border&doi=10.3201%2Feid2208.160004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border</span></div><div class="casAuthors">Boulle Mikael; Witkowski Benoit; Duru Valentine; Sriprawat Kanlaya; Nair Shalini K; McDew-White Marina; Anderson Tim J C; Phyo Aung Pyae; Menard Didier; Nosten Francois</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1503-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS333hXxw2omCCEBeYuoi7AfW6udTcc2eYvQLC8oifM_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3itlSrtw%253D%253D&md5=ed366660db2212e0f87353b146a258a2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3201%2Feid2208.160004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid2208.160004%26sid%3Dliteratum%253Aachs%26aulast%3DBoull%25C3%25A9%26aufirst%3DM.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DSriprawat%26aufirst%3DK.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DMcDew-White%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26atitle%3DArtemisinin-resistant%2520Plasmodium%2520Falciparum%2520K13%2520Mutant%2520Alleles%252C%2520Thailand%25E2%2580%2593Myanmar%2520Border%26jtitle%3DEmerg.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D22%26spage%3D1503%26epage%3D1505%26doi%3D10.3201%2Feid2208.160004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariën, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliën, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilatte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilissen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vreys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talloen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goris, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Jardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janicot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Emelen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angibaud, P.</span></span> <span> </span><span class="NLM_article-title">JNJ-26481585, a Novel “Second-generation” Oral Histone Deacetylase Inhibitor, Shows Broad-spectrum Preclinical Antitumoral Activity</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6841</span>– <span class="NLM_lpage">6851</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-0547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1158%2F1078-0432.CCR-09-0547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=19861438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=6841-6851&author=J.+Artsauthor=P.+Kingauthor=A.+Mari%C3%ABnauthor=W.+Florenauthor=A.+Beli%C3%ABnauthor=L.+Janssenauthor=I.+Pilatteauthor=B.+Rouxauthor=L.+Decraneauthor=R.+Gilissenauthor=I.+Hicksonauthor=V.+Vreysauthor=E.+Coxauthor=K.+Bolauthor=W.+Talloenauthor=I.+Gorisauthor=L.+Andriesauthor=M.+Du+Jardinauthor=M.+Janicotauthor=M.+Pageauthor=K.+van+Emelenauthor=P.+Angibaud&title=JNJ-26481585%2C+a+Novel+%E2%80%9CSecond-generation%E2%80%9D+Oral+Histone+Deacetylase+Inhibitor%2C+Shows+Broad-spectrum+Preclinical+Antitumoral+Activity&doi=10.1158%2F1078-0432.CCR-09-0547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity</span></div><div class="casAuthors">Arts, Janine; King, Peter; Marien, Ann; Floren, Wim; Belien, Ann; Janssen, Lut; Pilatte, Isabelle; Roux, Bruno; Decrane, Laurence; Gilissen, Ron; Hickson, Ian; Vreys, Veronique; Cox, Eugene; Bol, Kees; Talloen, Willem; Goris, Ilse; Andries, Luc; Du Jardin, Marc; Janicot, Michel; Page, Martin; van Emelen, Kristof; Angibaud, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6841-6851</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Histone deacetylase (HDAC) inhibitors have shown promising clin. activity in the treatment of hematol. malignancies, but their activity in solid tumor indications has been limited.  Most HDAC inhibitors in clin. development only transiently induce histone acetylation in tumor tissue.  Here, we sought to identify a "second-generation" class I HDAC inhibitor with prolonged pharmacodynamic response in vivo, to assess whether this results in superior antitumoral efficacy.  Exptl. Design: To identify novel HDAC inhibitors with superior pharmacodynamic properties, we developed a preclin. in vivo tumor model, in which tumor cells have been engineered to express fluorescent protein dependent on HDAC1 inhibition, thereby allowing noninvasive real-time evaluation of the tumor response to HDAC inhibitors.  Results: In vivo pharmacodynamic anal. of 140 potent pyrimidyl-hydroxamic acid analogs resulted in the identification of JNJ-26481585.  Once daily oral administration of JNJ-26481585 induced continuous histone H3 acetylation.  The prolonged pharmacodynamic response translated into complete tumor growth inhibition in Ras mutant HCT116 colon carcinoma xenografts, whereas 5-fluorouracil was less active.  JNJ-26481585 also fully inhibited the growth of C170HM2 colorectal liver metastases, whereas again 5-fluorouracil/Leucovorin showed modest activity.  Further characterization revealed that JNJ-26481585 is a pan-HDAC inhibitor with marked potency toward HDAC1 (IC50, 0.16 nmol/L).  Conclusions: The potent antitumor activity as a single agent in preclin. models combined with its favorable pharmacodynamic profile makes JNJ-26481585 a promising "second-generation" HDAC inhibitor.  The compd. is currently in clin. studies, to evaluate its potential applicability in a broad spectrum of both solid and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKc9hyMiADZrVg90H21EOLACvtfcHk0lgGZG8DilufDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ktLzE&md5=8f199c25c92c967a76f273d879d6c577</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0547%26sid%3Dliteratum%253Aachs%26aulast%3DArts%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DMari%25C3%25ABn%26aufirst%3DA.%26aulast%3DFloren%26aufirst%3DW.%26aulast%3DBeli%25C3%25ABn%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DL.%26aulast%3DPilatte%26aufirst%3DI.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DDecrane%26aufirst%3DL.%26aulast%3DGilissen%26aufirst%3DR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DVreys%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DE.%26aulast%3DBol%26aufirst%3DK.%26aulast%3DTalloen%26aufirst%3DW.%26aulast%3DGoris%26aufirst%3DI.%26aulast%3DAndries%26aufirst%3DL.%26aulast%3DDu%2BJardin%26aufirst%3DM.%26aulast%3DJanicot%26aufirst%3DM.%26aulast%3DPage%26aufirst%3DM.%26aulast%3Dvan%2BEmelen%26aufirst%3DK.%26aulast%3DAngibaud%26aufirst%3DP.%26atitle%3DJNJ-26481585%252C%2520a%2520Novel%2520%25E2%2580%259CSecond-generation%25E2%2580%259D%2520Oral%2520Histone%2520Deacetylase%2520Inhibitor%252C%2520Shows%2520Broad-spectrum%2520Preclinical%2520Antitumoral%2520Activity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D6841%26epage%3D6851%26doi%3D10.1158%2F1078-0432.CCR-09-0547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prommana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uthaipibull, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongsombat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamchonwongpaisan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuthavong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuepfer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. J.</span></span> <span> </span><span class="NLM_article-title">Inducible Knockdown of <i>Plasmodium</i> Gene Expression Using the <i>glmS</i> Ribozyme</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73783</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1371%2Fjournal.pone.0073783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24023691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=P.+Prommanaauthor=C.+Uthaipibullauthor=C.+Wongsombatauthor=S.+Kamchonwongpaisanauthor=Y.+Yuthavongauthor=E.+Knuepferauthor=A.+A.+Holderauthor=P.+J.+Shaw&title=Inducible+Knockdown+of+Plasmodium+Gene+Expression+Using+the+glmS+Ribozyme&doi=10.1371%2Fjournal.pone.0073783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Inducible knockdown of Plasmodium gene expression using the glmS ribozyme</span></div><div class="casAuthors">Prommana, Parichat; Uthaipibull, Chairat; Wongsombat, Chayaphat; Kamchonwongpaisan, Sumalee; Yuthavong, Yongyuth; Knuepfer, Ellen; Holder, Anthony A.; Shaw, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e73783</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Conventional reverse genetic approaches for study of Plasmodium malaria parasite gene function are limited, or not applicable.  Hence, new inducible systems are needed.  Here we describe a method to control P. falciparum gene expression in which target genes bearing a glmS ribozyme in the 3' untranslated region are efficiently knocked down in transgenic P. falciparum parasites in response to glucosamine inducer.  Using reporter genes, we show that the glmS ribozyme cleaves reporter mRNA in vivo leading to redn. in mRNA expression following glucosamine treatment.  Glucosamine-induced ribozyme activation led to efficient redn. of reporter protein, which could be rapidly reversed by removing the inducer.  The glmS ribozyme was validated as a reverse-genetic tool by integration into the essential gene and antifolate drug target dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).  Glucosamine treatment of transgenic parasites led to rapid and efficient knockdown of PfDHFR-TS mRNA and protein.  PfDHFR-TS knockdown led to a growth/arrest mutant phenotype and hypersensitivity to pyrimethamine.  The glmS ribozyme may thus be a tool for study of essential genes in P. falciparum and other parasite species amenable to transfection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9O7ED3rN_XbVg90H21EOLACvtfcHk0lg-qr9nxiC3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLnK&md5=8139aa444ad0931c0487ab01edf4ebc1</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073783%26sid%3Dliteratum%253Aachs%26aulast%3DPrommana%26aufirst%3DP.%26aulast%3DUthaipibull%26aufirst%3DC.%26aulast%3DWongsombat%26aufirst%3DC.%26aulast%3DKamchonwongpaisan%26aufirst%3DS.%26aulast%3DYuthavong%26aufirst%3DY.%26aulast%3DKnuepfer%26aufirst%3DE.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DShaw%26aufirst%3DP.%2BJ.%26atitle%3DInducible%2520Knockdown%2520of%2520Plasmodium%2520Gene%2520Expression%2520Using%2520the%2520glmS%2520Ribozyme%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghorbal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Rubio, J. J.</span></span> <span> </span><span class="NLM_article-title">Genome Editing in the Human Malaria Parasite <i>Plasmodium Falciparum</i> Using the CRISPR-Cas9 System</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1038/nbt.2925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnbt.2925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=24880488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=819-821&author=M.+Ghorbalauthor=M.+Gormanauthor=C.+R.+Macphersonauthor=R.+M.+Martinsauthor=A.+Scherfauthor=J.+J.+Lopez-Rubio&title=Genome+Editing+in+the+Human+Malaria+Parasite+Plasmodium+Falciparum+Using+the+CRISPR-Cas9+System&doi=10.1038%2Fnbt.2925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system</span></div><div class="casAuthors">Ghorbal, Mehdi; Gorman, Molly; MacPherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">819-821</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome manipulation in the malaria parasite Plasmodium falciparum remains largely intractable and improved genomic tools are needed to further understand pathogenesis and drug resistance.  We demonstrated the CRISPR-Cas9 system for use in P. falciparum by disrupting chromosomal loci and generating marker-free, single-nucleotide substitutions with high efficiency.  Addnl., an artemisinin-resistant strain was generated by introducing a previously implicated polymorphism, thus illustrating the value of efficient genome editing in malaria research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlTMgyo5Q0zrVg90H21EOLACvtfcHk0lg-qr9nxiC3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCgtLg%253D&md5=71e895d9c64baa6be829e9e9fb774705</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2925%26sid%3Dliteratum%253Aachs%26aulast%3DGhorbal%26aufirst%3DM.%26aulast%3DGorman%26aufirst%3DM.%26aulast%3DMacpherson%26aufirst%3DC.%2BR.%26aulast%3DMartins%26aufirst%3DR.%2BM.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DLopez-Rubio%26aufirst%3DJ.%2BJ.%26atitle%3DGenome%2520Editing%2520in%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%2520Using%2520the%2520CRISPR-Cas9%2520System%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26spage%3D819%26epage%3D821%26doi%3D10.1038%2Fnbt.2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ontoria, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrigno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biancofiore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malancona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresciani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsale, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veneziano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective Series of Inhibitors of <i>Plasmodium falciparum</i> HDACs</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00468</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00468" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=454-459&author=J.+M.+Ontoriaauthor=G.+Paonessaauthor=S.+Ponziauthor=F.+Ferrignoauthor=E.+Niziauthor=I.+Biancofioreauthor=S.+Malanconaauthor=R.+Grazianiauthor=D.+Robertsauthor=P.+Willisauthor=A.+Brescianiauthor=N.+Gennariauthor=O.+Cecchettiauthor=E.+Monteagudoauthor=M.+V.+Orsaleauthor=M.+Venezianoauthor=A.+Di+Marcoauthor=A.+Cellucciauthor=R.+Lauferauthor=S.+Altamuraauthor=V.+Summaauthor=S.+Harper&title=Discovery+of+a+Selective+Series+of+Inhibitors+of+Plasmodium+falciparum+HDACs&doi=10.1021%2Facsmedchemlett.5b00468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs</span></div><div class="casAuthors">Ontoria, Jesus M.; Paonessa, Giacomo; Ponzi, Simona; Ferrigno, Federica; Nizi, Emanuela; Biancofiore, Ilaria; Malancona, Savina; Graziani, Rita; Roberts, David; Willis, Paul; Bresciani, Alberto; Gennari, Nadia; Cecchetti, Ottavia; Monteagudo, Edith; Orsale, Maria V.; Veneziano, Maria; Di Marco, Annalise; Cellucci, Antonella; Laufer, Ralph; Altamura, Sergio; Summa, Vincenzo; Harper, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a new series of P. falciparum growth inhibitors is described.  Starting from a series of known human class I HDAC inhibitors a SAR exploration based on growth inhibitory activity in parasite and human cells-based assays led to the identification of compds. with submicromolar inhibition of P. falciparum growth (EC50 < 500 nM) and good selectivity over the activity of human HDAC in cells (up to >50-fold).  Inhibition of parasital HDACs as the mechanism of action of this new class of selective growth inhibitors is supported by hyperacetylation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2IhJExDD3WbVg90H21EOLACvtfcHk0liDgmAMAM3eww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqurw%253D&md5=e0155db1e624465bf36caf13b3a14271</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00468%26sid%3Dliteratum%253Aachs%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DFerrigno%26aufirst%3DF.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DBiancofiore%26aufirst%3DI.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DGraziani%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DWillis%26aufirst%3DP.%26aulast%3DBresciani%26aufirst%3DA.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DCecchetti%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DOrsale%26aufirst%3DM.%2BV.%26aulast%3DVeneziano%26aufirst%3DM.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DCellucci%26aufirst%3DA.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520Series%2520of%2520Inhibitors%2520of%2520Plasmodium%2520falciparum%2520HDACs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D454%26epage%3D459%26doi%3D10.1021%2Facsmedchemlett.5b00468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayavara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavstsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theander, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aravind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. H.</span></span> <span> </span><span class="NLM_article-title"><i>Pf</i>SETvs Methylation of Histone H3K36 Represses Virulence Genes in <i>Plasmodium falciparum</i></span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>499</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1038/nature12361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1038%2Fnature12361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=23823717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2013&pages=223-227&author=L.+Jiangauthor=J.+Muauthor=Q.+Zhangauthor=T.+Niauthor=P.+Srinivasanauthor=K.+Rayavaraauthor=W.+Yangauthor=L.+Turnerauthor=T.+Lavstsenauthor=T.+G.+Theanderauthor=W.+Pengauthor=G.+Weiauthor=Q.+Jingauthor=Y.+Wakabayashiauthor=A.+Bansalauthor=Y.+Luoauthor=J.+M.+C.+Ribeiroauthor=A.+Scherfauthor=L.+Aravindauthor=J.+Zhuauthor=K.+Zhaoauthor=L.+H.+Miller&title=PfSETvs+Methylation+of+Histone+H3K36+Represses+Virulence+Genes+in+Plasmodium+falciparum&doi=10.1038%2Fnature12361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum</span></div><div class="casAuthors">Jiang, Lubin; Mu, Jianbing; Zhang, Qingfeng; Ni, Ting; Srinivasan, Prakash; Rayavara, Kempaiah; Yang, Wenjing; Turner, Louise; Lavstsen, Thomas; Theander, Thor G.; Peng, Weiqun; Wei, Guiying; Jing, Qingqing; Wakabayashi, Yoshiyuki; Bansal, Abhisheka; Luo, Yan; Ribeiro, Jose M. C.; Scherf, Artur; Aravind, L.; Zhu, Jun; Zhao, Keji; Miller, Louis H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">499</span>
        (<span class="NLM_cas:issue">7457</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is expressed on the surface of P. falciparum-infected red blood cells, is a crit. virulence factor for malaria.  Each parasite has 60 antigenically distinct var genes that each code for a different PfEMP1 protein.  During infection, the clonal parasite population expresses only one gene at a time before switching to the expression of a new variant antigen as an immune-evasion mechanism to avoid the host antibody response.  The mechanism by which 59 of the 60 var genes are silenced remains largely unknown.  Here, the authors show that knocking out the P. falciparum variant-silencing SET gene (here termed PfSETvs), which encodes an ortholog of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, results in the transcription of virtually all var genes in the single parasite nuclei and their expression as proteins on the surface of individual infected red blood cells.  PfSETvs-dependent H3K36me3 is present along the entire gene body, including the transcription start site, to silence var genes.  With low occupancy of PfSETvs at both the transcription start site of var genes and the intronic promoter, expression of var genes coincides with transcription of their corresponding antisense long noncoding RNA.  These results uncover a previously unknown role of PfSETvs-dependent H3K36me3 in silencing var genes in P. falciparum that might provide a general mechanism by which orthologues of PfSETvs repress gene expression in other eukaryotes.  PfSETvs knockout parasites expressing all PfEMP1 proteins may also be applied to the development of a malaria vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2fB2f-8mUPbVg90H21EOLACvtfcHk0liDgmAMAM3eww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsr%252FM&md5=7c507e7aecd5b158738965204ebcb4fb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnature12361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12361%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DNi%26aufirst%3DT.%26aulast%3DSrinivasan%26aufirst%3DP.%26aulast%3DRayavara%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DTurner%26aufirst%3DL.%26aulast%3DLavstsen%26aufirst%3DT.%26aulast%3DTheander%26aufirst%3DT.%2BG.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DWakabayashi%26aufirst%3DY.%26aulast%3DBansal%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DAravind%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DL.%2BH.%26atitle%3DPfSETvs%2520Methylation%2520of%2520Histone%2520H3K36%2520Represses%2520Virulence%2520Genes%2520in%2520Plasmodium%2520falciparum%26jtitle%3DNature%26date%3D2013%26volume%3D499%26spage%3D223%26epage%3D227%26doi%3D10.1038%2Fnature12361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and Inexpensive Fluorescence-based Technique for High-throughput Antimalarial Drug Screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+Inexpensive+Fluorescence-based+Technique+for+High-throughput+Antimalarial+Drug+Screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lj0asQsHwztbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520Inexpensive%2520Fluorescence-based%2520Technique%2520for%2520High-throughput%2520Antimalarial%2520Drug%2520Screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinzei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuda, M.</span></span> <span> </span><span class="NLM_article-title">A Calcium-dependent Protein Kinase Regulates <i>Plasmodium</i> Ookinete Access to the Midgut Epithelial Cell</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.05014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1111%2Fj.1365-2958.2005.05014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=16430692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD28XislWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=1175-1184&author=T.+Ishinoauthor=Y.+Oritoauthor=Y.+Chinzeiauthor=M.+Yuda&title=A+Calcium-dependent+Protein+Kinase+Regulates+Plasmodium+Ookinete+Access+to+the+Midgut+Epithelial+Cell&doi=10.1111%2Fj.1365-2958.2005.05014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A calcium-dependent protein kinase regulates Plasmodium ookinete access to the midgut epithelial cell</span></div><div class="casAuthors">Ishino, Tomoko; Orito, Yuki; Chinzel, Yasuo; Yuda, Masao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Plasmodium parasites are fertilized in the mosquito midgut and develop into motile zygotes, called ookinetes, which invade the midgut epithelium.  Here we show that a calcium-dependent protein kinase, CDPK3, of the rodent malarial parasite (Plasmodium berghei) is produced in the ookinete stage and has a crit. role in parasite transmission to the mosquito vector.  Targeted disruption of the CDPK3 gene decreased ookinete ability to infect the mosquito midgut by nearly two orders of magnitude.  Electron microscopic analyses demonstrated that the disruptant ookinetes could not access midgut epithelial cells by traversing the layer covering the cell surface.  An in vitro migration assay showed that these ookinetes lack the ability to migrate through an artificial gel, suggesting that this defect caused their failure to access the epithelium.  In vitro migration assays also suggested that this motility is induced in the wild type by mobilization of intracellular stored calcium.  These results indicate that a signaling pathway involving calcium and CDPK3 regulates ookinete penetration of the layer covering the midgut epithelium.  Because humans do not possess CDPK family proteins, CDPK3 is a good target for blocking malarial transmission to the mosquito vector.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlHpqhGhm7nbVg90H21EOLACvtfcHk0lj0asQsHwztbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislWhsro%253D&md5=0298f9942e050150a025c8914d138d6c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.05014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.05014.x%26sid%3Dliteratum%253Aachs%26aulast%3DIshino%26aufirst%3DT.%26aulast%3DOrito%26aufirst%3DY.%26aulast%3DChinzei%26aufirst%3DY.%26aulast%3DYuda%26aufirst%3DM.%26atitle%3DA%2520Calcium-dependent%2520Protein%2520Kinase%2520Regulates%2520Plasmodium%2520Ookinete%2520Access%2520to%2520the%2520Midgut%2520Epithelial%2520Cell%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D59%26spage%3D1175%26epage%3D1184%26doi%3D10.1111%2Fj.1365-2958.2005.05014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brancucci, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederwieser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wampfler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freymond, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T. S.</span></span> <span> </span><span class="NLM_article-title">Heterochromatin Protein 1 Secures Survival and Transmission of Malaria Parasites</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=10.1016%2Fj.chom.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=25121746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=165-176&author=N.+M.+B.+Brancucciauthor=N.+L.+Bertschiauthor=L.+Zhuauthor=I.+Niederwieserauthor=W.+H.+Chinauthor=R.+Wampflerauthor=C.+Freymondauthor=M.+Rottmannauthor=I.+Felgerauthor=Z.+Bozdechauthor=T.+S.+Voss&title=Heterochromatin+Protein+1+Secures+Survival+and+Transmission+of+Malaria+Parasites&doi=10.1016%2Fj.chom.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Heterochromatin Protein 1 Secures Survival and Transmission of Malaria Parasites</span></div><div class="casAuthors">Brancucci, Nicolas M. B.; Bertschi, Nicole L.; Zhu, Lei; Niederwieser, Igor; Chin, Wai Hoe; Wampfler, Rahel; Freymond, Celine; Rottmann, Matthias; Felger, Ingrid; Bozdech, Zbynek; Voss, Till S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clonally variant expression of surface antigens allows the malaria parasite Plasmodium falciparum to evade immune recognition during blood stage infection and secure malaria transmission.  We demonstrate that heterochromatin protein 1 (HP1), an evolutionary conserved regulator of heritable gene silencing, controls expression of numerous P. falciparum virulence genes as well as differentiation into the sexual forms that transmit to mosquitoes.  Conditional depletion of P. falciparum HP1 (PfHP1) prevents mitotic proliferation of blood stage parasites and disrupts mutually exclusive expression and antigenic variation of the major virulence factor PfEMP1.  Addnl., PfHP1-dependent regulation of PfAP2-G, a transcription factor required for gametocyte conversion, controls the switch from asexual proliferation to sexual differentiation, providing insight into the epigenetic mechanisms underlying gametocyte commitment.  These findings show that PfHP1 is centrally involved in clonally variant gene expression and sexual differentiation in P. falciparum and have major implications for developing antidisease and transmission-blocking interventions against malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7HbcmA9FpHbVg90H21EOLACvtfcHk0lgeePA9uIBbdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KqsrfJ&md5=102db8673da3841a859d3eae9a828c3d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrancucci%26aufirst%3DN.%2BM.%2BB.%26aulast%3DBertschi%26aufirst%3DN.%2BL.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DNiederwieser%26aufirst%3DI.%26aulast%3DChin%26aufirst%3DW.%2BH.%26aulast%3DWampfler%26aufirst%3DR.%26aulast%3DFreymond%26aufirst%3DC.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DFelger%26aufirst%3DI.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DVoss%26aufirst%3DT.%2BS.%26atitle%3DHeterochromatin%2520Protein%25201%2520Secures%2520Survival%2520and%2520Transmission%2520of%2520Malaria%2520Parasites%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2014%26volume%3D16%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.chom.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoy, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billadeau, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">A Series of Potent and Selective, Triazolylphenyl-based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and <i>Plasmodium Falciparum</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3448</span>, <span class="refDoi"> DOI: 10.1021/jm701606b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701606b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3437-3448&author=Y.+Chenauthor=M.+Lopez-Sanchezauthor=D.+N.+Savoyauthor=D.+D.+Billadeauauthor=G.+S.+Dowauthor=A.+P.+Kozikowski&title=A+Series+of+Potent+and+Selective%2C+Triazolylphenyl-based+Histone+Deacetylases+Inhibitors+with+Activity+against+Pancreatic+Cancer+Cells+and+Plasmodium+Falciparum&doi=10.1021%2Fjm701606b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum</span></div><div class="casAuthors">Chen, Yufeng; Lopez-Sanchez, Miriam; Savoy, Doris N.; Billadeau, Daniel D.; Dow, Geoffrey S.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3437-3448</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the rules governing the inhibition of the various HDAC isoforms is likely to be key to identifying improved therapeutics that act as epigenetic modulators of gene transcription.  Herein we present results on the modification of the CAP region of a set of triazolylphenyl-based HDACIs, and show that the nature of substitution on the Ph ring plays a role in their selectivity for HDAC1 vs. HDAC6, with low to moderate selectivity (2-51-fold) being achieved.  In light of the valuable selectivity and potency that were identified for the triazolylphenyl ligand 6b in the inhibition of HDAC6 (IC50 = 1.9 nM), this compd. represents a valuable research tool and a candidate for further chem. modifications.  Lastly, these new HDACIs were studied for both their anticancer and antimalarial activity, which serve to validate the superior activity of the HDACI 10c.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtC-MXCaqyVLVg90H21EOLACvtfcHk0lgeePA9uIBbdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtF2rs7c%253D&md5=5a9e96ed8e268a04d387ca1f60b57837</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm701606b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701606b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLopez-Sanchez%26aufirst%3DM.%26aulast%3DSavoy%26aufirst%3DD.%2BN.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DA%2520Series%2520of%2520Potent%2520and%2520Selective%252C%2520Triazolylphenyl-based%2520Histone%2520Deacetylases%2520Inhibitors%2520with%2520Activity%2520against%2520Pancreatic%2520Cancer%2520Cells%2520and%2520Plasmodium%2520Falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3437%26epage%3D3448%26doi%3D10.1021%2Fjm701606b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i84"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02104">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57876"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02104?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02104</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC analysis data and purity spectra of compounds <b>2–32</b>, Body weight date of <i>in vivo</i> erythrocytic antimalarial assay, schematic diagram, and PCR identification and primers of <i>Pf</i>HDAC1 and <i>Pf</i>HDAC2 gene editing (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_001.pdf">jm0c02104_si_001.pdf (1.67 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02104/suppl_file/jm0c02104_si_002.csv">jm0c02104_si_002.csv (4.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02104&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02104%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02104" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799972bbcdf2521","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
